SHP2-interacting	B-protein
transmembrane	I-protein
adaptor	I-protein
protein	I-protein
(	O
SIT	B-protein
)	O
,	O
a	O
novel	O
disulfide-linked	B-protein
dimer	I-protein
regulating	O
human	O
T	O
cell	O
activation	O
.	O

T	B-cell_type
lymphocytes	I-cell_type
express	O
several	O
low	B-protein
molecular	I-protein
weight	I-protein
transmembrane	I-protein
adaptor	I-protein
proteins	I-protein
that	O
recruit	O
src	B-protein
homology	I-protein
(	I-protein
SH	I-protein
)	I-protein
2	I-protein
domain-containing	I-protein
intracellular	I-protein
molecules	I-protein
to	O
the	O
cell	O
membrane	O
via	O
tyrosine-based	O
signaling	O
motifs	O
.	O

We	O
describe	O
here	O
a	O
novel	O
molecule	O
of	O
this	O
group	O
termed	O
SIT	B-protein
(	O
SHP2	B-protein
interacting	I-protein
transmembrane	I-protein
adaptor	I-protein
protein	I-protein
)	O
.	O

SIT	B-protein
is	O
a	O
disulfide-linked	B-protein
homodimeric	I-protein
glycoprotein	I-protein
that	O
is	O
expressed	O
in	O
lymphocytes	B-cell_type
.	O

After	O
tyrosine	O
phosphorylation	O
by	O
src	B-protein
and	O
possibly	O
syk	B-protein
protein	B-protein
tyrosine	I-protein
kinases	I-protein
SIT	B-protein
recruits	O
the	O
SH2	B-protein
domain-containing	I-protein
tyrosine	I-protein
phosphatase	I-protein
SHP2	B-protein
via	O
an	O
immunoreceptor	O
tyrosine-based	O
inhibition	O
motif	O
.	O

Overexpression	O
of	O
SIT	B-protein
in	O
Jurkat	B-cell_line
cells	I-cell_line
downmodulates	O
T	O
cell	O
receptor-	O
and	O
phytohemagglutinin-mediated	O
activation	O
of	O
the	O
nuclear	B-protein
factor	I-protein
of	I-protein
activated	I-protein
T	I-protein
cells	I-protein
(	O
NF-AT	B-protein
)	O
by	O
interfering	O
with	O
signaling	O
processes	O
that	O
are	O
probably	O
located	O
upstream	O
of	O
activation	O
of	O
phospholipase	B-protein
C	I-protein
.	O

However	O
,	O
binding	O
of	O
SHP2	B-protein
to	O
SIT	B-protein
is	O
not	O
required	O
for	O
inhibition	O
of	O
NF-AT	B-protein
induction	O
,	O
suggesting	O
that	O
SIT	B-protein
not	O
only	O
regulates	O
NF-AT	B-protein
activity	O
but	O
also	O
controls	O
NF-AT	B-protein
unrelated	O
pathways	O
of	O
T	O
cell	O
activation	O
involving	O
SHP2	B-protein
.	O

SHP2-interacting	NULL
Transmembrane	NULL
Adaptor	NULL
Protein	NULL
(	NULL
SIT	NULL
)	NULL
,	NULL
A	NULL
Novel	NULL
Disulfide-linked	NULL
Dimer	NULL
Regulating	NULL
Human	NULL
T	NULL
Cell	NULL
Activation	NULL
By	NULL
Anne	NULL
Marie-Cardine	NULL
,	NULL
*	NULL
Henning	NULL
Kirchgessner	NULL
,	NULL
*	NULL
Eddy	NULL
Bruyns	NULL
,	NULL
*	NULL
Andrej	NULL
Shevchenko,8	NULL
Matthias	NULL
Mann	NULL
,	NULL
$	NULL
Frank	NULL
Autschbach	NULL
,	NULL
t	NULL
Sheldon	NULL
R	NULL
atnofsky	NULL
,	NULL
Stefan	NULL
Meuer	NULL
,	NULL
*	NULL
and	NULL
Burkhart	NULL
Schraven*	NULL
From	NULL
the	NULL
*	NULL
Immunomodulation	NULL
Laboratory	NULL
of	NULL
the	NULL
Institute	NULL
for	NULL
Immunology	NULL
,	NULL
and	NULL
the	NULL
*Institute	NULL
for	NULL
Pathology	NULL
,	NULL
University	NULL
of	NULL
Heidelberg	NULL
69120	NULL
Heidelberg	NULL
Germany	NULL
;	NULL
the	NULL
$	NULL
Protein	NULL
and	NULL
Peptide	NULL
Group	NULL
,	NULL
European	NULL
Molecular	NULL
Biology	NULL
Laboratories	NULL
69117	NULL
Heidelberg	NULL
Germany	NULL
;	NULL
and	NULL
the	NULL
IBA	NULL
SF	NULL
Bioresearch	NULL
Corporation	NULL
,	NULL
Worcester	NULL
Massachusetts	NULL
01605	NULL
Summary	NULL
T	NULL
lymphocytes	NULL
express	NULL
several	NULL
low	NULL
molecular	NULL
weight	NULL
transmembrane	NULL
adaptor	NULL
proteins	NULL
that	NULL
recruit	NULL
src	NULL
homology	NULL
(	NULL
SH	NULL
)	NULL
2	NULL
domain-containing	NULL
intracellular	NULL
molecules	NULL
to	NULL
the	NULL
cell	NULL
membrane	NULL
via	NULL
tyrosine-based	NULL
signaling	NULL
motifs	NULL
.	NULL

We	NULL
describe	NULL
here	NULL
a	NULL
novel	NULL
molecule	NULL
of	NULL
this	NULL
group	NULL
termed	NULL
SIT	NULL
(	NULL
SHP2	NULL
interacting	NULL
transmembrane	NULL
adaptor	NULL
protein	NULL
)	NULL
.	NULL

SIT	NULL
is	NULL
a	NULL
disulfide-linked	NULL
homodimeric	NULL
glycoprotein	NULL
that	NULL
is	NULL
expressed	NULL
in	NULL
lymphocytes	NULL
.	NULL

After	NULL
tyrosine	NULL
phosphorylation	NULL
by	NULL
src	NULL
and	NULL
possibly	NULL
syk	NULL
protein	NULL
tyrosine	NULL
kinases	NULL
SIT	NULL
recruits	NULL
the	NULL
SH2	NULL
domain-containing	NULL
tyrosine	NULL
phosphatase	NULL
SHP2	NULL
via	NULL
an	NULL
immunoreceptor	NULL
tyrosine-	NULL
based	NULL
inhibition	NULL
motif	NULL
.	NULL

Overexpression	NULL
of	NULL
SIT	NULL
in	NULL
Jurkat	NULL
cells	NULL
downmodulates	NULL
T	NULL
cell	NULL
receptor-	NULL
and	NULL
phytohemagglutinin-mediated	NULL
activation	NULL
of	NULL
the	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
NF-AT	NULL
)	NULL
by	NULL
interfering	NULL
with	NULL
signaling	NULL
processes	NULL
that	NULL
are	NULL
probably	NULL
located	NULL
upstream	NULL
of	NULL
activation	NULL
of	NULL
phospholipase	NULL
C.	NULL
However	NULL
,	NULL
binding	NULL
of	NULL
SHP2	NULL
to	NULL
SIT	NULL
is	NULL
not	NULL
required	NULL
for	NULL
inhibition	NULL
of	NULL
NF-AT	NULL
induction	NULL
,	NULL
suggesting	NULL
that	NULL
SIT	NULL
not	NULL
only	NULL
regulates	NULL
NF-AT	NULL
activity	NULL
but	NULL
also	NULL
controls	NULL
NF-AT	NULL
unrelated	NULL
pathways	NULL
of	NULL
T	NULL
cell	NULL
activation	NULL
involving	NULL
SHP2	NULL
.	NULL

Key	NULL
words	NULL
:	NULL
transduction	NULL
fter	NULL
binding	NULL
of	NULL
peptide-MHC	NULL
to	NULL
the	NULL
TCR	NULL
complex	NULL
,	NULL
a	NULL
ascade	NULL
of	NULL
biochemical	NULL
events	NULL
is	NULL
initiated	NULL
that	NULL
lead	NULL
fi-	NULL
nally	NULL
to	NULL
T	NULL
cell	NULL
proliferation	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

Among	NULL
the	NULL
earliest	NULL
signals	NULL
that	NULL
can	NULL
be	NULL
detected	NULL
after	NULL
triggering	NULL
of	NULL
the	NULL
TCR	NULL
are	NULL
increases	NULL
in	NULL
enzymatic	NULL
activities	NULL
of	NULL
cytoplasmic	NULL
protein	NULL
tyrosine	NULL
kinases	NULL
(	NULL
PTKs	NULL
)	NULL
,	NULL
'	NULL
including	NULL
the	NULL
src	NULL
kinases	NULL
p56	NULL
and	NULL
as	NULL
well	NULL
as	NULL
the	NULL
syk-related	NULL
PTKs	NULL
and	NULL
ZAP70	NULL
.	NULL

These	NULL
tyrosine	NULL
kinases	NULL
phosphorylate	NULL
intracellular	NULL
proteins	NULL
that	NULL
transmit	NULL
the	NULL
signal	NULL
further	NULL
into	NULL
the	NULL
intracellular	NULL
envi-	NULL
Anne	NULL
Maric-Cardine	NULL
and	NULL
Henning	NULL
Kirchgessner	NULL
contributed	NULL
equally	NULL
to	NULL
this	NULL
work	NULL
.	NULL
'	NULL

A	NULL
bbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
aa	NULL
,	NULL
amino	NULL
acid	NULL
;	NULL
EST	NULL
,	NULL
expressed	NULL
sequence	NULL
tag	NULL
;	NULL
Grb2	NULL
,	NULL
growth	NULL
factor	NULL
receptor	NULL
binding	NULL
protein	NULL
2	NULL
;	NULL
IEF	NULL
,	NULL
isoelectric	NULL
fo-cusing	NULL
;	NULL
ITAM	NULL
,	NULL
immunoreceptor	NULL
tyrosine-based	NULL
activation	NULL
motif	NULL
,	NULL
ITIM	NULL
,	NULL
immunoreceptor	NULL
tyrosine	NULL
based	NULL
inhibition	NULL
motif	NULL
;	NULL
LAT	NULL
,	NULL
linker	NULL
for	NULL
activation	NULL
of	NULL
T	NULL
cells	NULL
;	NULL
NF-AT	NULL
,	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
,	NULL
PI3-K	NULL
,	NULL
phos-phatidylinositol	NULL
3-kinase	NULL
;	NULL
PLC	NULL
,	NULL
phospholipase	NULL
C	NULL
;	NULL
PTK	NULL
,	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
;	NULL
PT	NULL
YR	NULL
,	NULL
phosphotyrosine	NULL
;	NULL
SH	NULL
,	NULL
src	NULL
homology	NULL
;	NULL
SHIP	NULL
,	NULL
SH2	NULL
containing	NULL
inositol	NULL
phosphatase	NULL
;	NULL
SHP	NULL
,	NULL
SH2	NULL
containing	NULL
protein	NULL
tyrosine	NULL
phosphatase	NULL
;	NULL
SIT	NULL
,	NULL
SHP2-interacting	NULL
transmembrane	NULL
adaptor	NULL
protein	NULL
;	NULL
SLP	NULL
,	NULL
SH2	NULL
domain	NULL
containing	NULL
leukocyte	NULL
phosphoprotein	NULL
;	NULL
TRIM	NULL
,	NULL
T	NULL
cell	NULL
receptor-interacting	NULL
molecule	NULL
.	NULL

1181	NULL
T	NULL
lymphocytes	NULL
Â«	NULL
T	NULL
cell	NULL
receptor	NULL
*	NULL
transmembrane	NULL
adaptor	NULL
proteins	NULL
*	NULL
signal	NULL
ronment	NULL
(	NULL
3	NULL
,	NULL
4	NULL
)	NULL
.	NULL

Among	NULL
a	NULL
plethora	NULL
of	NULL
intracellular	NULL
molecules	NULL
becoming	NULL
tyrosine	NULL
phosphorylated	NULL
,	NULL
several	NULL
polypeptides	NULL
have	NULL
been	NULL
identified	NULL
that	NULL
are	NULL
collectively	NULL
called	NULL
adaptor	NULL
proteins	NULL
(	NULL
for	NULL
review	NULL
see	NULL
references	NULL
5-7	NULL
)	NULL
.	NULL

According	NULL
to	NULL
their	NULL
definition	NULL
,	NULL
adaptor	NULL
proteins	NULL
lack	NULL
an	NULL
enzymatic	NULL
function	NULL
but	NULL
are	NULL
capable	NULL
of	NULL
mediating	NULL
noncovalent	NULL
protein-protein	NULL
interactions	NULL
with	NULL
other	NULL
signal-	NULL
transducing	NULL
molecules	NULL
via	NULL
tyro-sine-	NULL
based	NULL
signaling	NULL
motifs	NULL
(	NULL
8	NULL
)	NULL
or	NULL
modular	NULL
binding	NULL
domains	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
sic	NULL
homology	NULL
[	NULL
SH	NULL
]	NULL
2	NULL
,	NULL
SH3	NULL
,	NULL
pleckstrin	NULL
homology	NULL
,	NULL
WW	NULL
,	NULL
phosphotyrosine	NULL
[	NULL
PTYR	NULL
]	NULL
-binding	NULL
,	NULL
and	NULL
PDZ	NULL
domains	NULL
;	NULL
references	NULL
9-12	NULL
)	NULL
.	NULL

Adaptor	NULL
proteins	NULL
expressed	NULL
in	NULL
T	NULL
lymphocytes	NULL
include	NULL
Grb2	NULL
,	NULL
src	NULL
homologous	NULL
and	NULL
collagen	NULL
protein	NULL
(	NULL
SHC	NULL
)	NULL
,	NULL
SH2	NULL
domain-containing	NULL
leukocyte	NULL
phosphoprotein	NULL
(	NULL
SLP	NULL
)	NULL
-76	NULL
,	NULL
SLP-76-associated	NULL
phosphoprotein	NULL
(	NULL
SLAP	NULL
)	NULL
-130	NULL
,	NULL
src	NULL
kinase-associated	NULL
phosphoprotein	NULL
(	NULL
SKAP	NULL
)	NULL
55	NULL
,	NULL
and	NULL
SKAP-homologue	NULL
(	NULL
HOM	NULL
)	NULL
(	NULL
13-19	NULL
)	NULL
.	NULL

Most	NULL
recently	NULL
,	NULL
experimental	NULL
evidence	NULL
has	NULL
been	NULL
accumulated	NULL
showing	NULL
that	NULL
besides	NULL
cytoplasmic	NULL
adaptor	NULL
proteins	NULL
,	NULL
T	NULL
lymphocytes	NULL
express	NULL
low	NULL
mol	NULL
wt	NULL
transmembrane	NULL
proteins	NULL
that	NULL
are	NULL
characterized	NULL
by	NULL
short	NULL
extracellular	NULL
domains	NULL
and	NULL
comparably	NULL
long	NULL
cytoplasmic	NULL
tails	NULL
The	NULL
cytoplasmic	NULL
domains	NULL
of	NULL
these	NULL
polypeptides	NULL
contain	NULL
tyrosine	NULL
based	NULL
signaling	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

Â©	NULL
The	NULL
R	NULL
ockefeller	NULL
University	NULL
Press	NULL
Â«	NULL
0022-1007/99/	NULL
04/	NULL
1181/	NULL
14	NULL
$	NULL
2.00	NULL
Volume	NULL
189	NULL
,	NULL
Number	NULL
8	NULL
,	NULL
April	NULL
19	NULL
,	NULL
1999	NULL
1181-1194	NULL
http	NULL
:	NULL
//	NULL
www.jem.org	NULL
motifs	NULL
(	NULL
distinct	NULL
from	NULL
ITAMs	NULL
)	NULL
that	NULL
probably	NULL
mediate	NULL
interactions	NULL
with	NULL
the	NULL
SH2	NULL
domains	NULL
of	NULL
intracellular	NULL
signaling	NULL
molecules	NULL
.	NULL

We	NULL
had	NULL
suggested	NULL
calling	NULL
this	NULL
novel	NULL
group	NULL
of	NULL
polypeptides	NULL
transmembrane	NULL
adaptor	NULL
proteins	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Before	NULL
now	NULL
,	NULL
two	NULL
transmembrane	NULL
adaptor	NULL
molecules	NULL
have	NULL
been	NULL
described	NULL
,	NULL
namely	NULL
the	NULL
recently	NULL
cloned	NULL
proteins	NULL
LAT	NULL
(	NULL
linker	NULL
of	NULL
activation	NULL
of	NULL
T	NULL
lymphocytes	NULL
)	NULL
and	NULL
TRIM	NULL
(	NULL
T	NULL
cell	NULL
receptor-interacting	NULL
molecule	NULL
)	NULL
(	NULL
20-22	NULL
)	NULL
.	NULL

Both	NULL
LAT	NULL
and	NULL
TRIM	NULL
are	NULL
reported	NULL
to	NULL
as	NULL
sociate	NULL
with	NULL
intracellular	NULL
signaling	NULL
molecules	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
Grb2	NULL
,	NULL
phospholipase	NULL
C	NULL
[	NULL
PLC	NULL
]	NULL
-y	NULL
,	NULL
SLP-76	NULL
,	NULL
and	NULL
phosphatidylinosi-tol	NULL
3	NULL
kinase	NULL
[	NULL
PI3-K	NULL
]	NULL
)	NULL
after	NULL
tyrosine	NULL
phosphorylation	NULL
.	NULL

In	NULL
this	NULL
study	NULL
we	NULL
report	NULL
the	NULL
identification	NULL
,	NULL
nanoelectrospray	NULL
tandem	NULL
mass	NULL
spectrometry	NULL
sequencing	NULL
,	NULL
molecular	NULL
cloning	NULL
,	NULL
and	NULL
functional	NULL
characterization	NULL
of	NULL
a	NULL
novel	NULL
transmembrane	NULL
adaptor	NULL
protein	NULL
termed	NULL
SIT	NULL
(	NULL
SHP	NULL
?	NULL

-interacting	NULL
transmembrane	NULL
adaptor	NULL
protein	NULL
)	NULL
.	NULL

SIT	NULL
represents	NULL
a	NULL
disulfide-linked	NULL
homodimeric	NULL
lymphocyte-specific	NULL
glycoprotein	NULL
with	NULL
a	NULL
short	NULL
extracellular	NULL
domain	NULL
of	NULL
18	NULL
amino	NULL
acids	NULL
(	NULL
aa	NULL
)	NULL
possessing	NULL
a	NULL
single	NULL
N-linked	NULL
glycosylation	NULL
site	NULL
,	NULL
a	NULL
20-aa	NULL
transmembrane	NULL
re-gion	NULL
,	NULL
and	NULL
a	NULL
136-aa	NULL
cytoplasmic	NULL
tail	NULL
.	NULL

The	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
SIT	NULL
contains	NULL
five	NULL
tyrosine-based	NULL
signaling	NULL
motifs	NULL
that	NULL
could	NULL
mediate	NULL
SH2	NULL
domain-dependent	NULL
interactions	NULL
with	NULL
intracellular	NULL
signaling	NULL
molecules	NULL
.	NULL

Indeed	NULL
,	NULL
after	NULL
T	NULL
cell	NULL
activation	NULL
,	NULL
SIT	NULL
associates	NULL
with	NULL
the	NULL
SH2	NULL
domain-containing	NULL
cytoplasmic	NULL
tyrosine	NULL
phosphatase	NULL
SHP2	NULL
via	NULL
an	NULL
ITIM	NULL
.	NULL

Importantly	NULL
,	NULL
overexpression	NULL
of	NULL
SIT	NULL
in	NULL
Jurkat	NULL
cells	NULL
downmodulates	NULL
TCR-	NULL
and	NULL
PHA-mediated	NULL
induction	NULL
of	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
NF-AT	NULL
)	NULL
activity	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
induction	NULL
of	NULL
NF-AT	NULL
activity	NULL
after	NULL
triggering	NULL
of	NULL
the	NULL
G	NULL
protein-coupled	NULL
muscarinic	NULL
receptor	NULL
is	NULL
not	NULL
influenced	NULL
by	NULL
overexpression	NULL
of	NULL
SIT	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
SIT	NULL
is	NULL
probably	NULL
involved	NULL
in	NULL
an	NULL
unknown	NULL
signaling	NULL
pathway	NULL
that	NULL
regulates	NULL
transcriptional	NULL
activity	NULL
of	NULL
NF-AT	NULL
upstream	NULL
of	NULL
PLC	NULL
.	NULL

However	NULL
,	NULL
overexpression	NULL
of	NULL
a	NULL
mutated	NULL
form	NULL
of	NULL
SIT	NULL
lacking	NULL
the	NULL
SHP2	NULL
binding	NULL
site	NULL
revealed	NULL
that	NULL
the	NULL
association	NULL
between	NULL
SIT	NULL
and	NULL
SHP2	NULL
is	NULL
not	NULL
required	NULL
for	NULL
SIT	NULL
-mediated	NULL
inhibition	NULL
of	NULL
NF-AT	NULL
activity	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
propose	NULL
that	NULL
SIT	NULL
not	NULL
only	NULL
regulates	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
NF-AT	NULL
,	NULL
but	NULL
also	NULL
controls	NULL
NF-AT	NULL
unrelated	NULL
pathways	NULL
of	NULL
T	NULL
cell	NULL
activation	NULL
that	NULL
involve	NULL
SHP2	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Purifiaation	NULL
of	NULL
gp30/	NULL
40	NULL
.	NULL

_	NULL
Purification	NULL
of	NULL
gp30/	NULL
40	NULL
,	NULL
in-	NULL
gel	NULL
diges-tion	NULL
,	NULL
nanoelectrospray	NULL
tandem	NULL
mass	NULL
spectrometric	NULL
sequencing	NULL
,	NULL
and	NULL
assembly	NULL
of	NULL
peptide	NULL
sequence	NULL
tags	NULL
for	NULL
database	NULL
searching	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
20	NULL
,	NULL
23-26	NULL
)	NULL
.	NULL

Peptide	NULL
esterification	NULL
was	NULL
performed	NULL
on	NULL
a	NULL
part	NULL
of	NULL
the	NULL
unseparated	NULL
digest	NULL
by	NULL
treatment	NULL
with	NULL
2	NULL
M	NULL
HCl	NULL
in	NULL
aqueous	NULL
free	NULL
methanol	NULL
for	NULL
45	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

After	NULL
derivatization	NULL
,	NULL
the	NULL
reaction	NULL
mixture	NULL
was	NULL
dried	NULL
in	NULL
a	NULL
vacuum	NULL
centrifuge	NULL
.	NULL

dD	NULL
)	NULL
NA	NULL
Cloning	NULL
.	NULL

Based	NULL
on	NULL
an	NULL
expressed	NULL
sequence	NULL
tag	NULL
(	NULL
EST	NULL
)	NULL
cDNA	NULL
sequence	NULL
corresponding	NULL
to	NULL
the	NULL
(	NULL
YSEVV	NULL
(	NULL
L/	NULL
DDSEPK	NULL
)	NULL
peptide	NULL
obtained	NULL
by	NULL
nanoelectrospray	NULL
sequencing	NULL
of	NULL
purified	NULL
pp29/	NULL
30	NULL
,	NULL
forward	NULL
and	NULL
nested	NULL
forward	NULL
oligonucleotides	NULL
(	NULL
CCTGCCAG-GGCTGCAGAGGAGGTG	NULL
and	NULL
CCCCGAGCCGGAGCTC-TATGCCTC	NULL
)	NULL
and	NULL
reverse	NULL
and	NULL
nested	NULL
reverse	NULL
oligonucleotides	NULL
(	NULL
TGCGGGTCTGGGCACATACTGAGGC	NULL
and	NULL
CACCTCCT-CTGCAGCCCTGGCAGG	NULL
)	NULL
were	NULL
used	NULL
for	NULL
3'-	NULL
and	NULL
5'-rapid	NULL
1182	NULL
amplification	NULL
of	NULL
cDNA	NULL
end	NULL
(	NULL
R	NULL
ACE	NULL
)	NULL
reactions	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
20	NULL
)	NULL
.	NULL

The	NULL
resulting	NULL
products	NULL
were	NULL
purified	NULL
from	NULL
agarose	NULL
gels	NULL
and	NULL
sequenced	NULL
directly	NULL
.	NULL

5'-	NULL
and	NULL
3	NULL
``	NULL
-specific	NULL
primers	NULL
corresponding	NULL
to	NULL
the	NULL
deduced	NULL
untranslated	NULL
regions	NULL
were	NULL
used	NULL
to	NULL
amplify	NULL
the	NULL
complete	NULL
cDN	NULL
A	NULL
,	NULL
which	NULL
was	NULL
double-strand	NULL
sequenced	NULL
.	NULL

For	NULL
cloning	NULL
of	NULL
murine	NULL
gp30/	NULL
40	NULL
,	NULL
a	NULL
partial	NULL
cDN	NULL
A	NULL
was	NULL
generated	NULL
using	NULL
5	NULL
``	NULL
and	NULL
3	NULL
'	NULL
primers	NULL
(	NULL
CAGCAACTTTGACACTGTCAGTG	NULL
and	NULL
ATCCGACCTTGAGCTGGTCGC	NULL
,	NULL
respectively	NULL
)	NULL
deduced	NULL
from	NULL
a	NULL
mouse	NULL
gp30/40	NULL
EST	NULL
clone	NULL
.	NULL

The	NULL
fragment	NULL
was	NULL
then	NULL
used	NULL
for	NULL
screening	NULL
a	NULL
mouse	NULL
genomic	NULL
library	NULL
(	NULL
provided	NULL
by	NULL
Dr.	NULL
K.	NULL
Pfeffer	NULL
,	NULL
Technical	NULL
University	NULL
,	NULL
Munich	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

R	NULL
esulting	NULL
clones	NULL
were	NULL
sequenced	NULL
and	NULL
primers	NULL
specific	NULL
for	NULL
the	NULL
putative	NULL
5	NULL
'	NULL
and	NULL
3	NULL
'	NULL
untranslated	NULL
regions	NULL
were	NULL
used	NULL
to	NULL
amplify	NULL
murine	NULL
gp30/40	NULL
from	NULL
mouse	NULL
thymocyte	NULL
cDN	NULL
A	NULL
.	NULL

The	NULL
resulting	NULL
fragment	NULL
was	NULL
gel-purified	NULL
and	NULL
double-strand	NULL
sequenced	NULL
.	NULL

All	NULL
sequencing	NULL
reactions	NULL
and	NULL
computer-assisted	NULL
sequence	NULL
analysis	NULL
were	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
20	NULL
)	NULL
.	NULL

dD	NULL
)	NULL
NA	NULL
Constuds	NULL
.	NULL

The	NULL
coding	NULL
region	NULL
of	NULL
human	NULL
wild-type	NULL
gp30/	NULL
40	NULL
was	NULL
amplified	NULL
from	NULL
HPB-	NULL
ALL	NULL
cells	NULL
cDNA	NULL
using	NULL
5	NULL
'	NULL
and	NULL
3	NULL
``	NULL
specific	NULL
forward	NULL
and	NULL
reverse	NULL
primers	NULL
(	NULL
CCCTCGAGCTATGA-ACCAGGC	NULL
TGACCCTCGGC	NULL
and	NULL
CCTCGAGCTCTACG-GGGGGCTGGGGCAGTG	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

The	NULL
purified	NULL
fragment	NULL
was	NULL
cloned	NULL
into	NULL
the	NULL
expression	NULL
vector	NULL
pEF-BOS	NULL
(	NULL
27	NULL
)	NULL
.	NULL

The	NULL
chimeric	NULL
CD8-gp30/	NULL
40	NULL
construct	NULL
(	NULL
CCG	NULL
chimera	NULL
)	NULL
consists	NULL
of	NULL
the	NULL
extracellular	NULL
and	NULL
transmembrane	NULL
regions	NULL
(	NULL
aa	NULL
1-145	NULL
)	NULL
of	NULL
CD8a	NULL
fused	NULL
to	NULL
residues	NULL
65-196	NULL
of	NULL
human	NULL
gp30/	NULL
40	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

It	NULL
was	NULL
generated	NULL
by	NULL
separately	NULL
amplifying	NULL
the	NULL
cDNA	NULL
encoding	NULL
the	NULL
extracellular	NULL
and	NULL
transmembrane	NULL
domains	NULL
of	NULL
CD8a	NULL
using	NULL
a	NULL
CD8a-specific	NULL
5	NULL
'	NULL
primer	NULL
(	NULL
ATGGCCTTACCAGTGACCGCCTTG	NULL
)	NULL
,	NULL
a	NULL
chimeric	NULL
3	NULL
'	NULL
primer	NULL
(	NULL
GCTCCGGCCCCTGGTCCACTGGGACAAGTGGTTGCA-GTAAAGGGTGAT	NULL
A	NULL
ACCAG	NULL
)	NULL
and	NULL
the	NULL
gp30/	NULL
40	NULL
fragment	NULL
with	NULL
an	NULL
overlapping	NULL
5	NULL
'	NULL
primer	NULL
(	NULL
GCTCCGGCCCCTGGTCCACTG-GGACAAGTGGTTGCAGTAAAGGGTGATAACCAG	NULL
)	NULL
and	NULL
a	NULL
gp30/	NULL
40-specific	NULL
3	NULL
'	NULL
primer	NULL
(	NULL
see	NULL
above	NULL
)	NULL
.	NULL

The	NULL
two	NULL
overlapping	NULL
fragments	NULL
were	NULL
used	NULL
as	NULL
templates	NULL
for	NULL
a	NULL
chimeric	NULL
PCR	NULL
with	NULL
CD8a	NULL
Â«	NULL
-5	NULL
'	NULL
and	NULL
gp30/40-3	NULL
'	NULL
primers	NULL
.	NULL

Mutants	NULL
of	NULL
gp30/	NULL
40	NULL
and	NULL
the	NULL
CCG	NULL
chimera	NULL
were	NULL
produced	NULL
by	NULL
site-directed	NULL
mutagenesis	NULL
using	NULL
the	NULL
Quick	NULL
Change	NULL
site-directed	NULL
mutagenesis	NULL
kit	NULL
(	NULL
Stratagene	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
procedure	NULL
.	NULL

The	NULL
following	NULL
mutants	NULL
were	NULL
used	NULL
in	NULL
this	NULL
study	NULL
:	NULL
gp30/40-N-Q	NULL
(	NULL
NZ	NULL
to	NULL
Q	NULL
)	NULL
,	NULL
gp30/40-ITIM	NULL
(	NULL
Y	NULL
'	NULL
to	NULL
F	NULL
)	NULL
,	NULL
gp30/	NULL
40-STOP	NULL
(	NULL
where	NULL
a	NULL
FLAG-tag	NULL
coding	NULL
sequence	NULL
followed	NULL
by	NULL
a	NULL
stop	NULL
codon	NULL
was	NULL
inserted	NULL
after	NULL
H*	NULL
)	NULL
,	NULL
CC-ITIM	NULL
(	NULL
YÂ¥'*	NULL
to	NULL
F	NULL
)	NULL
,	NULL
and	NULL
CC-STOP	NULL
(	NULL
S	NULL
'	NULL
to	NULL
stop	NULL
codon	NULL
)	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
all	NULL
constructs	NULL
was	NULL
confirmed	NULL
by	NULL
double-strand	NULL
sequencing	NULL
.	NULL

Northem	NULL
Blot	NULL
Analysis	NULL
.	NULL

-	NULL
Human	NULL
multiple-tissue	NULL
Northern	NULL
blots	NULL
(	NULL
Clontech	NULL
)	NULL
were	NULL
probed	NULL
with	NULL
full-length	NULL
radiolabeled	NULL
cDNA	NULL
of	NULL
gp30/	NULL
40	NULL
under	NULL
stringent	NULL
conditions	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

Cells	NULL
and	NULL
Antibodies	NULL
.	NULL

-	NULL
Cells	NULL
were	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
FCS	NULL
,	NULL
1	NULL
%	NULL
penicillin-streptomycin	NULL
,	NULL
and	NULL
2	NULL
%	NULL
glutamine	NULL
(	NULL
GIBCO	NULL
BRL	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

The	NULL
Jurkat	NULL
variant	NULL
CCG	NULL
(	NULL
stably	NULL
expressing	NULL
the	NULL
CCG	NULL
chimera	NULL
)	NULL
was	NULL
established	NULL
as	NULL
described	NULL
elsewhere	NULL
(	NULL
20	NULL
)	NULL
.	NULL

The	NULL
Jurkat	NULL
variant	NULL
J.HM1.2.2	NULL
(	NULL
27-30	NULL
)	NULL
,	NULL
which	NULL
is	NULL
stably	NULL
transfected	NULL
with	NULL
the	NULL
human	NULL
muscarinic	NULL
receptor	NULL
type	NULL
1	NULL
,	NULL
was	NULL
provided	NULL
by	NULL
Dr.	NULL
Arthur	NULL
Weiss	NULL
,	NULL
University	NULL
of	NULL
California	NULL
at	NULL
San	NULL
Francisco	NULL
,	NULL
San	NULL
Francisco	NULL
,	NULL
CA	NULL
,	NULL
with	NULL
the	NULL
authorization	NULL
of	NULL
Genentech	NULL
Inc.	NULL
,	NULL
and	NULL
was	NULL
cultured	NULL
under	NULL
standard	NULL
conditions	NULL
.	NULL

The	NULL
polyclonal	NULL
antiserum	NULL
directed	NULL
at	NULL
gp30/	NULL
40	NULL
was	NULL
generated	NULL
by	NULL
immunizing	NULL
rabbits	NULL
with	NULL
a	NULL
KLH-coupled	NULL
synthetic	NULL
peptide	NULL
corresponding	NULL
to	NULL
aa	NULL
96-114	NULL
of	NULL
gp30/	NULL
40	NULL
.	NULL

Affinity	NULL
purification	NULL
of	NULL
the	NULL
antiserum	NULL
was	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
31	NULL
)	NULL
.	NULL

SHP2	NULL
,	NULL
MAP	NULL
ki-nase	NULL
,	NULL
PTYR	NULL
(	NULL
4G10	NULL
)	NULL
Abs	NULL
(	NULL
Upstate	NULL
Biotechnology	NULL
Inc.	NULL
)	NULL
,	NULL
myc	NULL
(	NULL
9E10	NULL
,	NULL
a	NULL
gift	NULL
from	NULL
Dr.	NULL
D.	NULL
Cantrell	NULL
,	NULL
Imperial	NULL
Cancer	NULL
Research	NULL
Fund	NULL
,	NULL
Lon-don	NULL
,	NULL
UK	NULL
)	NULL
,	NULL
and	NULL
FLAG	NULL
(	NULL
M2	NULL
,	NULL
Kodak	NULL
)	NULL
Abs	NULL
were	NULL
used	NULL
at	NULL
1	NULL
pg/ml	NULL
for	NULL
The	NULL
interacting	NULL
Transmembrane	NULL
Adaptor	NULL
Protein	NULL
SIT	NULL
Western	NULL
blotting	NULL
,	NULL
and	NULL
rabbit	NULL
p59	NULL
%	NULL
``	NULL
and	NULL
p56	NULL
antisera	NULL
(	NULL
provided	NULL
by	NULL
Dr.	NULL
A.	NULL
Veillette	NULL
,	NULL
McGill	NULL
Cancer	NULL
Center	NULL
,	NULL
McGill	NULL
University	NULL
,	NULL
Mon-treal	NULL
,	NULL
Canada	NULL
)	NULL
were	NULL
diluted	NULL
1:2,000	NULL
(	NULL
vol/vol	NULL
)	NULL
.	NULL

CD3-e	NULL
(	NULL
OKT3	NULL
,	NULL
IgG2a	NULL
)	NULL
or	NULL
TCR	NULL
(	NULL
C305	NULL
,	NULL
IgM	NULL
,	NULL
provided	NULL
by	NULL
Dr.	NULL
A.	NULL
Weiss	NULL
)	NULL
mAbs	NULL
were	NULL
used	NULL
at	NULL
5	NULL
pg/ml	NULL
or	NULL
as	NULL
hybridoma	NULL
supernatant	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
polyclonal	NULL
antiserum	NULL
directed	NULL
at	NULL
lymphocyte	NULL
phosphatase-associated	NULL
phosphoprotein	NULL
has	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
31	NULL
)	NULL
and	NULL
was	NULL
used	NULL
at	NULL
a	NULL
1:5,000	NULL
dilution	NULL
for	NULL
Western	NULL
blot	NULL
analysis	NULL
.	NULL

For	NULL
immunoprecipitation	NULL
experiments	NULL
,	NULL
protein	NULL
A-Sepharose-purified	NULL
PTYR	NULL
(	NULL
PY72	NULL
,	NULL
provided	NULL
by	NULL
Dr.	NULL
B.	NULL
Sefton	NULL
,	NULL
Salk	NULL
Institute	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
CD3-e	NULL
,	NULL
or	NULL
CD8	NULL
(	NULL
AICD8.1	NULL
,	NULL
IgG1	NULL
)	NULL
mAbs	NULL
were	NULL
covalently	NULL
coupled	NULL
to	NULL
cyanogen	NULL
bro-mide-activated	NULL
Sepharose	NULL
beads	NULL
(	NULL
6	NULL
mg/	NULL
ml	NULL
packed	NULL
beads	NULL
)	NULL
.	NULL

Typically	NULL
,	NULL
15	NULL
pl	NULL
of	NULL
packed	NULL
coupled	NULL
beads	NULL
were	NULL
used	NULL
for	NULL
immunoprecipitation	NULL
.	NULL

Predpitation	NULL
Experiments	NULL
.	NULL

-	NULL
Cells	NULL
were	NULL
activated	NULL
with	NULL
culture	NULL
supernatant	NULL
of	NULL
C305	NULL
mAb	NULL
or	NULL
a	NULL
combination	NULL
of	NULL
biotinylated	NULL
CD3-	NULL
e	NULL
plus	NULL
CD4	NULL
Abs	NULL
(	NULL
10	NULL
mg/ml	NULL
each	NULL
)	NULL
followed	NULL
by	NULL
cross-linking	NULL
with	NULL
avidin	NULL
(	NULL
80	NULL
g/	NULL
ml	NULL
)	NULL
,	NULL
PHA	NULL
(	NULL
1	NULL
mg/	NULL
ml	NULL
)	NULL
,	NULL
0.1	NULL
mM	NULL
Na	NULL
Vanadate	NULL
plus	NULL
1	NULL
mM	NULL
H	NULL
;	NULL
,0	NULL
;	NULL
at	NULL
37Â°C	NULL
.	NULL

Immunoprecipitations	NULL
were	NULL
performed	NULL
using	NULL
gp30/	NULL
40	NULL
antiserum	NULL
(	NULL
1:100	NULL
vol/	NULL
vol	NULL
dilution	NULL
)	NULL
followed	NULL
by	NULL
protein	NULL
A-Sepharose	NULL
,	NULL
or	NULL
using	NULL
CD8	NULL
,	NULL
CD3	NULL
,	NULL
or	NULL
anti-PTYR	NULL
mAb-coupled	NULL
beads	NULL
,	NULL
as	NULL
described	NULL
elsewhere	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Alternatively	NULL
,	NULL
the	NULL
isolated	NULL
SH2	NULL
domain	NULL
of	NULL
SHP2	NULL
(	NULL
provided	NULL
by	NULL
Dr.	NULL
B.	NULL
Neel	NULL
,	NULL
Beth	NULL
Israel	NULL
Deaconess	NULL
Medical	NULL
Center	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
)	NULL
,	NULL
was	NULL
expressed	NULL
as	NULL
glutathione-S-transferase	NULL
(	NULL
GST	NULL
)	NULL
fusion	NULL
protein	NULL
and	NULL
used	NULL
for	NULL
precipitation	NULL
experiments	NULL
as	NULL
previously	NULL
reported	NULL
(	NULL
17	NULL
,	NULL
32	NULL
)	NULL
.	NULL

After	NULL
washes	NULL
,	NULL
the	NULL
individual	NULL
precipitates	NULL
were	NULL
subjected	NULL
to	NULL
SDS-PAGE	NULL
and	NULL
further	NULL
processed	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
.	NULL

In	NULL
vitro	NULL
kinase	NULL
assay	NULL
,	NULL
reprecipitation	NULL
of	NULL
in	NULL
vitro	NULL
phosphorylated	NULL
proteins	NULL
,	NULL
two-dimensional	NULL
gel	NULL
electrophoresis	NULL
,	NULL
and	NULL
Western	NULL
blot	NULL
analysis	NULL
were	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
20	NULL
,	NULL
33	NULL
)	NULL
.	NULL

Deglycosylation	NULL
Experiment	NULL
.	NULL

-	NULL
In	NULL
vitro-labeled	NULL
gp30/	NULL
40	NULL
was	NULL
obtained	NULL
from	NULL
a	NULL
primary	NULL
CD3	NULL
immunoprecipitate	NULL
by	NULL
reprecipitation	NULL
using	NULL
gp30/	NULL
40	NULL
antiserum	NULL
as	NULL
reported	NULL
elsewhere	NULL
(	NULL
31	NULL
)	NULL
.	NULL

The	NULL
repre-cipitated	NULL
material	NULL
was	NULL
subjected	NULL
to	NULL
SDS-PAGE	NULL
and	NULL
the	NULL
position	NULL
of	NULL
SIT	NULL
was	NULL
determined	NULL
by	NULL
autoradiography	NULL
.	NULL

The	NULL
corresponding	NULL
band	NULL
was	NULL
excised	NULL
from	NULL
the	NULL
dried	NULL
gel	NULL
,	NULL
electroeluted	NULL
,	NULL
precipitated	NULL
with	NULL
acetone	NULL
,	NULL
and	NULL
subjected	NULL
to	NULL
deglycosylation	NULL
using	NULL
endoglyco-sidase	NULL
F	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
)	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
34	NULL
)	NULL
.	NULL

Preparation	NULL
of	NULL
Membrane	NULL
and	NULL
Cytosolic	NULL
Fractions	NULL
.	NULL

-	NULL
Jurkat	NULL
cells	NULL
(	NULL
7.5	NULL
X	NULL
10	NULL
``	NULL
)	NULL
were	NULL
stimulated	NULL
with	NULL
0.1	NULL
mM	NULL
pervanadate	NULL
plus	NULL
1	NULL
mM	NULL
H	NULL
;	NULL
0	NULL
;	NULL
,	NULL
for	NULL
2	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

After	NULL
one	NULL
wash	NULL
in	NULL
cold	NULL
TBS	NULL
,	NULL
cells	NULL
were	NULL
resuspended	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
hypotonic	NULL
buffer	NULL
(	NULL
50	NULL
mM	NULL
Tris	NULL
HCI	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
10	NULL
mM	NULL
KC	NULL
]	NULL
,	NULL
1	NULL
mM	NULL
CaC	NULL
)	NULL
J	NULL
;	NULL
,	NULL
1	NULL
mM	NULL
MgC	NULL
)	NULL
,	NULL
1	NULL
mM	NULL
vanadate	NULL
,	NULL
1	NULL
mM	NULL
PMSF	NULL
,	NULL
1	NULL
jig/ml	NULL
aprotinin	NULL
,	NULL
and	NULL
1	NULL
jig/ml	NULL
leupep-tin	NULL
)	NULL
and	NULL
left	NULL
on	NULL
ice	NULL
for	NULL
45	NULL
min	NULL
.	NULL

After	NULL
sonication	NULL
,	NULL
cells	NULL
were	NULL
spun	NULL
down	NULL
for	NULL
15	NULL
min	NULL
at	NULL
15,000	NULL
rpm	NULL
and	NULL
4Â°C	NULL
.	NULL

Supernatant	NULL
(	NULL
=	NULL
total	NULL
lysate	NULL
)	NULL
was	NULL
adjusted	NULL
to	NULL
5	NULL
ml	NULL
with	NULL
hypotonic	NULL
buffer	NULL
and	NULL
centrifuged	NULL
for	NULL
40	NULL
min	NULL
at	NULL
33,000	NULL
rpm	NULL
and	NULL
4Â°C	NULL
using	NULL
a	NULL
SW	NULL
55Ti	NULL
rotor	NULL
.	NULL

The	NULL
supernatant	NULL
(	NULL
=	NULL
cytosol	NULL
)	NULL
was	NULL
collected	NULL
,	NULL
supplemented	NULL
with	NULL
detergent	NULL
and	NULL
NaCl	NULL
to	NULL
reach	NULL
final	NULL
concentrations	NULL
of	NULL
1	NULL
%	NULL
NP-40	NULL
and	NULL
150	NULL
mM	NULL
NaC	NULL
]	NULL
,	NULL
respectively	NULL
,	NULL
and	NULL
further	NULL
processed	NULL
for	NULL
anti-gp30/	NULL
40	NULL
immunoprecipitation	NULL
.	NULL

The	NULL
pellet	NULL
(	NULL
=	NULL
membrane	NULL
fraction	NULL
)	NULL
was	NULL
washed	NULL
in	NULL
5	NULL
ml	NULL
of	NULL
high	NULL
salt	NULL
buffer	NULL
(	NULL
50	NULL
mM	NULL
Tris	NULL
HCI	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
500	NULL
mM	NULL
NaCl	NULL
,	NULL
1	NULL
mM	NULL
vanadate	NULL
,	NULL
1	NULL
mM	NULL
PMSF	NULL
,	NULL
1	NULL
g/	NULL
ml	NULL
aprotinin	NULL
,	NULL
and	NULL
leupeptin	NULL
)	NULL
,	NULL
solubilized	NULL
in	NULL
lysis	NULL
buffer	NULL
containing	NULL
1	NULL
%	NULL
NP-40	NULL
,	NULL
and	NULL
subjected	NULL
to	NULL
anti-	NULL
gp30/	NULL
40	NULL
immunoprecipitation	NULL
as	NULL
previously	NULL
described	NULL
.	NULL

Lasersam	NULL
Microsaopy	NULL
.	NULL

-	NULL
The	NULL
confocal	NULL
laserscan	NULL
microscopy	NULL
of	NULL
HPB-	NULL
ALL	NULL
cells	NULL
and	NULL
Jurkat	NULL
cells	NULL
was	NULL
essentially	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
20	NULL
)	NULL
with	NULL
the	NULL
exception	NULL
that	NULL
for	NULL
the	NULL
experiments	NULL
shown	NULL
in	NULL
panels	NULL
5	NULL
and	NULL
6	NULL
of	NULL
Fig	NULL
.	NULL

4	NULL
A	NULL
a	NULL
mixture	NULL
of	NULL
affinity-purified	NULL
SIT	NULL
(	NULL
5	NULL
mg/	NULL
ml	NULL
)	NULL
and	NULL
CD8	NULL
(	NULL
AICD8.1	NULL
,	NULL
IgG1	NULL
,	NULL
10	NULL
g/	NULL
ml	NULL
)	NULL
Abs	NULL
was	NULL
used	NULL
,	NULL
whereas	NULL
all	NULL
other	NULL
experiments	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
were	NULL
performed	NULL
using	NULL
20	NULL
g/	NULL
ml	NULL
of	NULL
affinity-purified	NULL
SIT	NULL
antibody	NULL
.	NULL

1183	NULL
Marie-Cardine	NULL
et	NULL
al	NULL
.	NULL

T	NULL
rnsfection	NULL
of	NULL
COS	NULL
Cell	NULL
.	NULL

-	NULL
COS	NULL
cells	NULL
were	NULL
transfected	NULL
as	NULL
previously	NULL
reported	NULL
(	NULL
20	NULL
)	NULL
.	NULL

The	NULL
constructs	NULL
used	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
wild-type	NULL
Fyn	NULL
(	NULL
T	NULL
)	NULL
or	NULL
Leck	NULL
cloned	NULL
in	NULL
pSR	NULL
a	NULL
expression	NULL
vector	NULL
(	NULL
provided	NULL
by	NULL
Dr.	NULL
A.	NULL
da	NULL
Silva	NULL
,	NULL
Dana	NULL
Farber	NULL
Cancer	NULL
Center	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
)	NULL
,	NULL
FLAG-tagged	NULL
Syk	NULL
cloned	NULL
into	NULL
the	NULL
p5C7	NULL
vector	NULL
(	NULL
donated	NULL
by	NULL
Dr.	NULL
W.	NULL
Kolanus	NULL
,	NULL
Gene	NULL
Center	NULL
,	NULL
Munich	NULL
,	NULL
Germany	NULL
)	NULL
,	NULL
and	NULL
myc-tagged	NULL
ZAP7O0	NULL
inserted	NULL
into	NULL
the	NULL
pcDNA3	NULL
vector	NULL
(	NULL
a	NULL
gift	NULL
from	NULL
Dr.	NULL
R.	NULL
Abraham	NULL
,	NULL
Mayo	NULL
Clinic	NULL
,	NULL
Rochester	NULL
,	NULL
MN	NULL
)	NULL
.	NULL

Ludferase	NULL
Reporter	NULL
Gene	NULL
Assay	NULL
.	NULL

-	NULL
Jurkat	NULL
cells	NULL
or	NULL
J.HM1.2.2	NULL
cells	NULL
were	NULL
transfected	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
20	NULL
)	NULL
,	NULL
using	NULL
30	NULL
pg	NULL
of	NULL
the	NULL
indicated	NULL
cDNA	NULL
construct	NULL
together	NULL
with	NULL
10	NULL
jpg	NULL
of	NULL
the	NULL
NF-AT	NULL
luciferase	NULL
reporter	NULL
construct	NULL
.	NULL

At	NULL
18	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
8	NULL
X	NULL
104	NULL
cells	NULL
well	NULL
were	NULL
stimulated	NULL
in	NULL
duplicates	NULL
with	NULL
medium	NULL
,	NULL
PHA	NULL
(	NULL
1	NULL
ug/ml	NULL
)	NULL
,	NULL
PMA	NULL
(	NULL
10-8	NULL
M	NULL
)	NULL
plus	NULL
ionomycin	NULL
(	NULL
1	NULL
pg/ml	NULL
!	NULL
)	NULL

immobilized	NULL
anti-TCR	NULL
mAb	NULL
C305	NULL
,	NULL
or	NULL
carbachol	NULL
(	NULL
500	NULL
M	NULL
,	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
)	NULL
in	NULL
a	NULL
96-	NULL
well	NULL
plate	NULL
(	NULL
U96	NULL
Maxisorp	NULL
,	NULL
Nunc	NULL
immunoplate	NULL
)	NULL
.	NULL

After	NULL
6	NULL
h	NULL
of	NULL
stimulation	NULL
cells	NULL
were	NULL
harvested	NULL
,	NULL
washed	NULL
twice	NULL
in	NULL
PBS	NULL
,	NULL
and	NULL
lysed	NULL
for	NULL
15	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

After	NULL
centrifugation	NULL
,	NULL
30	NULL
pul	NULL
of	NULL
the	NULL
supernatants	NULL
were	NULL
analyzed	NULL
as	NULL
duplicates	NULL
for	NULL
luciferase	NULL
activity	NULL
using	NULL
a	NULL
luminometer	NULL
(	NULL
Berthold	NULL
Lumat	NULL
9507	NULL
)	NULL
.	NULL

Luciferase	NULL
activity	NULL
is	NULL
expressed	NULL
as	NULL
percentage	NULL
of	NULL
the	NULL
maximal	NULL
promoter	NULL
activity	NULL
induced	NULL
by	NULL
incubating	NULL
the	NULL
transfected	NULL
cells	NULL
with	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
.	NULL

Results	NULL
Purification	NULL
of	NULL
g	NULL
Â»	NULL
30/	NULL
40	NULL
and	NULL
Cloning	NULL
of	NULL
the	NULL
Corresponding	NULL
DNA	NULL
.	NULL

We	NULL
have	NULL
recently	NULL
reported	NULL
the	NULL
molecular	NULL
cloning	NULL
of	NULL
a	NULL
novel	NULL
disulfide-linked	NULL
transmembrane	NULL
adaptor	NULL
protein	NULL
,	NULL
called	NULL
TR	NULL
IM	NULL
,	NULL
that	NULL
associates	NULL
with	NULL
the	NULL
TCR-CD3-	NULL
complex	NULL
in	NULL
T	NULL
lymphocytes	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Four	NULL
proteins	NULL
were	NULL
copurified	NULL
with	NULL
TRIM	NULL
,	NULL
namely	NULL
three	NULL
caseins	NULL
as	NULL
well	NULL
as	NULL
an	NULL
additional	NULL
protein	NULL
that	NULL
could	NULL
not	NULL
be	NULL
identified	NULL
by	NULL
searching	NULL
comprehensive	NULL
databases	NULL
using	NULL
a	NULL
tryptic	NULL
peptide	NULL
sequence	NULL
tag	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Therefore	NULL
de	NULL
novo	NULL
sequencing	NULL
of	NULL
peptides	NULL
was	NULL
performed	NULL
after	NULL
esterification	NULL
of	NULL
the	NULL
original	NULL
tryptic	NULL
digest	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
24	NULL
,	NULL
26	NULL
)	NULL
.	NULL

The	NULL
fragmentation	NULL
spectrum	NULL
of	NULL
peptide	NULL
T	NULL
,	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
A	NULL
)	NULL
yielded	NULL
complete	NULL
aa	NULL
sequences	NULL
,	NULL
whereas	NULL
those	NULL
of	NULL
peptide	NULL
T	NULL
;	NULL
,	NULL
and	NULL
T	NULL
;	NULL
yielded	NULL
only	NULL
partial	NULL
aa	NULL
sequences	NULL
.	NULL

Searching	NULL
EST	NULL
databases	NULL
with	NULL
the	NULL
sequence	NULL
YSEVV	NULL
(	NULL
L/	NULL
D	NULL
)	NULL
DSEPK	NULL
determined	NULL
for	NULL
peptide	NULL
T	NULL
,	NULL
resulted	NULL
in	NULL
the	NULL
identification	NULL
of	NULL
an	NULL
EST	NULL
coding	NULL
for	NULL
this	NULL
peptide	NULL
as	NULL
well	NULL
as	NULL
for	NULL
additional	NULL
73	NULL
aa	NULL
that	NULL
all	NULL
belonged	NULL
to	NULL
an	NULL
as	NULL
yet	NULL
undescribed	NULL
polypeptide	NULL
.	NULL

Reverse	NULL
and	NULL
forward	NULL
oligonucleotides	NULL
deduced	NULL
from	NULL
the	NULL
EST	NULL
sequence	NULL
were	NULL
used	NULL
in	NULL
5	NULL
and	NULL
3	NULL
'	NULL
RACE	NULL
experiments	NULL
,	NULL
respectively	NULL
,	NULL
to	NULL
amplify	NULL
the	NULL
rest	NULL
of	NULL
the	NULL
corresponding	NULL
gene	NULL
.	NULL

An	NULL
open	NULL
reading	NULL
frame	NULL
of	NULL
588	NULL
nucleotides	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
codes	NULL
for	NULL
a	NULL
protein	NULL
of	NULL
196	NULL
aa	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
B	NULL
)	NULL
.	NULL

The	NULL
first	NULL
22	NULL
NH-terminal	NULL
residues	NULL
of	NULL
the	NULL
newly	NULL
identified	NULL
protein	NULL
are	NULL
hydrophobic	NULL
,	NULL
suggesting	NULL
that	NULL
they	NULL
could	NULL
represent	NULL
a	NULL
leader	NULL
peptide	NULL
required	NULL
for	NULL
transmembrane	NULL
transport	NULL
.	NULL

A	NULL
putative	NULL
extracellular	NULL
domain	NULL
comprising	NULL
18	NULL
aa	NULL
contains	NULL
one	NULL
potential	NULL
site	NULL
for	NULL
N-linked	NULL
glycosylation	NULL
(	NULL
N2Â®	NULL
)	NULL
as	NULL
well	NULL
as	NULL
one	NULL
cysteine	NULL
residue	NULL
(	NULL
C*	NULL
``	NULL
)	NULL
,	NULL
which	NULL
could	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
formation	NULL
of	NULL
an	NULL
interchain	NULL
disulfide	NULL
bond	NULL
.	NULL

Residues	NULL
41-60	NULL
are	NULL
highly	NULL
hydrophobic	NULL
and	NULL
probably	NULL
represent	NULL
a	NULL
transmembrane	NULL
domain	NULL
.	NULL

The	NULL
putative	NULL
cytoplasmic	NULL
portion	NULL
of	NULL
the	NULL
protein	NULL
(	NULL
resi-dues	NULL
61-196	NULL
)	NULL
contains	NULL
several	NULL
potential	NULL
phosphorylation	NULL
sites	NULL
for	NULL
protein	NULL
kinase	NULL
C	NULL
(	NULL
TÂ°Â®	NULL
)	NULL
and/	NULL
or	NULL
for	NULL
casein	NULL
kinase	NULL
I	NULL
(	NULL
S*	NULL
J	NULL
>	NULL
&	NULL
9	NULL
human	NULL
-	NULL
1	NULL
.	NULL

MNOADPRLRAVCLWTLTSAAMSRGDNCT	NULL
.	NULL

.	NULL

DLLALGTPSTTOAWGLWVLL	NULL
48	NULL
Lb	NULL
noe	NULL
f	NULL
ode	NULL
AN	NULL
MOUS	NULL
@	NULL
-	NULL
1	NULL
.	NULL

2	NULL
lle	NULL
lenee	NULL
nes	NULL
MSRDYNCTTDDOLAWGIPSTSHAWGLWALD	NULL
|	NULL
30	NULL
49	NULL
-	NULL
.	NULL

RSGESVEEVPLYGNLHYLO	NULL
-	NULL
97	NULL
Loco	NULL
oso	NULL
be	NULL
p	NULL
31	NULL
.	NULL

[	NULL
GVVTVLLLISLARLLSOWTRGRRRNORGOGPHSCRSAREVPLXGNLHYLO	NULL
-	NULL
80	NULL
YxNL	NULL
98	NULL
-	NULL
TGRLSQDPEPDQQD	NULL
.	NULL

PTLCCPARAAREVMCYTSLOLRPPOGRIPGPGTPY	NULL
-	NULL
146	NULL
ELE	NULL
c	NULL
-	NULL
cobb	NULL
ob	NULL
coa	NULL
(	NULL
oc	NULL
EEE	NULL
EEA	NULL
EA	NULL
A	NULL
Â®	NULL
81	NULL
.	NULL

TGRLSOEPRSEEODPPSSCCLARGAEEANCYTSLQLRPAQCRIPSSGNPT	NULL
-	NULL
130	NULL
YxxL	NULL
I/V	NULL
Relative	NULL
Intensity	NULL
,	NULL
(	NULL
%	NULL
)	NULL
147	NULL
-	NULL
KYSEVVLDSEPKSQASGPEPELYASVCAQTRRARASFPDQAYANSQPAAS*	NULL
196	NULL
|	NULL
|	NULL
novo	NULL
vcore	NULL
oue	NULL
]	NULL
131	NULL
KYCEVVLDSEPKPQAPGPEPELYASVCAOTRRCRASFPDQAYANSQPAPS+*	NULL
180	NULL
xtboxy	NULL
texy	NULL
Â¥xNn	NULL
Figure	NULL
1	NULL
.	NULL

-	NULL
Sequencing	NULL
of	NULL
the	NULL
gel-purified	NULL
gp30/	NULL
40	NULL
by	NULL
nanoelectrospray	NULL
tandem	NULL
mass	NULL
spectrometry	NULL
and	NULL
cloning	NULL
of	NULL
its	NULL
corresponding	NULL
cDNA	NULL
.	NULL

(	NULL
A	NULL
)	NULL
(	NULL
Top	NULL
)	NULL
Part	NULL
of	NULL
the	NULL
spectrum	NULL
of	NULL
the	NULL
unseparated	NULL
in-gel	NULL
tryptic	NULL
digest	NULL
of	NULL
the	NULL
previously	NULL
described	NULL
pp29/30	NULL
.	NULL

Peaks	NULL
designated	NULL
with	NULL
asterisks	NULL
belong	NULL
to	NULL
trypsin	NULL
autolysis	NULL
products	NULL
.	NULL

All	NULL
peptide	NULL
ions	NULL
labeled	NULL
in	NULL
the	NULL
spectrum	NULL
were	NULL
in	NULL
turn	NULL
isolated	NULL
by	NULL
the	NULL
first	NULL
quadrupole	NULL
mass	NULL
analyzer	NULL
of	NULL
a	NULL
triple	NULL
quadrupole	NULL
instrument	NULL
and	NULL
fragmented	NULL
in	NULL
the	NULL
collision	NULL
cell	NULL
,	NULL
and	NULL
their	NULL
tandem	NULL
mass	NULL
spectra	NULL
were	NULL
acquired	NULL
.	NULL

Peptide	NULL
ions	NULL
designated	NULL
with	NULL
T	NULL
originate	NULL
from	NULL
gp30/	NULL
40	NULL
.	NULL

Peptides	NULL
designated	NULL
with	NULL
t	NULL
originate	NULL
from	NULL
TRIM	NULL
.	NULL

(	NULL
Bottom	NULL
)	NULL
Tandem	NULL
mass	NULL
spectrum	NULL
of	NULL
the	NULL
doubly	NULL
charged	NULL
ion	NULL
T	NULL
;	NULL
with	NULL
a	NULL
mass	NULL
to	NULL
charge	NULL
ratio	NULL
(	NULL
m/z	NULL
)	NULL
of	NULL
633.4	NULL
.	NULL

Upon	NULL
their	NULL
collisional	NULL
fragmentation	NULL
,	NULL
tryptic	NULL
peptides	NULL
produce	NULL
continuous	NULL
series	NULL
of	NULL
fragment	NULL
ions	NULL
containing	NULL
the	NULL
COOH	NULL
terminus	NULL
(	NULL
Y	NULL
``	NULL
-ions	NULL
)	NULL
.	NULL

The	NULL
peptide	NULL
sequence	NULL
is	NULL
deduced	NULL
by	NULL
considering	NULL
precise	NULL
mass	NULL
differences	NULL
between	NULL
adjacent	NULL
Y	NULL
``	NULL
-ions	NULL
in	NULL
the	NULL
series	NULL
.	NULL

Y	NULL
``	NULL
ions	NULL
dominate	NULL
in	NULL
the	NULL
m/z	NULL
region	NULL
above	NULL
the	NULL
parent	NULL
ion	NULL
(	NULL
M+2H	NULL
)	NULL
>	NULL
*	NULL
and	NULL
therefore	NULL
the	NULL
peptide	NULL
sequence	NULL
could	NULL
be	NULL
determined	NULL
unambiguously	NULL
here	NULL
.	NULL

However	NULL
,	NULL
the	NULL
m/z	NULL
region	NULL
below	NULL
the	NULL
parent	NULL
ion	NULL
is	NULL
densely	NULL
populated	NULL
by	NULL
fragment	NULL
ions	NULL
of	NULL
different	NULL
type	NULL
and	NULL
origin	NULL
.	NULL

In	NULL
this	NULL
region	NULL
it	NULL
is	NULL
not	NULL
usually	NULL
possible	NULL
to	NULL
extend	NULL
the	NULL
series	NULL
of	NULL
Y	NULL
``	NULL
ions	NULL
to	NULL
the	NULL
COOH	NULL
terminus	NULL
of	NULL
a	NULL
peptide	NULL
using	NULL
the	NULL
mass	NULL
differences	NULL
between	NULL
the	NULL
adjacent	NULL
fragment	NULL
ions	NULL
as	NULL
a	NULL
guide	NULL
.	NULL

Therefore	NULL
,	NULL
additional	NULL
data	NULL
are	NULL
required	NULL
to	NULL
confirm	NULL
that	NULL
a	NULL
particular	NULL
ion	NULL
indeed	NULL
belongs	NULL
to	NULL
the	NULL
Y	NULL
``	NULL
series	NULL
of	NULL
peptide	NULL
fragments	NULL
.	NULL

To	NULL
acquire	NULL
this	NULL
information	NULL
,	NULL
a	NULL
part	NULL
of	NULL
the	NULL
unseparated	NULL
digest	NULL
was	NULL
esterified	NULL
and	NULL
tandem	NULL
mass	NULL
spectra	NULL
of	NULL
the	NULL
peptides	NULL
were	NULL
acquired	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Software	NULL
assisted	NULL
comparison	NULL
of	NULL
the	NULL
tandem	NULL
mass	NULL
spectra	NULL
of	NULL
the	NULL
derivatized	NULL
peptides	NULL
and	NULL
the	NULL
nonderivatized	NULL
peptides	NULL
enables	NULL
determination	NULL
of	NULL
peptide	NULL
sequences	NULL
with	NULL
high	NULL
confidence	NULL
(	NULL
25	NULL
,	NULL
47	NULL
)	NULL
.	NULL

Note	NULL
that	NULL
after	NULL
the	NULL
full	NULL
length	NULL
sequence	NULL
of	NULL
gp30/	NULL
40	NULL
had	NULL
been	NULL
obtained	NULL
,	NULL
the	NULL
tandem	NULL
mass	NULL
spectra	NULL
of	NULL
the	NULL
ions	NULL
T	NULL
;	NULL
and	NULL
T	NULL
,	NULL
were	NULL
retrospectively	NULL
matched	NULL
to	NULL
the	NULL
corresponding	NULL
tryptic	NULL
peptides	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
note	NULL
that	NULL
the	NULL
shown	NULL
sequence	NULL
reads	NULL
from	NULL
the	NULL
COOH	NULL
terminus	NULL
to	NULL
the	NULL
NH	NULL
terminus	NULL
.	NULL

(	NULL
B	NULL
)	NULL
aa	NULL
sequences	NULL
of	NULL
human	NULL
and	NULL
mouse	NULL
gp30/	NULL
40	NULL
.	NULL

The	NULL
putative	NULL
transmembrane	NULL
regions	NULL
are	NULL
boxed	NULL
.	NULL

The	NULL
tyrosine-based	NULL
signaling	NULL
motifs	NULL
are	NULL
depicted	NULL
underneath	NULL
the	NULL
corresponding	NULL
sequences	NULL
,	NULL
and	NULL
the	NULL
peptide	NULL
sequence	NULL
obtained	NULL
by	NULL
nanoelectrospray	NULL
tandem	NULL
mass	NULL
spectrometry	NULL
is	NULL
indicated	NULL
by	NULL
a	NULL
double	NULL
line	NULL
over	NULL
the	NULL
corresponding	NULL
sequence	NULL
.	NULL

Tyrosine	NULL
residues	NULL
are	NULL
underlined	NULL
.	NULL

The	NULL
sequence	NULL
data	NULL
are	NULL
available	NULL
from	NULL
EMBL/	NULL
GenBank/	NULL
DDBJ	NULL
Relative	NULL
Intensity	NULL
,	NULL
[	NULL
%	NULL
]	NULL
under	NULL
accession	NULL
number	NULL
AJQ10059	NULL
(	NULL
human	NULL
)	NULL
and	NULL
AJ236881	NULL
(	NULL
mouse	NULL
)	NULL
.	NULL

and	NULL
S'*2	NULL
)	NULL
.	NULL

Importantly	NULL
,	NULL
it	NULL
also	NULL
contains	NULL
six	NULL
tyrosine	NULL
residues	NULL
,	NULL
five	NULL
of	NULL
which	NULL
could	NULL
be	NULL
involved	NULL
in	NULL
SH2	NULL
domain-mediated	NULL
protein-protein	NULL
interactions	NULL
after	NULL
phosphorylation	NULL
.	NULL

Two	NULL
of	NULL
these	NULL
tyrosine	NULL
residues	NULL
represent	NULL
YxxL/	NULL
V-motifs	NULL
(	NULL
Y	NULL
'	NULL
and	NULL
Y*	NULL
)	NULL
,	NULL
indicating	NULL
the	NULL
possibility	NULL
of	NULL
a	NULL
phosphorylation-dependent	NULL
interaction	NULL
with	NULL
SH2	NULL
domains	NULL
of	NULL
src	NULL
PTKs	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
tyrosines	NULL
YÂ°Â°	NULL
and	NULL
Y'*Â®	NULL
are	NULL
potential	NULL
binding	NULL
sites	NULL
for	NULL
the	NULL
SH2	NULL
domain	NULL
of	NULL
the	NULL
adaptor	NULL
molecule	NULL
Grb2	NULL
.	NULL

Finally	NULL
,	NULL
the	NULL
cytoplasmic	NULL
portion	NULL
of	NULL
the	NULL
novel	NULL
molecule	NULL
possesses	NULL
one	NULL
potential	NULL
ITIM	NULL
(	NULL
VxY'**xxV	NULL
)	NULL
,	NULL
which	NULL
might	NULL
mediate	NULL
interactions	NULL
with	NULL
the	NULL
SH2	NULL
domains	NULL
of	NULL
cytoplasmic	NULL
tyrosine	NULL
phosphatases	NULL
like	NULL
SHP1	NULL
and	NULL
SHP2	NULL
or	NULL
with	NULL
the	NULL
inositol	NULL
phos	NULL
phatase	NULL
SHIP	NULL
(	NULL
35	NULL
,	NULL
36	NULL
)	NULL
.	NULL

It	NULL
is	NULL
noteworthy	NULL
to	NULL
mention	NULL
that	NULL
tyrosine-based	NULL
sequence	NULL
motifs	NULL
with	NULL
similarity	NULL
to	NULL
the	NULL
EEVPLY*Â®	NULL
GNL	NULL
and	NULL
the	NULL
MCY	NULL
!	NULL

``	NULL
TSL	NULL
motif	NULL
are	NULL
also	NULL
present	NULL
in	NULL
the	NULL
cytoplasmic	NULL
portion	NULL
of	NULL
TRIM	NULL
(	NULL
EDTPIYÂ®GNL	NULL
motif	NULL
and	NULL
MCYUÂ°ASL	NULL
motif	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

This	NULL
could	NULL
indicate	NULL
that	NULL
both	NULL
polypeptides	NULL
partially	NULL
interact	NULL
with	NULL
the	NULL
same	NULL
proteins	NULL
in	NULL
T	NULL
lymphocytes	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
similar	NULL
to	NULL
TRIM	NULL
,	NULL
the	NULL
trans	NULL
membrane	NULL
region	NULL
of	NULL
the	NULL
novel	NULL
protein	NULL
contains	NULL
the	NULL
sequence	NULL
motif	NULL
W	NULL
GxxxxxG	NULL
,	NULL
which	NULL
shows	NULL
some	NULL
similarity	NULL
to	NULL
a	NULL
recently	NULL
described	NULL
dimerization	NULL
motif	NULL
in	NULL
Â«	NULL
-helices	NULL
(	NULL
37	NULL
)	NULL
.	NULL

Comparison	NULL
of	NULL
the	NULL
predicted	NULL
aa	NULL
sequence	NULL
of	NULL
the	NULL
new	NULL
protein	NULL
(	NULL
preliminarily	NULL
termed	NULL
gp30/	NULL
40	NULL
)	NULL
with	NULL
all	NULL
available	NULL
databases	NULL
did	NULL
not	NULL
reveal	NULL
a	NULL
significant	NULL
homology	NULL
with	NULL
any	NULL
known	NULL
polypeptides	NULL
(	NULL
with	NULL
the	NULL
exception	NULL
of	NULL
TR	NULL
IM	NULL
,	NULL
see	NULL
above	NULL
)	NULL
.	NULL

1184	NULL
The	NULL
mouse	NULL
homologue	NULL
of	NULL
gp30/	NULL
40	NULL
was	NULL
identified	NULL
by	NULL
using	NULL
a	NULL
mouse	NULL
EST	NULL
obtained	NULL
from	NULL
an	NULL
EST	NULL
database	NULL
for	NULL
screening	NULL
a	NULL
genomic	NULL
library	NULL
.	NULL

The	NULL
sequence	NULL
information	NULL
from	NULL
positive	NULL
clones	NULL
was	NULL
then	NULL
used	NULL
to	NULL
generate	NULL
the	NULL
complete	NULL
mouse	NULL
cDNA	NULL
by	NULL
PCR	NULL
.	NULL

A	NULL
comparison	NULL
between	NULL
the	NULL
mouse	NULL
and	NULL
human	NULL
aa	NULL
sequences	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
B	NULL
)	NULL
revealed	NULL
that	NULL
all	NULL
five	NULL
tyrosine-based	NULL
signaling	NULL
motifs	NULL
as	NULL
well	NULL
as	NULL
the	NULL
putative	NULL
dimerization	NULL
motif	NULL
in	NULL
the	NULL
transmembrane	NULL
domains	NULL
are	NULL
conserved	NULL
between	NULL
the	NULL
two	NULL
species	NULL
.	NULL

However	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
human	NULL
protein	NULL
,	NULL
mouse	NULL
gp30/	NULL
40	NULL
lacks	NULL
a	NULL
leader	NULL
peptide	NULL
.	NULL

g30/40	NULL
Represents	NULL
a	NULL
Disulfide-linked	NULL
Dimeric	NULL
Glycoprotein	NULL
.	NULL

Previous	NULL
data	NULL
suggested	NULL
that	NULL
gp30/	NULL
40	NULL
,	NULL
like	NULL
TRIM	NULL
,	NULL
represents	NULL
a	NULL
disulfide-linked	NULL
dimer	NULL
that	NULL
associates	NULL
with	NULL
the	NULL
complex	NULL
under	NULL
mild	NULL
detergent	NULL
conditions	NULL
(	NULL
20	NULL
,	NULL
33	NULL
)	NULL
.	NULL

To	NULL
further	NULL
characterize	NULL
gp30/	NULL
40	NULL
,	NULL
HPB-	NULL
ALL	NULL
cells	NULL
were	NULL
lysed	NULL
in	NULL
Brij58	NULL
containing	NULL
lysis	NULL
buffer	NULL
to	NULL
preserve	NULL
weak	NULL
protein-protein	NULL
interactions	NULL
.	NULL

Postnuclear	NULL
lysates	NULL
were	NULL
subjected	NULL
to	NULL
CD3	NULL
immunoprecipitation	NULL
followed	NULL
by	NULL
in	NULL
vitro	NULL
kinase	NULL
assay	NULL
.	NULL

10	NULL
%	NULL
of	NULL
the	NULL
in	NULL
vitro-labeled	NULL
immunoprecipitate	NULL
was	NULL
directly	NULL
loaded	NULL
onto	NULL
two-dimensional	NULL
IEF/	NULL
SDS-PAGE	NULL
,	NULL
and	NULL
the	NULL
remaining	NULL
90	NULL
%	NULL
were	NULL
incubated	NULL
with	NULL
lysis	NULL
buffer	NULL
containing	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
plus	NULL
0.5	NULL
%	NULL
SDS	NULL
in	NULL
order	NULL
to	NULL
release	NULL
the	NULL
in	NULL
vitro-labeled	NULL
proteins	NULL
from	NULL
the	NULL
primary	NULL
immunoprecipitate	NULL
(	NULL
33	NULL
)	NULL
.	NULL

The	NULL
released	NULL
material	NULL
was	NULL
then	NULL
subjected	NULL
to	NULL
reprecipitation	NULL
using	NULL
a	NULL
polyclonal	NULL
anti-gp30/	NULL
40	NULL
antibody	NULL
which	NULL
was	NULL
raised	NULL
in	NULL
rabbits	NULL
immunized	NULL
The	NULL
interacting	NULL
Transmembrane	NULL
Adaptor	NULL
Protein	NULL
SIT	NULL
with	NULL
a	NULL
KLH	NULL
peptide	NULL
corresponding	NULL
to	NULL
aa	NULL
96-114	NULL
.	NULL

The	NULL
two-dimensional	NULL
IEF/	NULL
SDS-PAGE	NULL
analysis	NULL
of	NULL
the	NULL
secondary	NULL
immunoprecipitate	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
A	NULL
,	NULL
panel	NULL
4	NULL
,	NULL
indicates	NULL
that	NULL
the	NULL
anti-gp30/	NULL
40	NULL
antibody	NULL
reprecipitates	NULL
an	NULL
in	NULL
vitro-labeled	NULL
protein	NULL
from	NULL
the	NULL
primary	NULL
CD3	NULL
immunoprecipitate	NULL
that	NULL
produces	NULL
at	NULL
least	NULL
four	NULL
vertical	NULL
stripes	NULL
with	NULL
mol	NULL
wt	NULL
between	NULL
30	NULL
and	NULL
50	NULL
kD	NULL
and	NULL
differential	NULL
isoelectric	NULL
points	NULL
in	NULL
IEF	NULL
.	NULL

These	NULL
biochemical	NULL
characteristics	NULL
indicate	NULL
that	NULL
in	NULL
vitro-labeled	NULL
gp30/40	NULL
is	NULL
differentially	NULL
phosphorylated	NULL
on	NULL
several	NULL
distinct	NULL
phosphorylation	NULL
sites	NULL
and	NULL
that	NULL
its	NULL
extracellular	NULL
domain	NULL
is	NULL
highly	NULL
glycosylated	NULL
.	NULL

Indeed	NULL
,	NULL
the	NULL
deglycosylation	NULL
experiment	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
C	NULL
demonstrates	NULL
that	NULL
en-doglycosidase	NULL
treatment	NULL
of	NULL
gp30/40	NULL
reduces	NULL
its	NULL
apparent	NULL
mol	NULL
wt	NULL
in	NULL
SDS-PAGE	NULL
from	NULL
~40	NULL
to	NULL
~20	NULL
kD	NULL
.	NULL

Thus	NULL
,	NULL
glycosylation	NULL
of	NULL
the	NULL
single	NULL
asparagine	NULL
residue	NULL
in	NULL
the	NULL
extracellular	NULL
portion	NULL
of	NULL
gp30/	NULL
40	NULL
accounts	NULL
for	NULL
~20	NULL
kD	NULL
of	NULL
mol	NULL
wt	NULL
.	NULL

Fig	NULL
.	NULL

2	NULL
B	NULL
further	NULL
demonstrates	NULL
that	NULL
gp30/	NULL
40	NULL
represents	NULL
a	NULL
disulfide-linked	NULL
dimer	NULL
as	NULL
judged	NULL
from	NULL
its	NULL
differential	NULL
migration	NULL
on	NULL
nonreducing	NULL
versus	NULL
reducing	NULL
SDS-PAGE	NULL
.	NULL

A	NULL
:	NULL
Reprecipitation	NULL
(	NULL
2D	NULL
)	NULL
1	NULL
hour	NULL
24	NULL
hours	NULL
68	NULL
4	NULL
Â»	NULL
)	NULL
!	NULL

P	NULL
*	NULL
#	NULL
43	NULL
4	NULL
Â»	NULL
primary	NULL
27	NULL
#	NULL
had	NULL
[	NULL
Co34P	NULL
,	NULL
t	NULL
~-	NULL
Q|	NULL
Â®	NULL
``	NULL
*	NULL
lu	NULL
27	NULL
#	NULL
Â»	NULL
a	NULL
secondary	NULL
gp30-40	NULL
IP	NULL
18	NULL
4	NULL
Â»	NULL
preimmune	NULL
immune	NULL
B	NULL
:	NULL
Reprecipitation	NULL
(	NULL
1D	NULL
)	NULL
C	NULL
:	NULL
Deglycosylation	NULL
ESR	NULL
ENDO	NULL
F	NULL
imm	NULL
,	NULL
pre	NULL
.	NULL

_	NULL
f	NULL
200	NULL
4	NULL
Â»	NULL
96	NULL
96	NULL
#	NULL
Â»	NULL
68	NULL
%	NULL
#	NULL
68	NULL
4	NULL
Â»	NULL
43	NULL
4	NULL
Â»	NULL
.	NULL

27	NULL
4	NULL
Â»	NULL
a	NULL
,	NULL
Â«	NULL
s	NULL
Â»	NULL
Â£1	NULL
18	NULL
tm	NULL
nr	NULL
.	NULL

red	NULL
{	NULL
4	NULL
Â»	NULL
|	NULL
Figure	NULL
2	NULL
.	NULL

-	NULL
Biochemical	NULL
characterization	NULL
of	NULL
gp30/40	NULL
.	NULL

(	NULL
A	NULL
)	NULL
10	NULL
``	NULL
HPB-ALL	NULL
cells	NULL
lysed	NULL
in	NULL
Brij58-containing	NULL
buffer	NULL
were	NULL
subjected	NULL
to	NULL
CD3	NULL
immunoprecipitation	NULL
followed	NULL
by	NULL
in	NULL
vitro	NULL
kinase	NULL
assay	NULL
.	NULL

10	NULL
%	NULL
of	NULL
the	NULL
in	NULL
vitro-labeled	NULL
material	NULL
was	NULL
directly	NULL
applied	NULL
to	NULL
two-dimensional	NULL
IEF/	NULL
SDS-PAGE	NULL
(	NULL
panels	NULL
1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

The	NULL
remaining	NULL
90	NULL
%	NULL
was	NULL
subjected	NULL
to	NULL
reprecipitation	NULL
using	NULL
preimmune	NULL
serum	NULL
(	NULL
panel	NULL
3	NULL
)	NULL
or	NULL
immune	NULL
anti-gp30/	NULL
40	NULL
serum	NULL
(	NULL
panel	NULL
4	NULL
)	NULL
.	NULL

Panel	NULL
2	NULL
was	NULL
overexposed	NULL
to	NULL
visualize	NULL
gp30/	NULL
40	NULL
in	NULL
the	NULL
CD3	NULL
immunoprecipitate	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
same	NULL
experiment	NULL
except	NULL
that	NULL
the	NULL
precipitates	NULL
were	NULL
analyzed	NULL
by	NULL
one-dimensional	NULL
SDS-PAGE	NULL
under	NULL
nonreducing	NULL
(	NULL
nr	NULL
.	NULL
)	NULL

or	NULL
reducing	NULL
(	NULL
red	NULL
.	NULL
)	NULL

conditions	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Deglycosylation	NULL
experiment	NULL
.	NULL

In	NULL
vitro-labeled	NULL
gp30/40	NULL
was	NULL
left	NULL
untreated	NULL
(	NULL
-	NULL
)	NULL
or	NULL
incubated	NULL
with	NULL
buffer	NULL
supplemented	NULL
with	NULL
endo-glycosidase	NULL
F	NULL
(	NULL
+	NULL
)	NULL
followed	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
autoradiography	NULL
.	NULL

1185	NULL
Marie-Cardine	NULL
et	NULL
al	NULL
.	NULL

The	NULL
data	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
panels	NULL
1	NULL
and	NULL
2	NULL
,	NULL
explain	NULL
why	NULL
we	NULL
have	NULL
not	NULL
recognized	NULL
the	NULL
existence	NULL
of	NULL
gp30/	NULL
40	NULL
as	NULL
a	NULL
part	NULL
of	NULL
the	NULL
CD3-associated	NULL
signaling	NULL
complex	NULL
in	NULL
our	NULL
previous	NULL
studies	NULL
.	NULL

Thus	NULL
,	NULL
on	NULL
a	NULL
standard	NULL
1-h	NULL
exposure	NULL
of	NULL
the	NULL
in	NULL
vitro-labeled	NULL
CD3	NULL
immunoprecipitate	NULL
gp30/40	NULL
is	NULL
not	NULL
visible	NULL
,	NULL
perhaps	NULL
because	NULL
of	NULL
its	NULL
migration	NULL
in	NULL
IEF/	NULL
SDS-PAGE	NULL
as	NULL
a	NULL
diffuse	NULL
and	NULL
only	NULL
weakly	NULL
focusing	NULL
polypeptide	NULL
.	NULL

Only	NULL
upon	NULL
overexposure	NULL
of	NULL
the	NULL
dried	NULL
gels	NULL
do	NULL
the	NULL
long	NULL
stripes	NULL
corresponding	NULL
to	NULL
in	NULL
vitro-labeled	NULL
gp30/	NULL
40	NULL
become	NULL
visible	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
A	NULL
,	NULL
panel	NULL
2	NULL
)	NULL
.	NULL

These	NULL
properties	NULL
of	NULL
gp30/	NULL
40	NULL
also	NULL
provide	NULL
an	NULL
explanation	NULL
for	NULL
the	NULL
difficulties	NULL
to	NULL
analyze	NULL
gp30/	NULL
40	NULL
bio-chemically	NULL
(	NULL
see	NULL
below	NULL
)	NULL
.	NULL

Tissue	NULL
Distnbution	NULL
of	NULL
g30/	NULL
40	NULL
.	NULL

_	NULL
Expression	NULL
of	NULL
the	NULL
gp30/	NULL
40	NULL
gene	NULL
was	NULL
determined	NULL
by	NULL
Northern	NULL
blot	NULL
analysis	NULL
using	NULL
a	NULL
gp30/	NULL
40	NULL
cDNA	NULL
probe	NULL
.	NULL

The	NULL
multiple	NULL
tissue	NULL
Northern	NULL
blots	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
demonstrate	NULL
that	NULL
gp30/	NULL
40	NULL
is	NULL
strongly	NULL
expressed	NULL
in	NULL
thymus	NULL
and	NULL
to	NULL
a	NULL
lesser	NULL
extent	NULL
in	NULL
spleen	NULL
and	NULL
lymph	NULL
nodes	NULL
.	NULL

Upon	NULL
overexposure	NULL
of	NULL
the	NULL
shown	NULL
blots	NULL
,	NULL
weak	NULL
gp30/	NULL
40	NULL
mRNA	NULL
signals	NULL
are	NULL
also	NULL
detectable	NULL
in	NULL
peripheral	NULL
blood	NULL
leukocytes	NULL
and	NULL
bone	NULL
marrow	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
low	NULL
amounts	NULL
of	NULL
gp30/	NULL
40	NULL
are	NULL
expressed	NULL
not	NULL
only	NULL
in	NULL
T	NULL
cells	NULL
but	NULL
also	NULL
in	NULL
other	NULL
cells	NULL
of	NULL
hematopoietic	NULL
origin	NULL
.	NULL

Indeed	NULL
,	NULL
further	NULL
analysis	NULL
revealed	NULL
that	NULL
gp30/	NULL
40	NULL
is	NULL
expressed	NULL
in	NULL
the	NULL
HPB-	NULL
ALL	NULL
and	NULL
Jurkat	NULL
T	NULL
cell	NULL
lines	NULL
and	NULL
to	NULL
a	NULL
lower	NULL
extent	NULL
in	NULL
the	NULL
B	NULL
cell	NULL
lines	NULL
LAZ509	NULL
and	NULL
SKW6.9	NULL
,	NULL
whereas	NULL
it	NULL
is	NULL
not	NULL
detectable	NULL
in	NULL
monocytic	NULL
cell	NULL
lines	NULL
HL-60	NULL
and	NULL
U937	NULL
,	NULL
nor	NULL
the	NULL
erythroleukemic	NULL
cell	NULL
line	NULL
K562	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
data	NULL
collectively	NULL
suggest	NULL
that	NULL
gp30/40	NULL
is	NULL
selectively	NULL
expressed	NULL
in	NULL
lymphocytes	NULL
.	NULL

Subcellular	NULL
Locliz	NULL
ation	NULL
of	NULL
g	NULL
Â»	NULL
30/	NULL
40	NULL
.	NULL

The	NULL
aa	NULL
sequence	NULL
of	NULL
gp30/	NULL
40	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
B	NULL
)	NULL
strongly	NULL
suggested	NULL
that	NULL
it	NULL
represents	NULL
an	NULL
integral	NULL
membrane	NULL
protein	NULL
.	NULL

We	NULL
attempted	NULL
to	NULL
assess	NULL
the	NULL
subcellular	NULL
localization	NULL
of	NULL
gp30/	NULL
40	NULL
in	NULL
the	NULL
T	NULL
cell	NULL
lines	NULL
HPB-ALL	NULL
and	NULL
Jurkat	NULL
(	NULL
both	NULL
expressing	NULL
endogenous	NULL
gp30/	NULL
40	NULL
)	NULL
by	NULL
indirect	NULL
immunofluorescence	NULL
using	NULL
an	NULL
affinity-purified	NULL
gp30/	NULL
40	NULL
antiserum	NULL
.	NULL

However	NULL
,	NULL
our	NULL
attempts	NULL
to	NULL
localize	NULL
endogenous	NULL
gp30/	NULL
40	NULL
within	NULL
the	NULL
two	NULL
cell	NULL
lines	NULL
remained	NULL
un-successful	NULL
,	NULL
perhaps	NULL
because	NULL
the	NULL
amounts	NULL
gp30/	NULL
40	NULL
that	NULL
are	NULL
constitutively	NULL
expressed	NULL
are	NULL
too	NULL
low	NULL
to	NULL
be	NULL
detected	NULL
by	NULL
our	NULL
E	NULL
ia	NULL
P	NULL
zn	NULL
z	NULL
E	NULL
3	NULL
400	NULL
$	NULL
s	NULL
a	NULL
=	NULL
9	NULL
&	NULL
5	NULL
m	NULL
5	NULL
<	NULL
e	NULL
F	NULL
Z	NULL
u	NULL
$	NULL
4	NULL
=	NULL
B	NULL
2	NULL
5	NULL
2	NULL
4	NULL
&	NULL
ES	NULL
O19	NULL
af	NULL
.	NULL

,	NULL
kb	NULL
85	NULL
m	NULL
&	NULL
2	NULL
1	NULL
z	NULL
2	NULL
%	NULL
E	NULL
4	NULL
Q	NULL
&	NULL
=	NULL
U	NULL
S	NULL
$	NULL
3	NULL
29	NULL
4	NULL
2	NULL
E	NULL
a	NULL
&	NULL
:	NULL
o	NULL
Â®	NULL
o	NULL
aS	NULL
$	NULL
a	NULL
ass	NULL
<	NULL
2	NULL
D	NULL
A	NULL
zZ	NULL
&	NULL
Â»	NULL
=	NULL
m	NULL
9	NULL
ia	NULL
I	NULL
g	NULL
u	NULL
2	NULL
2	NULL
0	NULL
m	NULL
Hx	NULL
J	NULL
2	NULL
Ak	NULL
5	NULL
<	NULL
wa	NULL
fom	NULL
m	NULL
ok	NULL
oBRom	NULL
BR	NULL
O	NULL
m	NULL
Qo	NULL
m	NULL
E	NULL
m	NULL
&	NULL
4	NULL
Lw	NULL
&	NULL
c	NULL
7.5	NULL
4.4	NULL
#	NULL
>	NULL
4	NULL
4p	NULL
<	NULL
&	NULL
g	NULL
1.35	NULL
.	NULL

$	NULL
Figure	NULL
3	NULL
.	NULL

-	NULL
Tissue	NULL
distribution	NULL
of	NULL
gp30/40	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
demonstrating	NULL
expression	NULL
of	NULL
gp30/40	NULL
in	NULL
hematopoietic	NULL
cells	NULL
A	NULL
full-length	NULL
gp30/	NULL
40	NULL
cDNA	NULL
probe	NULL
was	NULL
used	NULL
for	NULL
hybridization	NULL
.	NULL

antiserum	NULL
(	NULL
for	NULL
example	NULL
see	NULL
Fig	NULL
.	NULL

6	NULL
A	NULL
)	NULL
.	NULL

To	NULL
circumvent	NULL
this	NULL
problem	NULL
,	NULL
we	NULL
transiently	NULL
overexpressed	NULL
gp30/	NULL
40	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
and	NULL
COS	NULL
cells	NULL
.	NULL

The	NULL
transfectants	NULL
were	NULL
then	NULL
permeabi-lized	NULL
with	NULL
acetone	NULL
and	NULL
stained	NULL
with	NULL
affinity-purified	NULL
gp30/	NULL
40	NULL
antiserum	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
the	NULL
antiserum	NULL
was	NULL
proven	NULL
in	NULL
a	NULL
Jurkat	NULL
variant	NULL
stably	NULL
expressing	NULL
a	NULL
chimeric	NULL
gp30/40	NULL
molecule	NULL
in	NULL
which	NULL
the	NULL
cytoplasmic	NULL
part	NULL
of	NULL
gp30/	NULL
40	NULL
was	NULL
fused	NULL
to	NULL
the	NULL
extracellular	NULL
and	NULL
transmembrane	NULL
domains	NULL
of	NULL
CD8	NULL
(	NULL
CCG	NULL
chimera	NULL
,	NULL
Fig	NULL
.	NULL

4	NULL
A	NULL
,	NULL
panels	NULL
5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

The	NULL
confocal	NULL
laser	NULL
scan	NULL
images	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
A	NULL
,	NULL
panels	NULL
1	NULL
,	NULL
2	NULL
(	NULL
Jurkat	NULL
cells	NULL
)	NULL
,	NULL
and	NULL
4	NULL
(	NULL
COS	NULL
cells	NULL
)	NULL
indicated	NULL
that	NULL
,	NULL
as	NULL
expected	NULL
,	NULL
gp30/	NULL
40	NULL
appears	NULL
to	NULL
accumulate	NULL
at	NULL
the	NULL
level	NULL
of	NULL
the	NULL
plasma	NULL
membrane	NULL
.	NULL

No	NULL
reactivity	NULL
of	NULL
the	NULL
antiserum	NULL
was	NULL
seen	NULL
in	NULL
nontransfected	NULL
COS	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
A	NULL
,	NULL
panel	NULL
3	NULL
)	NULL
,	NULL
ruling	NULL
out	NULL
the	NULL
possibility	NULL
of	NULL
A	NULL
1	NULL
2	NULL
3.4	NULL
<	NULL
.ï¬	NULL
nonspecific	NULL
reactivity	NULL
of	NULL
the	NULL
antiserum	NULL
with	NULL
a	NULL
membrane	NULL
associated	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
unrelated	NULL
to	NULL
gp30/	NULL
40	NULL
.	NULL

To	NULL
further	NULL
prove	NULL
membrane	NULL
association	NULL
of	NULL
endogenously	NULL
expressed	NULL
gp30/	NULL
40	NULL
in	NULL
nontransfected	NULL
T	NULL
cells	NULL
,	NULL
cytosolic	NULL
and	NULL
high	NULL
salt-washed	NULL
membrane	NULL
fractions	NULL
were	NULL
prepared	NULL
from	NULL
pervanadate-treated	NULL
Jurkat	NULL
cells	NULL
and	NULL
subjected	NULL
to	NULL
gp30/	NULL
40	NULL
immunoprecipitation	NULL
followed	NULL
by	NULL
anti-PTYR	NULL
Western	NULL
blot	NULL
analysis	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
the	NULL
left	NULL
panel	NULL
of	NULL
Fig	NULL
.	NULL

4	NULL
B	NULL
,	NULL
gp30/	NULL
40	NULL
is	NULL
exclusively	NULL
detectable	NULL
in	NULL
the	NULL
membrane	NULL
fraction	NULL
,	NULL
whereas	NULL
no	NULL
signal	NULL
was	NULL
obtained	NULL
when	NULL
the	NULL
immunoprecipitate	NULL
was	NULL
prepared	NULL
from	NULL
the	NULL
cytosolic	NULL
fraction	NULL
.	NULL

The	NULL
purity	NULL
of	NULL
the	NULL
individual	NULL
fractions	NULL
was	NULL
proven	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
us	NULL
ing	NULL
antibodies	NULL
directed	NULL
at	NULL
MAP	NULL
kinase	NULL
and	NULL
the	NULL
recently	NULL
described	NULL
transmembrane	NULL
protein	NULL
LPAP	NULL
.	NULL

MAP	NULL
kinase	NULL
was	NULL
C	NULL
M	NULL
L	NULL
C	NULL
M	NULL
200	NULL
#	NULL
Â»	NULL
96	NULL
30/40	NULL
68	NULL
Ep	NULL
B	NULL
43m	NULL
iet	NULL
s=	NULL
ae	NULL
0	NULL
{	NULL
MAP	NULL
-	NULL
__	NULL
ews	NULL
LPAP	NULL
27	NULL
IP	NULL
:	NULL
gp30/40	NULL
BLOT	NULL
:	NULL
PTYR	NULL
1	NULL
2	NULL
3	NULL
%	NULL
4050607	NULL
8	NULL
%	NULL
9100	NULL
Had2ddsd4ds	NULL
96	NULL
-~	NULL
68	NULL
-m	NULL
43	NULL
-t	NULL
Â»	NULL
i	NULL
*	NULL
!	NULL

e	NULL
|-*	NULL
s	NULL
27	NULL
#	NULL
Â»	NULL
Â©	NULL
is	NULL
Â»	NULL
)	NULL
*_	NULL
@	NULL
@	NULL
lu	NULL
Â«	NULL
14	NULL
-	NULL
#	NULL
Â»	NULL
HPB-ALL/L	NULL
_	NULL
HPB-ALL2Z	NULL
-	NULL
_	NULL
JRT3-T31	NULL
Figure	NULL
4	NULL
.	NULL

-	NULL
Subcellular	NULL
localization	NULL
of	NULL
gp30/40	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Confocal	NULL
laser	NULL
scan	NULL
microscopy	NULL
depicting	NULL
the	NULL
subcellular	NULL
localization	NULL
of	NULL
gp30/	NULL
40	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
(	NULL
panels	NULL
1	NULL
and	NULL
2	NULL
)	NULL
or	NULL
COS	NULL
cells	NULL
(	NULL
panels	NULL
3	NULL
and	NULL
4	NULL
)	NULL
were	NULL
left	NULL
untransfected	NULL
(	NULL
panel	NULL
3	NULL
)	NULL
or	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
a	NULL
plasmid	NULL
encoding	NULL
wild-type	NULL
gp30/	NULL
40	NULL
(	NULL
panels	NULL
1	NULL
,	NULL
2	NULL
,	NULL
and	NULL
4	NULL
)	NULL
.	NULL

The	NULL
subcellular	NULL
localization	NULL
of	NULL
gp30/	NULL
40	NULL
was	NULL
then	NULL
assessed	NULL
using	NULL
an	NULL
affinity-	NULL
purified	NULL
gp30/	NULL
40	NULL
antiserum	NULL
.	NULL

Note	NULL
that	NULL
panel	NULL
2	NULL
is	NULL
an	NULL
inverted	NULL
image	NULL
of	NULL
panel	NULL
1	NULL
that	NULL
allows	NULL
visualization	NULL
of	NULL
cells	NULL
that	NULL
express	NULL
only	NULL
very	NULL
low	NULL
levels	NULL
of	NULL
the	NULL
transfected	NULL
molecule	NULL
.	NULL

Panels	NULL
5	NULL
and	NULL
6	NULL
show	NULL
specificity	NULL
controls	NULL
for	NULL
the	NULL
antiserum	NULL
.	NULL

Jurkat	NULL
cells	NULL
stably	NULL
expressing	NULL
a	NULL
chimeric	NULL
gp30/	NULL
40	NULL
molecule	NULL
(	NULL
the	NULL
cytoplasmic	NULL
part	NULL
of	NULL
gp30/	NULL
40	NULL
fused	NULL
to	NULL
the	NULL
extracellular	NULL
and	NULL
transmembrane	NULL
portions	NULL
of	NULL
human	NULL
CD8	NULL
,	NULL
CCG	NULL
chimera	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
gp30/	NULL
40	NULL
(	NULL
red	NULL
fluorescence	NULL
,	NULL
Cy3	NULL
,	NULL
panel	NULL
5	NULL
)	NULL
and	NULL
CD8	NULL
(	NULL
green	NULL
fluorescence	NULL
,	NULL
Cy2	NULL
,	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
antibodies	NULL
.	NULL

Panel	NULL
5	NULL
depicts	NULL
the	NULL
membrane	NULL
localization	NULL
of	NULL
gp30/	NULL
40	NULL
in	NULL
CCG	NULL
cells	NULL
,	NULL
and	NULL
panel	NULL
6	NULL
shows	NULL
the	NULL
colocalization	NULL
of	NULL
CD8	NULL
and	NULL
gp30/	NULL
40	NULL
.	NULL

(	NULL
B	NULL
)	NULL
gp30/	NULL
40	NULL
is	NULL
an	NULL
integral	NULL
membrane	NULL
protein	NULL
.	NULL

(	NULL
Left	NULL
)	NULL
Cytosolic	NULL
(	NULL
C	NULL
)	NULL
and	NULL
membrane	NULL
(	NULL
M	NULL
)	NULL
fractions	NULL
were	NULL
prepared	NULL
from	NULL
pervanadate-treated	NULL
Jurkat	NULL
T	NULL
cells	NULL
and	NULL
subjected	NULL
to	NULL
anti-gp30/	NULL
40	NULL
immunoprecipitation	NULL
.	NULL

Precipitates	NULL
were	NULL
then	NULL
separated	NULL
by	NULL
nonreducing	NULL
SDS-PAGE	NULL
and	NULL
analyzed	NULL
by	NULL
anti-PTYR	NULL
Western	NULL
blot	NULL
.	NULL

gp30/	NULL
40	NULL
is	NULL
visible	NULL
under	NULL
these	NULL
experimental	NULL
conditions	NULL
as	NULL
a	NULL
broad	NULL
band	NULL
migrating	NULL
between	NULL
60	NULL
and	NULL
90	NULL
kD	NULL
.	NULL

(	NULL
Right	NULL
)	NULL
Specificity	NULL
controls	NULL
.	NULL

Aliquots	NULL
of	NULL
total	NULL
lysates	NULL
(	NULL
L	NULL
,	NULL
10Â°	NULL
cells	NULL
)	NULL
,	NULL
the	NULL
cytosolic	NULL
fraction	NULL
(	NULL
C	NULL
,	NULL
10Â°	NULL
cells	NULL
)	NULL
and	NULL
the	NULL
membrane	NULL
fraction	NULL
(	NULL
M	NULL
,	NULL
5	NULL
X	NULL
106	NULL
cells	NULL
)	NULL
were	NULL
separated	NULL
on	NULL
reducing	NULL
SDS-PAGE	NULL
and	NULL
sequentially	NULL
immunoblotted	NULL
with	NULL
antibodies	NULL
directed	NULL
at	NULL
MAP-kinase	NULL
or	NULL
the	NULL
CD45	NULL
associated	NULL
transmembrane	NULL
protein	NULL
LPAP	NULL
.	NULL

(	NULL
C	NULL
)	NULL
gp30/	NULL
40	NULL
localizes	NULL
at	NULL
the	NULL
cell	NULL
membrane	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

3	NULL
X	NULL
10	NULL
``	NULL
HPB-ALL	NULL
(	NULL
left	NULL
)	NULL
or	NULL
TCR	NULL
-defficient	NULL
JRT3-T3.1	NULL
cells	NULL
(	NULL
right	NULL
)	NULL
were	NULL
externally	NULL
labeled	NULL
with	NULL
CD3	NULL
mAb	NULL
(	NULL
OKT-3	NULL
)	NULL
.	NULL

Unbound	NULL
antibodies	NULL
were	NULL
removed	NULL
by	NULL
washing	NULL
and	NULL
cells	NULL
were	NULL
lysed	NULL
in	NULL
1	NULL
%	NULL
Brij58-containing	NULL
buffer	NULL
.	NULL

Preformed	NULL
immune	NULL
complexes	NULL
were	NULL
collected	NULL
with	NULL
protein	NULL
A-Sepharose	NULL
and	NULL
subjected	NULL
to	NULL
in	NULL
vitro	NULL
kinase	NULL
assay	NULL
.	NULL

In	NULL
vitro	NULL
phosphorylated	NULL
proteins	NULL
were	NULL
subjected	NULL
to	NULL
reprecipitation	NULL
using	NULL
protein	NULL
A-Sepharose	NULL
alone	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
11	NULL
)	NULL
,	NULL
anti-gp30/	NULL
40	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
12	NULL
)	NULL
,	NULL
anti-	NULL
{	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
13	NULL
)	NULL
,	NULL
anti-	NULL
TRIM	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
14	NULL
)	NULL
,	NULL
or	NULL
CD3-e	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
15	NULL
)	NULL
antibodies	NULL
.	NULL

Lanes	NULL
6-10	NULL
show	NULL
the	NULL
same	NULL
experiment	NULL
as	NULL
in	NULL
lanes	NULL
1-5	NULL
except	NULL
that	NULL
in	NULL
lanes	NULL
6-10	NULL
HPB-	NULL
ALL	NULL
cells	NULL
were	NULL
first	NULL
lysed	NULL
in	NULL
digitonin	NULL
and	NULL
then	NULL
subjected	NULL
to	NULL
CD3-e	NULL
immunoprecipitation	NULL
.	NULL

1186	NULL
_	NULL
The	NULL
SHP2-interacting	NULL
Transmembrane	NULL
Adaptor	NULL
Protein	NULL
SIT	NULL
exclusively	NULL
found	NULL
in	NULL
the	NULL
cytosolic	NULL
fraction	NULL
,	NULL
whereas	NULL
LPAP	NULL
selectively	NULL
localized	NULL
in	NULL
the	NULL
membrane	NULL
preparation	NULL
.	NULL

Thus	NULL
,	NULL
gp30/	NULL
40	NULL
is	NULL
an	NULL
integral	NULL
membrane	NULL
protein	NULL
.	NULL

To	NULL
finally	NULL
assess	NULL
whether	NULL
gp30/	NULL
40	NULL
is	NULL
expressed	NULL
at	NULL
the	NULL
cell	NULL
surface	NULL
of	NULL
T	NULL
lymphocytes	NULL
,	NULL
HPB-ALL	NULL
T	NULL
cells	NULL
were	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
30	NULL
min	NULL
with	NULL
a	NULL
CD3-e	NULL
mAb	NULL
of	NULL
the	NULL
IgG2a	NULL
isotype	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
washed	NULL
with	NULL
ice-cold	NULL
buffer	NULL
(	NULL
to	NULL
remove	NULL
all	NULL
unbound	NULL
CD3	NULL
mAbs	NULL
)	NULL
and	NULL
lysed	NULL
in	NULL
Brij58-containing	NULL
buffer	NULL
,	NULL
which	NULL
preserves	NULL
the	NULL
association	NULL
between	NULL
gp30/	NULL
40	NULL
and	NULL
the	NULL
TCR-CD3-Â£	NULL
complex	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

2	NULL
A	NULL
)	NULL
.	NULL

Af	NULL
ter	NULL
depletion	NULL
of	NULL
the	NULL
nuclei	NULL
,	NULL
the	NULL
preformed	NULL
immune	NULL
complexes	NULL
were	NULL
collected	NULL
using	NULL
protein	NULL
A-Sepharose	NULL
and	NULL
subjected	NULL
to	NULL
in	NULL
vitro	NULL
kinase	NULL
assay	NULL
.	NULL

The	NULL
in	NULL
vitro-labeled	NULL
proteins	NULL
were	NULL
subsequently	NULL
released	NULL
from	NULL
the	NULL
primary	NULL
immunoprecipitates	NULL
using	NULL
SDS-containing	NULL
buffer	NULL
and	NULL
subjected	NULL
to	NULL
a	NULL
second	NULL
round	NULL
of	NULL
immunoprecipitation	NULL
using	NULL
gp30/	NULL
40	NULL
antiserum	NULL
.	NULL

These	NULL
secondary	NULL
immunoprecipitates	NULL
were	NULL
separated	NULL
on	NULL
reducing	NULL
14	NULL
%	NULL
SDS-PAGE	NULL
and	NULL
analyzed	NULL
by	NULL
autoradiography	NULL
.	NULL

As	NULL
a	NULL
positive	NULL
control	NULL
,	NULL
we	NULL
used	NULL
antisera	NULL
directed	NULL
at	NULL
proteins	NULL
that	NULL
are	NULL
known	NULL
to	NULL
associate	NULL
with	NULL
the	NULL
TCR	NULL
on	NULL
the	NULL
cell	NULL
surface	NULL
,	NULL
namely	NULL
CD3-e	NULL
,	NULL
the	NULL
{	NULL
chains	NULL
,	NULL
and	NULL
TRIM	NULL
.	NULL

The	NULL
left	NULL
panel	NULL
of	NULL
Fig	NULL
.	NULL

4	NULL
C	NULL
demonstrates	NULL
that	NULL
gp30/	NULL
40	NULL
co-precipitates	NULL
with	NULL
cell	NULL
surface-expressed	NULL
CD3-e	NULL
in	NULL
the	NULL
HPB-ALL	NULL
T	NULL
cell	NULL
line	NULL
.	NULL

This	NULL
association	NULL
seems	NULL
to	NULL
be	NULL
similar	NULL
to	NULL
the	NULL
association	NULL
that	NULL
is	NULL
detectable	NULL
in	NULL
HPB-	NULL
ALL	NULL
cells	NULL
that	NULL
are	NULL
first	NULL
lysed	NULL
and	NULL
then	NULL
subjected	NULL
to	NULL
CD3	NULL
immunoprecipitation	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
C	NULL
,	NULL
middle	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
when	NULL
Jur-	NULL
kat	NULL
T	NULL
cells	NULL
were	NULL
analyzed	NULL
in	NULL
an	NULL
identical	NULL
fashion	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
whereas	NULL
no	NULL
specific	NULL
signal	NULL
was	NULL
detectable	NULL
in	NULL
a	NULL
TCR	NULL
a	NULL
chain-deficient	NULL
Jurkat	NULL
variant	NULL
(	NULL
JR	NULL
T3-T3.1	NULL
)	NULL
lacking	NULL
cell	NULL
surface	NULL
expression	NULL
of	NULL
the	NULL
TCR-CD3-Â£	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
C	NULL
,	NULL
right	NULL
)	NULL
.	NULL

This	NULL
rules	NULL
out	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
externally	NULL
applied	NULL
CD3	NULL
mAb	NULL
passed	NULL
the	NULL
cell	NULL
membrane	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
data	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
collectively	NULL
demonstrate	NULL
that	NULL
gp30/	NULL
40	NULL
is	NULL
an	NULL
integral	NULL
membrane	NULL
protein	NULL
that	NULL
is	NULL
expressed	NULL
at	NULL
the	NULL
cell	NULL
surface	NULL
of	NULL
T	NULL
cells	NULL
.	NULL

Tyrosine	NULL
Phosphorylation	NULL
of	NULL
g30/	NULL
40	NULL
after	NULL
T	NULL
Cell	NULL
Adivation	NULL
.	NULL

To	NULL
investigate	NULL
whether	NULL
gp30/40	NULL
becomes	NULL
tyrosine	NULL
phos	NULL
phorylated	NULL
after	NULL
TCR	NULL
-mediated	NULL
activation	NULL
of	NULL
T	NULL
lymphocytes	NULL
,	NULL
HPB-ALL	NULL
cells	NULL
were	NULL
stimulated	NULL
for	NULL
various	NULL
periods	NULL
of	NULL
time	NULL
with	NULL
a	NULL
mixture	NULL
of	NULL
biotinylated	NULL
CD3	NULL
and	NULL
CD4	NULL
mAbs	NULL
that	NULL
were	NULL
cross-linked	NULL
on	NULL
the	NULL
cell	NULL
surface	NULL
with	NULL
avidin	NULL
.	NULL

Subsequently	NULL
,	NULL
cells	NULL
were	NULL
lysed	NULL
in	NULL
NP-40-containing	NULL
buffer	NULL
and	NULL
subjected	NULL
to	NULL
immunoprecipitation	NULL
with	NULL
anti-PTYR	NULL
mAb	NULL
PY72	NULL
.	NULL

Immunoprecipitates	NULL
were	NULL
separated	NULL
on	NULL
SDS-PAGE	NULL
and	NULL
analyzed	NULL
by	NULL
anti-gp30/40	NULL
Western	NULL
blot	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
A	NULL
,	NULL
low	NULL
amounts	NULL
of	NULL
constitutively	NULL
tyrosine	NULL
phosphorylated	NULL
gp30/	NULL
40	NULL
are	NULL
detectable	NULL
in	NULL
nonstimulated	NULL
HPB-	NULL
ALL	NULL
cells	NULL
.	NULL

Perhaps	NULL
more	NULL
importantly	NULL
,	NULL
the	NULL
level	NULL
of	NULL
phosphorylation	NULL
of	NULL
gp30/	NULL
40	NULL
strongly	NULL
increased	NULL
after	NULL
cross-linking	NULL
of	NULL
the	NULL
CD3	NULL
and	NULL
CD4	NULL
receptor	NULL
molecules	NULL
.	NULL

Moreover	NULL
,	NULL
a	NULL
dramatic	NULL
increase	NULL
in	NULL
gp30/	NULL
40	NULL
tyrosine	NULL
phosphorylation	NULL
was	NULL
induced	NULL
in	NULL
HPB-	NULL
ALL	NULL
cells	NULL
stimulated	NULL
with	NULL
pervanadate	NULL
.	NULL

Similar	NULL
results	NULL
as	NULL
shown	NULL
here	NULL
were	NULL
obtained	NULL
when	NULL
gp30/	NULL
40	NULL
immu-	NULL
A	NULL
CD3	NULL
x	NULL
CD4	NULL
C	NULL
s	NULL
Â»	NULL
semon=o	NULL
[	NULL
+	NULL
]	NULL
+	NULL
]	NULL
+	NULL
]	NULL
+	NULL
]	NULL
+	NULL
>	NULL
+	NULL
g	NULL
IP	NULL
30/4ON-	NULL
>	NULL
0	NULL
2	NULL
10	NULL
``	NULL
z	NULL
sa	NULL
[	NULL
p	NULL
*+	NULL
>	NULL
r	NULL
g	NULL
200	NULL
4	NULL
Â»	NULL
zAaP70	NULL
+	NULL
+	NULL
|	NULL
+	NULL
fyn	NULL
06	NULL
Â»	NULL
'	NULL
syk	NULL
+	NULL
zap	NULL
-	NULL
syk	NULL
ws	NULL
we	NULL
96	NULL
Â»	NULL
~A	NULL
=	NULL
am	NULL
68	NULL
-	NULL
#	NULL
]	NULL
-	NULL
__	NULL
5	NULL
f	NULL
}	NULL
I	NULL
,	NULL
TKq	NULL
gp30/0|	NULL
--	NULL
--	NULL
=	NULL
%	NULL
B	NULL
=s	NULL
-	NULL
=	NULL
43	NULL
4	NULL
Â»	NULL
43-4	NULL
*	NULL
s	NULL
;	NULL
al	NULL
<	NULL
a	NULL
ass	NULL
27	NULL
#	NULL
Â»	NULL
27	NULL
#	NULL
Â»	NULL
*	NULL
<	NULL
-	NULL
gp30/40	NULL
fyn	NULL
ases	NULL
-	NULL
Â»	NULL
]	NULL
-	NULL
|	NULL
Lysates	NULL
-I	NULL
18-81	NULL
__	NULL
ZAP70	NULL
cue	NULL
=_	NULL
-	NULL
-	NULL
Â»	NULL
PTYR-IP	NULL
m	NULL
-	NULL
|	NULL
<	NULL
syki	NULL
~	NULL
gp30/40	NULL
Blot	NULL
a	NULL
.	NULL

<	NULL
-	NULL
gp30/40	NULL
T	NULL
B	NULL
C305	NULL
PV	NULL
0	NULL
1	NULL
``	NULL
55	NULL
15Â°	NULL
30Â°	NULL
,	NULL
2Â°	NULL
Figure	NULL
5	NULL
.	NULL

-	NULL
Tyrosine	NULL
phosphorylation	NULL
of	NULL
gp30/	NULL
40	NULL
.	NULL

(	NULL
A	NULL
)	NULL
3	NULL
X	NULL
10	NULL
``	NULL
HPB-	NULL
ALL	NULL
cells	NULL
were	NULL
ac-	NULL
#	NULL
!	NULL

.	NULL

IP	NULL
:	NULL
CD8	NULL
tivated	NULL
with	NULL
a	NULL
mixture	NULL
of	NULL
biotinylated	NULL
CD3	NULL
(	NULL
OKT-3	NULL
)	NULL
and	NULL
CD4	NULL
(	NULL
AICD4.1	NULL
)	NULL
mAbs	NULL
fol-BLOT	NULL
:	NULL
a-PTYR	NULL
lowed	NULL
by	NULL
cross-linking	NULL
with	NULL
avidin	NULL
.	NULL

As	NULL
a	NULL
positive	NULL
control	NULL
,	NULL
cells	NULL
were	NULL
stimulated	NULL
for	NULL
2	NULL
min	NULL
reprobin	NULL
;	NULL
with	NULL
pervanadate	NULL
.	NULL

Lysates	NULL
were	NULL
subjected	NULL
to	NULL
anti-PTYR	NULL
immunoprecipitation	NULL
(	NULL
PY72	NULL
)	NULL
Â«	NULL
wa	NULL
ta	NULL
oB	NULL
an|	NULL
wh	NULL
&	NULL
P	NULL
307	NULL
.	NULL

43	NULL
followed	NULL
by	NULL
gp30/40	NULL
Western	NULL
blot	NULL
analysis	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Jurkat	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
~SP	NULL
.	NULL

with	NULL
30	NULL
pug	NULL
of	NULL
plasmid	NULL
coding	NULL
for	NULL
the	NULL
CCG	NULL
chimera	NULL
.	NULL

After	NULL
overnight	NULL
incubation	NULL
,	NULL
2	NULL
X	NULL
106	NULL
200	NULL
>	NULL
cells	NULL
were	NULL
stimulated	NULL
for	NULL
the	NULL
indicated	NULL
periods	NULL
of	NULL
time	NULL
with	NULL
the	NULL
clonotypic	NULL
anti-TCR	NULL
mAb	NULL
C305	NULL
.	NULL

Subsequently	NULL
cells	NULL
were	NULL
lysed	NULL
and	NULL
subjected	NULL
to	NULL
CD8	NULL
immunoprecipitation	NULL
96	NULL
>	NULL
Â«	NULL
-m	NULL
ane	NULL
awan	NULL
-	NULL
followed	NULL
by	NULL
anti-PTYR	NULL
Western	NULL
blotting	NULL
(	NULL
top	NULL
)	NULL
.	NULL

The	NULL
blot	NULL
was	NULL
then	NULL
stripped	NULL
and	NULL
reincu-68	NULL
Â«	NULL
tte	NULL
Tills	NULL
ust	NULL
bated	NULL
with	NULL
gp30/40	NULL
antibodies	NULL
(	NULL
middle	NULL
)	NULL
.	NULL

Lysates	NULL
corresponding	NULL
to	NULL
3	NULL
X	NULL
10Â°	NULL
cells	NULL
were	NULL
-	NULL
>	NULL
Â»	NULL
Lysates	NULL
separately	NULL
analyzed	NULL
for	NULL
induction	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
by	NULL
anti-PTYR	NULL
Western	NULL
Â©	NULL
c-PTYR	NULL
blotting	NULL
(	NULL
bottom	NULL
)	NULL
.	NULL

(	NULL
C	NULL
)	NULL
COS	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
the	NULL
cDNA	NULL
constructs	NULL
43	NULL
>	NULL
depicted	NULL
on	NULL
top	NULL
of	NULL
each	NULL
lane	NULL
.	NULL

10	NULL
%	NULL
of	NULL
the	NULL
transfectants	NULL
was	NULL
analyzed	NULL
by	NULL
anti-PTYR	NULL
West-	NULL
@	NULL
m	NULL
-	NULL
ern	NULL
blot	NULL
(	NULL
top	NULL
left	NULL
)	NULL
.	NULL

The	NULL
blot	NULL
was	NULL
stripped	NULL
and	NULL
expression	NULL
of	NULL
the	NULL
individual	NULL
constructs	NULL
as	NULL
sessed	NULL
using	NULL
gp30/	NULL
40	NULL
,	NULL
Lok	NULL
,	NULL
Fyn	NULL
,	NULL
myc	NULL
(	NULL
myc-ZAP70	NULL
)	NULL
,	NULL
and	NULL
FLAG	NULL
(	NULL
FLAG-Syk	NULL
)	NULL
antibodies	NULL
,	NULL
respectively	NULL
(	NULL
right	NULL
)	NULL
.	NULL

The	NULL
remaining	NULL
90	NULL
%	NULL
of	NULL
the	NULL
lysates	NULL
was	NULL
subjected	NULL
to	NULL
anti-PTYR	NULL
im-28	NULL
>	NULL
munoprecipitation	NULL
and	NULL
analyzed	NULL
by	NULL
gp30/	NULL
40	NULL
Western	NULL
blot	NULL
(	NULL
bottom	NULL
left	NULL
)	NULL
.	NULL

1187	NULL
Marie-Cardine	NULL
et	NULL
al	NULL
.	NULL

noprecipitates	NULL
were	NULL
analyzed	NULL
by	NULL
anti-PTYR	NULL
Western	NULL
blot	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
more	NULL
directly	NULL
demonstrate	NULL
TCR	NULL
-mediated	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
gp30/	NULL
40	NULL
,	NULL
we	NULL
transiently	NULL
transfected	NULL
Jurkat	NULL
T	NULL
cells	NULL
with	NULL
the	NULL
above	NULL
described	NULL
CCG	NULL
chimera	NULL
.	NULL

After	NULL
overnight	NULL
incubation	NULL
,	NULL
cells	NULL
were	NULL
stimulated	NULL
for	NULL
increasing	NULL
periods	NULL
of	NULL
time	NULL
with	NULL
the	NULL
clonotypic	NULL
anti-TCR	NULL
mAb	NULL
C305	NULL
or	NULL
,	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
,	NULL
with	NULL
pervanadate	NULL
.	NULL

Subsequently	NULL
,	NULL
CD8	NULL
immunoprecipitates	NULL
were	NULL
prepared	NULL
from	NULL
resting	NULL
or	NULL
activated	NULL
cells	NULL
and	NULL
analyzed	NULL
for	NULL
their	NULL
PTYR	NULL
content	NULL
by	NULL
Western	NULL
blot	NULL
.	NULL

Fig	NULL
.	NULL

5	NULL
B	NULL
,	NULL
top	NULL
,	NULL
demonstrates	NULL
that	NULL
the	NULL
chimera	NULL
becomes	NULL
rapidly	NULL
phosphorylated	NULL
on	NULL
tyrosine	NULL
residues	NULL
after	NULL
TCR	NULL
triggering	NULL
with	NULL
a	NULL
maximum	NULL
of	NULL
phosphorylation	NULL
being	NULL
observed	NULL
after	NULL
five	NULL
min	NULL
of	NULL
â¬305	NULL
stimulation	NULL
.	NULL

Reprobing	NULL
of	NULL
the	NULL
blots	NULL
with	NULL
gp30/40	NULL
antiserum	NULL
revealed	NULL
that	NULL
identical	NULL
amounts	NULL
of	NULL
the	NULL
chimera	NULL
were	NULL
loaded	NULL
onto	NULL
the	NULL
individual	NULL
lanes	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
B	NULL
,	NULL
middle	NULL
)	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
the	NULL
data	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
A	NULL
and	NULL
B	NULL
,	NULL
clearly	NULL
demonstrate	NULL
that	NULL
gp30/	NULL
40	NULL
represents	NULL
a	NULL
substrate	NULL
for	NULL
TCR	NULL
-activated	NULL
PT	NULL
Ks	NULL
.	NULL

To	NULL
analyze	NULL
which	NULL
tyrosine	NULL
kinase	NULL
can	NULL
phosphorylate	NULL
gp30/	NULL
40	NULL
in	NULL
vivo	NULL
,	NULL
we	NULL
transiently	NULL
expressed	NULL
gp30/	NULL
40	NULL
in	NULL
COS	NULL
cells	NULL
together	NULL
with	NULL
plasmids	NULL
coding	NULL
for	NULL
either	NULL
Fyn	NULL
,	NULL
Lck	NULL
,	NULL
ZAP70	NULL
,	NULL
and	NULL
Syk	NULL
or	NULL
with	NULL
a	NULL
combination	NULL
of	NULL
Leck/Fyn	NULL
and	NULL
ZAP70	NULL
.	NULL

However	NULL
,	NULL
in	NULL
pilot	NULL
experiments	NULL
in	NULL
which	NULL
we	NULL
used	NULL
a	NULL
cDNA	NULL
coding	NULL
for	NULL
wild-type	NULL
gp30/	NULL
40	NULL
for	NULL
transfection	NULL
,	NULL
we	NULL
realized	NULL
that	NULL
detection	NULL
of	NULL
the	NULL
transfected	NULL
protein	NULL
by	NULL
Western	NULL
blotting	NULL
was	NULL
hardly	NULL
possible	NULL
because	NULL
of	NULL
the	NULL
highly	NULL
variable	NULL
levels	NULL
of	NULL
glycosylation	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
expressed	NULL
a	NULL
mutant	NULL
of	NULL
gp30/	NULL
40	NULL
in	NULL
COS	NULL
cells	NULL
in	NULL
which	NULL
the	NULL
glycosylation	NULL
site	NULL
(	NULL
N*	NULL
)	NULL
was	NULL
mutated	NULL
to	NULL
glutamine	NULL
(	NULL
gp30/40-N-Q	NULL
mutant	NULL
)	NULL
.	NULL

Mutation	NULL
of	NULL
this	NULL
residue	NULL
resulted	NULL
in	NULL
expression	NULL
of	NULL
a	NULL
20-kD	NULL
doublet	NULL
that	NULL
can	NULL
be	NULL
detected	NULL
by	NULL
our	NULL
antiserum	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
C	NULL
,	NULL
top	NULL
right	NULL
)	NULL
.	NULL

Lysates	NULL
of	NULL
CO	NULL
S	NULL
cells	NULL
transiently	NULL
transfected	NULL
with	NULL
a	NULL
combination	NULL
of	NULL
the	NULL
cDNA	NULL
construct	NULL
coding	NULL
for	NULL
the	NULL
gp30/40-N-Q	NULL
mutant	NULL
and	NULL
the	NULL
above	NULL
described	NULL
tyrosine	NULL
kinases	NULL
were	NULL
analyzed	NULL
by	NULL
anti-PTYR	NULL
Western	NULL
blot	NULL
.	NULL

At	NULL
the	NULL
same	NULL
time	NULL
,	NULL
anti-PTYR	NULL
immunoprecipitates	NULL
were	NULL
prepared	NULL
from	NULL
the	NULL
trans	NULL
fected	NULL
cells	NULL
and	NULL
investigated	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
tyrosine	NULL
phosphorylated	NULL
gp30/	NULL
40	NULL
by	NULL
means	NULL
of	NULL
anti-gp30/40	NULL
Western	NULL
blotting	NULL
.	NULL

The	NULL
left	NULL
panels	NULL
of	NULL
Fig	NULL
.	NULL

5	NULL
B	NULL
demonstrate	NULL
that	NULL
under	NULL
these	NULL
experimental	NULL
conditions	NULL
gp30/	NULL
40	NULL
becomes	NULL
tyrosine	NULL
phosphorylated	NULL
by	NULL
Lck	NULL
and	NULL
to	NULL
a	NULL
stronger	NULL
extent	NULL
by	NULL
Fyn	NULL
,	NULL
but	NULL
is	NULL
only	NULL
very	NULL
weakly	NULL
tyrosine	NULL
phosphorylated	NULL
when	NULL
the	NULL
molecule	NULL
is	NULL
coexpressed	NULL
with	NULL
either	NULL
ZAP7O0	NULL
or	NULL
Syk	NULL
alone	NULL
.	NULL

However	NULL
,	NULL
when	NULL
Fyn	NULL
and	NULL
ZAP70	NULL
are	NULL
concomitantly	NULL
expressed	NULL
,	NULL
tyrosine	NULL
phosphorylated	NULL
gp30/40	NULL
migrates	NULL
at	NULL
a	NULL
slightly	NULL
higher	NULL
apparent	NULL
mol	NULL
wt	NULL
compared	NULL
with	NULL
co-expres-sion	NULL
with	NULL
Fyn	NULL
alone	NULL
.	NULL

Since	NULL
identical	NULL
data	NULL
were	NULL
obtained	NULL
in	NULL
three	NULL
independent	NULL
experiments	NULL
,	NULL
these	NULL
findings	NULL
suggest	NULL
that	NULL
gp30/	NULL
40	NULL
represents	NULL
not	NULL
only	NULL
a	NULL
substrate	NULL
for	NULL
sre	NULL
PTKs	NULL
but	NULL
that	NULL
it	NULL
can	NULL
also	NULL
become	NULL
phosphorylated	NULL
by	NULL
ZAP70	NULL
.	NULL

Expression	NULL
of	NULL
g30/40	NULL
in	NULL
Jurkat	NULL
Cells	NULL
Inhibits	NULL
TCR-	NULL
and	NULL
PHA	NULL
-mediated	NULL
Adivation	NULL
of	NULL
the	NULL
Transaiption	NULL
Fador	NULL
NF-AT	NULL
.	NULL

To	NULL
obtain	NULL
initial	NULL
information	NULL
on	NULL
the	NULL
in	NULL
vivo	NULL
function	NULL
of	NULL
gp30/	NULL
40	NULL
,	NULL
we	NULL
transiently	NULL
transfected	NULL
Jurkat	NULL
T	NULL
cells	NULL
with	NULL
increasing	NULL
concentrations	NULL
of	NULL
a	NULL
plasmid	NULL
coding	NULL
for	NULL
a	NULL
full-length	NULL
gp30/	NULL
40	NULL
molecule	NULL
together	NULL
with	NULL
a	NULL
luciferase	NULL
reporter	NULL
gene	NULL
con	NULL
1188	NULL
struct	NULL
driven	NULL
by	NULL
a	NULL
triplicated	NULL
NF-AT	NULL
binding	NULL
site	NULL
of	NULL
the	NULL
human	NULL
IL-2	NULL
promoter	NULL
(	NULL
38	NULL
)	NULL
.	NULL

At	NULL
18	NULL
h	NULL
of	NULL
transfection	NULL
,	NULL
expression	NULL
of	NULL
transfected	NULL
gp30/40	NULL
was	NULL
determined	NULL
by	NULL
Western	NULL
blotting	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
A	NULL
,	NULL
insets	NULL
)	NULL
,	NULL
and	NULL
cells	NULL
were	NULL
stimulated	NULL
for	NULL
an	NULL
additional	NULL
6	NULL
h	NULL
with	NULL
either	NULL
the	NULL
clonotypic	NULL
anti-TCR	NULL
mAb	NULL
C305	NULL
or	NULL
the	NULL
polyclonal	NULL
mitogen	NULL
PHA	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
A	NULL
,	NULL
overexpression	NULL
of	NULL
SIT	NULL
inhibited	NULL
both	NULL
PHA-	NULL
and	NULL
TCR	NULL
mediated	NULL
induction	NULL
of	NULL
NF-	NULL
AT	NULL
activity	NULL
in	NULL
a	NULL
dose-dependent	NULL
fashion	NULL
.	NULL

Thus	NULL
,	NULL
compared	NULL
with	NULL
the	NULL
vector	NULL
control	NULL
,	NULL
a	NULL
significant	NULL
reduction	NULL
of	NULL
the	NULL
signals	NULL
was	NULL
already	NULL
observed	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
transfected	NULL
gp30/40	NULL
cDNA	NULL
,	NULL
whereas	NULL
transfection	NULL
with	NULL
30	NULL
ug	NULL
cDNA	NULL
resulted	NULL
in	NULL
a	NULL
91	NULL
%	NULL
reduction	NULL
of	NULL
the	NULL
PHA	NULL
signal	NULL
and	NULL
a	NULL
76	NULL
%	NULL
reduction	NULL
of	NULL
the	NULL
TCR	NULL
-induced	NULL
NF-AT	NULL
activity	NULL
,	NULL
respectively	NULL
.	NULL

Similarly	NULL
,	NULL
transient	NULL
overexpression	NULL
of	NULL
gp30/	NULL
40	NULL
in	NULL
Jurkat	NULL
cells	NULL
resulted	NULL
in	NULL
a	NULL
strong	NULL
inhibition	NULL
of	NULL
the	NULL
CD2-mediated	NULL
pathway	NULL
of	NULL
T	NULL
cell	NULL
activation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
assess	NULL
whether	NULL
the	NULL
cytoplasmic	NULL
portion	NULL
of	NULL
gp30/	NULL
40	NULL
was	NULL
responsible	NULL
for	NULL
the	NULL
inhibitory	NULL
effect	NULL
of	NULL
gp30/	NULL
40	NULL
on	NULL
the	NULL
TCR-	NULL
and	NULL
PHA-mediated	NULL
pathways	NULL
of	NULL
T	NULL
cell	NULL
activation	NULL
,	NULL
we	NULL
transiently	NULL
transfected	NULL
a	NULL
truncated	NULL
mutant	NULL
of	NULL
gp30/	NULL
40	NULL
into	NULL
Jurkat	NULL
cells	NULL
in	NULL
which	NULL
a	NULL
FLAG	NULL
epitope	NULL
was	NULL
introduced	NULL
at	NULL
H	NULL
of	NULL
gp30/	NULL
40	NULL
followed	NULL
by	NULL
a	NULL
STOP	NULL
codon	NULL
(	NULL
gp30/40-STOP	NULL
mutant	NULL
)	NULL
.	NULL

The	NULL
Fig	NULL
.	NULL

6	NULL
B	NULL
,	NULL
left	NULL
,	NULL
demonstrates	NULL
that	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
wild-type	NULL
protein	NULL
,	NULL
expression	NULL
of	NULL
the	NULL
gp30/	NULL
40-STOP	NULL
mutant	NULL
exerts	NULL
no	NULL
negative	NULL
regulatory	NULL
effect	NULL
on	NULL
NF-AT	NULL
activity	NULL
.	NULL

This	NULL
indicates	NULL
that	NULL
the	NULL
negative	NULL
regulatory	NULL
role	NULL
of	NULL
wild-type	NULL
gp30/40	NULL
on	NULL
TCR-	NULL
and	NULL
PHA-induced	NULL
transcriptional	NULL
activity	NULL
of	NULL
NF-AT	NULL
requires	NULL
an	NULL
intact	NULL
cytoplasmic	NULL
tail	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
finding	NULL
that	NULL
stimulation	NULL
of	NULL
the	NULL
transfectants	NULL
with	NULL
a	NULL
combination	NULL
of	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
bypassed	NULL
gp30/40-mediated	NULL
inhibition	NULL
of	NULL
NF-AT	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
B	NULL
,	NULL
middle	NULL
)	NULL
strongly	NULL
suggests	NULL
that	NULL
gp30/	NULL
40	NULL
probably	NULL
regulates	NULL
a	NULL
proximal	NULL
signaling	NULL
event	NULL
(	NULL
s	NULL
)	NULL
of	NULL
human	NULL
T	NULL
cell	NULL
activation	NULL
(	NULL
see	NULL
below	NULL
)	NULL
.	NULL

Inhibition	NULL
of	NULL
TCR-	NULL
and	NULL
PHA-mediated	NULL
induction	NULL
of	NULL
NF-	NULL
AT	NULL
activity	NULL
was	NULL
also	NULL
observed	NULL
when	NULL
the	NULL
above	NULL
described	NULL
CCG	NULL
chimera	NULL
(	NULL
see	NULL
Figs	NULL
.	NULL

2	NULL
and	NULL
4	NULL
)	NULL
was	NULL
expressed	NULL
in	NULL
Jurkat	NULL
cells	NULL
,	NULL
whereas	NULL
expression	NULL
of	NULL
a	NULL
truncated	NULL
version	NULL
in	NULL
which	NULL
S	NULL
``	NULL
of	NULL
gp30/	NULL
40	NULL
was	NULL
mutated	NULL
to	NULL
a	NULL
STOP-codon	NULL
(	NULL
CC-STOP	NULL
chi-mera	NULL
)	NULL
,	NULL
or	NULL
of	NULL
a	NULL
control	NULL
chimera	NULL
(	NULL
consisting	NULL
of	NULL
the	NULL
extracellular	NULL
domain	NULL
of	NULL
human	NULL
HLA-A2	NULL
fused	NULL
to	NULL
a	NULL
full	NULL
length	NULL
TRIM	NULL
molecule	NULL
,	NULL
Ch_F	NULL
)	NULL
,	NULL
did	NULL
not	NULL
affect	NULL
signaling	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
C	NULL
)	NULL
.	NULL

Col-lectively	NULL
,	NULL
these	NULL
data	NULL
indicate	NULL
that	NULL
gp30/	NULL
40	NULL
,	NULL
when	NULL
overexpressed	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
acts	NULL
as	NULL
a	NULL
negative	NULL
regulator	NULL
for	NULL
both	NULL
TCR-	NULL
and	NULL
PHA-mediated	NULL
transcriptional	NULL
activity	NULL
of	NULL
NF-AT	NULL
.	NULL

To	NULL
more	NULL
precisely	NULL
localize	NULL
where	NULL
gp30/40	NULL
exerts	NULL
its	NULL
function	NULL
during	NULL
TCR	NULL
-mediated	NULL
signaling	NULL
,	NULL
we	NULL
transfected	NULL
a	NULL
gp30/	NULL
40	NULL
cDNA	NULL
together	NULL
with	NULL
the	NULL
NF-AT-driven	NULL
reporter	NULL
construct	NULL
into	NULL
a	NULL
Jurkat	NULL
variant	NULL
stably	NULL
expressing	NULL
the	NULL
human	NULL
muscarinic	NULL
receptor	NULL
type	NULL
1	NULL
(	NULL
J.HM1.2.2	NULL
cells	NULL
)	NULL
.	NULL

Stimulation	NULL
of	NULL
this	NULL
heterologous	NULL
receptor	NULL
with	NULL
carbachol	NULL
results	NULL
in	NULL
activation	NULL
of	NULL
PLC	NULL
via	NULL
a	NULL
G	NULL
protein-coupled	NULL
mechanism	NULL
that	NULL
does	NULL
not	NULL
involve	NULL
PTK-mediated	NULL
signaling	NULL
(	NULL
27-30	NULL
)	NULL
.	NULL

Fig	NULL
.	NULL

6	NULL
D	NULL
demonstrates	NULL
that	NULL
overexpression	NULL
of	NULL
gp30/	NULL
40	NULL
in	NULL
J.HM1.2.2	NULL
cells	NULL
inhibited	NULL
CD3-mediated	NULL
induction	NULL
of	NULL
NF-AT	NULL
activity	NULL
to	NULL
a	NULL
similar	NULL
extent	NULL
as	NULL
in	NULL
wild-type	NULL
Jurkat	NULL
cells	NULL
.	NULL

Importantly	NULL
,	NULL
The	NULL
interacting	NULL
Transmembrane	NULL
Adaptor	NULL
Protein	NULL
SIT	NULL
[	NULL
]	NULL
sos	NULL
i	NULL
â	NULL
irujnmu	NULL
~	NULL
O	NULL
â	NULL
Luauâslur	NULL
BOS	NULL
z	NULL
6	NULL
3	NULL
]	NULL
100	NULL
g	NULL
|	NULL
&	NULL
.	NULL

16	NULL
-I	NULL
m	NULL
7	NULL
a	NULL
1	NULL
$	NULL
7	NULL
.	NULL

ee	NULL
R	NULL
1	NULL
a	NULL
+	NULL
__|	NULL
ee	NULL
f	NULL
Â®	NULL
200	NULL
-	NULL
lB	NULL
|	NULL
a	NULL
31	NULL
a	NULL
TC	NULL
Â£	NULL
h	NULL
s	NULL
OC	NULL
27	NULL
-I	NULL
1	NULL
#	NULL
0	NULL
A-p	NULL
--	NULL
-p	NULL
--	NULL
4	NULL
p-0	NULL
8	NULL
10	NULL
20	NULL
30	NULL
concentration	NULL
of	NULL
gp30/40	NULL
construct	NULL
(	NULL
ug	NULL
)	NULL
.	NULL

PMA+IONO	NULL
stimulus	NULL
C	NULL
E	NULL
J.HM1.2.2	NULL
gros	NULL
ece	NULL
g	NULL
ecsror	NULL
geo	NULL
CJ	NULL
sos	NULL
E	NULL
s23040	NULL
CD8	NULL
CD8	NULL
Â£p30/40	NULL
w	NULL
2	NULL
.	NULL

|	NULL
--	NULL
CCG	NULL
30	NULL
as	NULL
.	NULL
)	NULL

cestor	NULL
OCS	NULL
Cee	NULL
CBBC	NULL
CTT	NULL
We	NULL
Cofe	NULL
-L	NULL
-	NULL
(	NULL
-J	NULL
(	NULL
Bf	NULL
1	NULL
c	NULL
gp3040-8	NULL
TOP	NULL
HLA-A2	NULL
TRIM	NULL
ERIM	NULL
PO	NULL
.	NULL

Sme	NULL
Pol	NULL
m	NULL
me	NULL
mame	NULL
=	NULL
>	NULL
mome	NULL
_	NULL
mame	NULL
BSH	NULL
*	NULL
%	NULL
ICR	NULL
f	NULL
PHA	NULL
CD3	NULL
Carbachol	NULL
stimulus	NULL
stimulus	NULL
Figure	NULL
6	NULL
.	NULL

-	NULL
gp30/40	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

(	NULL
A	NULL
)	NULL
2	NULL
X	NULL
10	NULL
``	NULL
Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
increasing	NULL
concentrations	NULL
of	NULL
wild-type	NULL
gp30/	NULL
40	NULL
cDNA	NULL
and	NULL
reporter	NULL
construct	NULL
driven	NULL
by	NULL
a	NULL
triplicated	NULL
NF-AT	NULL
binding	NULL
site	NULL
of	NULL
the	NULL
human	NULL
IL-2	NULL
promoter	NULL
.	NULL

An	NULL
appropriate	NULL
amount	NULL
of	NULL
empty	NULL
vector	NULL
DNA	NULL
was	NULL
added	NULL
to	NULL
all	NULL
samples	NULL
to	NULL
yield	NULL
equal	NULL
amounts	NULL
of	NULL
transfected	NULL
DNA	NULL
.	NULL

Lysates	NULL
corresponding	NULL
to	NULL
5	NULL
X	NULL
10Â°	NULL
cells	NULL
were	NULL
analyzed	NULL
for	NULL
expression	NULL
of	NULL
gp30/	NULL
40	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
.	NULL

Note	NULL
that	NULL
due	NULL
to	NULL
the	NULL
low	NULL
levels	NULL
of	NULL
gp30/	NULL
40	NULL
expression	NULL
the	NULL
protein	NULL
is	NULL
not	NULL
detected	NULL
in	NULL
nontransfected	NULL
cells	NULL
.	NULL

At	NULL
18	NULL
h	NULL
after	NULL
transfection	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
anti-TCR	NULL
mAb	NULL
C305	NULL
or	NULL
with	NULL
PHA	NULL
.	NULL

6	NULL
h	NULL
later	NULL
luciferase	NULL
activity	NULL
was	NULL
determined	NULL
.	NULL

Depicted	NULL
are	NULL
relative	NULL
responses	NULL
which	NULL
were	NULL
obtained	NULL
by	NULL
the	NULL
following	NULL
calculation	NULL
:	NULL
luciferase	NULL
units	NULL
produced	NULL
by	NULL
TCR	NULL
or	NULL
PHA-stimulation	NULL
divided	NULL
by	NULL
luciferase	NULL
units	NULL
produced	NULL
by	NULL
stimulating	NULL
the	NULL
cells	NULL
with	NULL
a	NULL
combination	NULL
of	NULL
PMA	NULL
and	NULL
ionomycin	NULL
(	NULL
=	NULL
maximal	NULL
response	NULL
)	NULL
X	NULL
100	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Jurkat	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
20	NULL
jug	NULL
empty	NULL
vector	NULL
(	NULL
BOS	NULL
)	NULL
,	NULL
wild-type	NULL
gp30/	NULL
40	NULL
or	NULL
the	NULL
gp30/	NULL
40-STOP	NULL
cDNAs	NULL
in	NULL
combination	NULL
with	NULL
the	NULL
above	NULL
reporter	NULL
construct	NULL
and	NULL
processed	NULL
as	NULL
in	NULL
A	NULL
(	NULL
left	NULL
)	NULL
.	NULL

Relative	NULL
luciferase	NULL
units	NULL
after	NULL
stimulation	NULL
of	NULL
the	NULL
transfectants	NULL
with	NULL
a	NULL
combination	NULL
of	NULL
PMA	NULL
and	NULL
ionomycin	NULL
(	NULL
middle	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
constructs	NULL
was	NULL
verified	NULL
by	NULL
gp30/	NULL
40	NULL
(	NULL
wild-type	NULL
protein	NULL
)	NULL
or	NULL
FLAG	NULL
(	NULL
gp30/40-STOP	NULL
)	NULL
Western	NULL
blot	NULL
analysis	NULL
(	NULL
right	NULL
)	NULL
.	NULL

(	NULL
C	NULL
)	NULL
2	NULL
X	NULL
10	NULL
``	NULL
Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
empty	NULL
vector	NULL
or	NULL
with	NULL
plasmids	NULL
coding	NULL
for	NULL
the	NULL
CCG	NULL
or	NULL
the	NULL
CC-STOP	NULL
chimeras	NULL
together	NULL
with	NULL
the	NULL
NF-AT-driven	NULL
luciferase	NULL
reporter	NULL
gene	NULL
construct	NULL
.	NULL

A	NULL
chimeric	NULL
TRIM	NULL
molecule	NULL
(	NULL
Ch_F	NULL
)	NULL
served	NULL
as	NULL
a	NULL
control	NULL
.	NULL

The	NULL
experiment	NULL
was	NULL
then	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
A	NULL
.	NULL

(	NULL
D	NULL
)	NULL
J.HM1.2.2	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
25	NULL
ug	NULL
wild-type	NULL
gp30/	NULL
40	NULL
cDNA	NULL
and	NULL
then	NULL
stimulated	NULL
with	NULL
either	NULL
anti-CD3	NULL
mAb	NULL
OKT	NULL
3	NULL
or	NULL
with	NULL
carbachol	NULL
followed	NULL
by	NULL
determination	NULL
of	NULL
luciferase	NULL
activity	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
construct	NULL
was	NULL
determined	NULL
by	NULL
gp30/	NULL
40	NULL
Western	NULL
blot	NULL
analysis	NULL
.	NULL

(	NULL
E	NULL
)	NULL
cDNA	NULL
constructs	NULL
used	NULL
for	NULL
the	NULL
experiments	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6.	NULL
however	NULL
,	NULL
in	NULL
the	NULL
same	NULL
cells	NULL
gp30/	NULL
40	NULL
did	NULL
not	NULL
influence	NULL
sig-	NULL
_	NULL
in	NULL
both	NULL
positive	NULL
and	NULL
negative	NULL
regulatory	NULL
signaling	NULL
pathways	NULL
naling	NULL
mediated	NULL
via	NULL
the	NULL
muscarinic	NULL
receptor	NULL
.	NULL

Thus	NULL
,	NULL
gp30/	NULL
in	NULL
lymphocytes	NULL
(	NULL
39-45	NULL
)	NULL
.	NULL

40	NULL
probably	NULL
regulates	NULL
TCR	NULL
-mediated	NULL
induction	NULL
of	NULL
NF-	NULL
AT	NULL
Jurkat	NULL
cells	NULL
were	NULL
stimulated	NULL
for	NULL
increasing	NULL
periods	NULL
of	NULL
time	NULL
activity	NULL
via	NULL
a	NULL
mechanism	NULL
that	NULL
is	NULL
located	NULL
upstream	NULL
of	NULL
activa-	NULL
__	NULL
with	NULL
either	NULL
C305	NULL
mAb	NULL
or	NULL
PHA	NULL
,	NULL
washed	NULL
,	NULL
and	NULL
lysed	NULL
in	NULL
NP-40-tion	NULL
of	NULL
PLC	NULL
.	NULL

containing	NULL
buffer	NULL
.	NULL

Subsequently	NULL
,	NULL
anti-gp30/40	NULL
immuno-	NULL
gp30/	NULL
40	NULL
Assodates	NULL
with	NULL
the	NULL
SHP2	NULL
Tyrosine	NULL
Phosphatase	NULL
af	NULL
_	NULL
precipitates	NULL
were	NULL
prepared	NULL
and	NULL
analyzed	NULL
for	NULL
coprecipitation	NULL
ter	NULL
T	NULL
Cell	NULL
Adivation	NULL
.	NULL

-	NULL
Asreported	NULL
above	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
B	NULL
)	NULL
,	NULL
gp30/40	NULL
_	NULL
of	NULL
the	NULL
above	NULL
phosphatases	NULL
by	NULL
Western	NULL
blotting	NULL
.	NULL

In	NULL
several	NULL
possesses	NULL
a	NULL
putative	NULL
ITIM	NULL
in	NULL
its	NULL
cytoplasmic	NULL
tail	NULL
(	NULL
VKY'*	NULL
_	NULL
individual	NULL
experiments	NULL
we	NULL
were	NULL
unable	NULL
to	NULL
demonstrate	NULL
a	NULL
SEV	NULL
)	NULL
(	NULL
35	NULL
,	NULL
36	NULL
)	NULL
.	NULL

Given	NULL
the	NULL
strong	NULL
negative	NULL
regulatory	NULL
effect	NULL
on	NULL
__	NULL
specific	NULL
interaction	NULL
of	NULL
gp30/	NULL
40	NULL
with	NULL
SHP1	NULL
or	NULL
SHIP	NULL
(	NULL
data	NULL
not	NULL
the	NULL
induction	NULL
of	NULL
NF-AT	NULL
activity	NULL
after	NULL
overexpression	NULL
of	NULL
_	NULL
shown	NULL
)	NULL
.	NULL

However	NULL
,	NULL
as	NULL
demonstrated	NULL
in	NULL
Fig	NULL
.	NULL

7	NULL
A	NULL
,	NULL
appreciable	NULL
gp30/	NULL
40	NULL
or	NULL
the	NULL
CCG	NULL
chimera	NULL
,	NULL
we	NULL
next	NULL
investigated	NULL
whether	NULL
_	NULL
levels	NULL
of	NULL
SHP2	NULL
coprecipitated	NULL
with	NULL
gp30/40	NULL
after	NULL
TCR-gp30/	NULL
40	NULL
,	NULL
in	NULL
its	NULL
tyrosine	NULL
phosphorylated	NULL
state	NULL
,	NULL
has	NULL
the	NULL
capac-	NULL
_	NULL
(	NULL
left	NULL
)	NULL
as	NULL
well	NULL
as	NULL
PHA-	NULL
(	NULL
right	NULL
)	NULL
mediated	NULL
activation	NULL
of	NULL
Jurkat	NULL
ity	NULL
to	NULL
recruit	NULL
SH2	NULL
domain-containing	NULL
cytoplasmic	NULL
phospha-	NULL
_	NULL
cells	NULL
.	NULL

tases	NULL
like	NULL
SHP1	NULL
,	NULL
SHP2	NULL
,	NULL
or	NULL
SHIP	NULL
to	NULL
the	NULL
cell	NULL
membrane	NULL
.	NULL

These	NULL
The	NULL
specificity	NULL
of	NULL
interaction	NULL
between	NULL
gp30/40	NULL
and	NULL
phosphatases	NULL
have	NULL
been	NULL
demonstrated	NULL
to	NULL
preferentially	NULL
bind	NULL
_	NULL
SHP2	NULL
was	NULL
further	NULL
proven	NULL
in	NULL
Jurkat	NULL
cells	NULL
treated	NULL
with	NULL
per-to	NULL
ITIMs	NULL
via	NULL
their	NULL
SH2	NULL
domains	NULL
and	NULL
seem	NULL
to	NULL
be	NULL
involved	NULL
_	NULL
vanadate	NULL
.	NULL

There	NULL
SHP2	NULL
was	NULL
found	NULL
to	NULL
specifically	NULL
coprecipi-	NULL
1189	NULL
Marie-Cardine	NULL
et	NULL
al	NULL
.	NULL

PI|0	NULL
1	NULL
st	NULL
ist	NULL
30	NULL
}	NULL
0	NULL
1	NULL
``	NULL
5	NULL
15	NULL
30Â°	NULL
PV	NULL
D	NULL
â	NULL
[	NULL
]	NULL
Bos	NULL
Hwt	NULL
f	NULL
ITM	NULL
l	NULL
35-Â§	NULL
-	NULL
Z	NULL
I	NULL
;	NULL
304	NULL
&	NULL
z	NULL
E	NULL
<	NULL
a	NULL
wey	NULL
SHP2	NULL
Â»	NULL
-	NULL
me	NULL
am	NULL
sae	NULL
oue	NULL
--	NULL
@	NULL
2	NULL
$	NULL
:	NULL
E	NULL
c	NULL
:	NULL
)	NULL
TCR	NULL
(	NULL
C305	NULL
)	NULL
PHA	NULL
1	NULL
ug/ml	NULL
g	NULL
Â®	NULL
E	NULL
Cen	NULL
o	NULL
M	NULL
#	NULL
(	NULL
7	NULL
<	NULL
T-	NULL
[	NULL
-	NULL
]	NULL
Â»	NULL
o	NULL
|-	NULL
Temt-	NULL
n	NULL
MED	NULL
.	NULL

TCR	NULL
PHA	NULL
Â«	NULL
=|	NULL
<	NULL
ll	NULL
pBS	NULL
B	NULL
SHP2	NULL
It	NULL
Â»	NULL
Â«	NULL
im	NULL
e	NULL
[	NULL
sit	NULL
tan	NULL
|	NULL
(	NULL
Bos	NULL
mW	NULL
coco	NULL
CC-I	NULL
'	NULL
I	NULL
â	NULL
IM	NULL
â	NULL
354	NULL
105	NULL
Â«	NULL
[	NULL
cco	NULL
w	NULL
301	NULL
]	NULL
;	NULL
E	NULL
1	NULL
[	NULL
:	NULL
I	NULL
E	NULL
=o	NULL
2541	NULL
i	NULL
ccatim	NULL
-	NULL
``	NULL
A	NULL
C	NULL
ev	NULL
[	NULL
-	NULL
1+	NULL
]	NULL
-	NULL
|+	NULL
]	NULL
-	NULL
|+	NULL
]	NULL
-|	NULL
+	NULL
Â£	NULL
sl	NULL
:	NULL
e	NULL
IP	NULL
:	NULL
CD8	NULL
2	NULL
fd	NULL
BLOT	NULL
:	NULL
SHP2	NULL
t-g	NULL
104	NULL
IP	NULL
:	NULL
CD8	NULL
z	NULL
-	NULL
0	NULL
as	NULL
#	NULL
BLOT	NULL
:	NULL
SIT	NULL
2	NULL
3d	NULL
thus	NULL
T	NULL
T	NULL
5Â°	NULL
h	NULL
s	NULL
]	NULL
noug	NULL
â	NULL
ccG	NULL
|	NULL
ITM	NULL
|	NULL
sToP	NULL
04	NULL
construct	NULL
MED	NULL
.	NULL

TCR	NULL
PHA	NULL
Figure	NULL
7	NULL
.	NULL

-	NULL
Interaction	NULL
between	NULL
gp30/	NULL
40	NULL
and	NULL
SHP2	NULL
.	NULL

(	NULL
A	NULL
)	NULL
3	NULL
X	NULL
10	NULL
``	NULL
Jurkat	NULL
cells	NULL
lane	NULL
were	NULL
activated	NULL
with	NULL
mAb	NULL
C305	NULL
or	NULL
with	NULL
PHA	NULL
.	NULL

Lysates	NULL
were	NULL
subjected	NULL
to	NULL
anti-gp30/	NULL
40	NULL
immunoprecipitation	NULL
followed	NULL
by	NULL
blotting	NULL
with	NULL
SHP2	NULL
mAb	NULL
.	NULL

PI	NULL
,	NULL
preimmune	NULL
serum	NULL
.	NULL

(	NULL
B	NULL
)	NULL
3	NULL
X	NULL
10	NULL
``	NULL
Jurkat	NULL
cells	NULL
were	NULL
left	NULL
unstimulated	NULL
or	NULL
were	NULL
treated	NULL
for	NULL
2	NULL
min	NULL
with	NULL
pervanadate	NULL
.	NULL

Lysates	NULL
were	NULL
subjected	NULL
to	NULL
gp30/	NULL
40	NULL
(	NULL
left	NULL
)	NULL
or	NULL
TRIM	NULL
immunoprecipitation	NULL
(	NULL
right	NULL
)	NULL
.	NULL

The	NULL
precipitates	NULL
were	NULL
blotted	NULL
onto	NULL
nitrocellulose	NULL
,	NULL
which	NULL
was	NULL
first	NULL
incubated	NULL
with	NULL
an	NULL
antibody	NULL
directed	NULL
at	NULL
the	NULL
85	NULL
kD	NULL
regulatory	NULL
subunit	NULL
of	NULL
PI3-K	NULL
(	NULL
p85	NULL
)	NULL
,	NULL
then	NULL
stripped	NULL
and	NULL
reincubated	NULL
with	NULL
SHP2	NULL
mAb	NULL
(	NULL
SHP2	NULL
)	NULL
.	NULL

(	NULL
C	NULL
)	NULL
5	NULL
X	NULL
10Â°	NULL
untransfected	NULL
Jurkat	NULL
cells	NULL
or	NULL
Jurkat	NULL
cells	NULL
transiently	NULL
transfected	NULL
with	NULL
cDN	NULL
As	NULL
coding	NULL
for	NULL
the	NULL
CCG	NULL
,	NULL
the	NULL
CCS	NULL
(	NULL
STOP	NULL
)	NULL
or	NULL
the	NULL
CC-ITIM	NULL
(	NULL
ITIM	NULL
)	NULL
chimeras	NULL
were	NULL
left	NULL
untreated	NULL
or	NULL
were	NULL
treated	NULL
for	NULL
2	NULL
min	NULL
with	NULL
pervanadate	NULL
.	NULL

Lysates	NULL
were	NULL
subjected	NULL
to	NULL
CD8	NULL
immunoprecipitation	NULL
followed	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
SHP2	NULL
Western	NULL
blot	NULL
analysis	NULL
.	NULL

Blots	NULL
were	NULL
stripped	NULL
and	NULL
reincubated	NULL
with	NULL
SIT	NULL
antiserum	NULL
.	NULL

Note	NULL
that	NULL
expression	NULL
of	NULL
the	NULL
CCS	NULL
mutant	NULL
could	NULL
not	NULL
be	NULL
assessed	NULL
by	NULL
SIT	NULL
Western	NULL
blot	NULL
analysis	NULL
due	NULL
to	NULL
lack	NULL
of	NULL
reactive	NULL
epitopes	NULL
.	NULL

Expression	NULL
of	NULL
this	NULL
construct	NULL
as	NULL
well	NULL
as	NULL
of	NULL
the	NULL
CCG	NULL
construct	NULL
was	NULL
verified	NULL
by	NULL
FACSÂ®	NULL
analysis	NULL
of	NULL
the	NULL
transfectant	NULL
using	NULL
a	NULL
CD8	NULL
mAb	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

(	NULL
D	NULL
)	NULL
(	NULL
Top	NULL
)	NULL
Jurkat	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
cDNAs	NULL
coding	NULL
for	NULL
wild	NULL
type	NULL
SIT	NULL
or	NULL
the	NULL
gp30/40-ITIM	NULL
mutant	NULL
.	NULL

TCR-	NULL
and	NULL
PHA-mediated	NULL
induction	NULL
of	NULL
NF-AT	NULL
activity	NULL
was	NULL
then	NULL
determined	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
constructs	NULL
was	NULL
assessed	NULL
by	NULL
SIT	NULL
immunoblotting	NULL
.	NULL

(	NULL
Bottom	NULL
)	NULL
The	NULL
same	NULL
experiment	NULL
using	NULL
cDNA	NULL
constructs	NULL
coding	NULL
for	NULL
the	NULL
CCG	NULL
and	NULL
the	NULL
CC-ITIM	NULL
chimeras	NULL
,	NULL
respectively	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
chimeric	NULL
molecules	NULL
was	NULL
analyzed	NULL
by	NULL
indirect	NULL
immunofluorescence	NULL
using	NULL
a	NULL
CD8	NULL
mAb	NULL
.	NULL

tate	NULL
with	NULL
gp30/	NULL
40	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
B	NULL
,	NULL
left	NULL
)	NULL
,	NULL
whereas	NULL
the	NULL
phosphatase	NULL
failed	NULL
to	NULL
interact	NULL
with	NULL
the	NULL
recently	NULL
cloned	NULL
transmembrane	NULL
adaptor	NULL
protein	NULL
TRIM	NULL
(	NULL
which	NULL
does	NULL
not	NULL
possess	NULL
an	NULL
ITIM	NULL
)	NULL
.	NULL

Conversely	NULL
,	NULL
as	NULL
previously	NULL
reported	NULL
,	NULL
the	NULL
p85	NULL
subunit	NULL
of	NULL
PI3-K	NULL
associated	NULL
inducibly	NULL
with	NULL
TRIM	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
B	NULL
,	NULL
right	NULL
)	NULL
,	NULL
but	NULL
not	NULL
with	NULL
gp30/	NULL
40	NULL
(	NULL
probably	NULL
because	NULL
gp30/	NULL
40	NULL
lacks	NULL
the	NULL
YxxM-motif	NULL
,	NULL
which	NULL
mediates	NULL
the	NULL
binding	NULL
between	NULL
p85	NULL
and	NULL
TRIM	NULL
[	NULL
reference	NULL
20	NULL
]	NULL
)	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
the	NULL
data	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
A	NULL
and	NULL
B	NULL
,	NULL
indicate	NULL
that	NULL
gp30/	NULL
40	NULL
specifically	NULL
associates	NULL
with	NULL
SHP2	NULL
after	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
termed	NULL
the	NULL
gp30/40	NULL
protein	NULL
SIT	NULL
(	NULL
SHP2-interacting	NULL
transmembrane	NULL
adaptor	NULL
protein	NULL
)	NULL
.	NULL

To	NULL
investigate	NULL
whether	NULL
the	NULL
interaction	NULL
between	NULL
SHP2	NULL
and	NULL
SIT	NULL
indeed	NULL
involves	NULL
the	NULL
ITIM	NULL
,	NULL
we	NULL
transiently	NULL
expressed	NULL
in	NULL
Jurkat	NULL
cells	NULL
the	NULL
above	NULL
shown	NULL
CCG	NULL
chimera	NULL
or	NULL
mutants	NULL
of	NULL
this	NULL
chimera	NULL
in	NULL
which	NULL
either	NULL
the	NULL
complete	NULL
intracellular	NULL
1190	NULL
portion	NULL
of	NULL
SIT	NULL
was	NULL
deleted	NULL
(	NULL
CC-	NULL
STOP	NULL
chimera	NULL
)	NULL
or	NULL
in	NULL
which	NULL
the	NULL
tyrosine	NULL
residue	NULL
of	NULL
the	NULL
ITIM	NULL
was	NULL
mutated	NULL
to	NULL
phenylalanine	NULL
(	NULL
CC-ITIM	NULL
chimera	NULL
)	NULL
.	NULL

By	NULL
expressing	NULL
CD8/CD8/	NULL
SIT	NULL
chimeras	NULL
instead	NULL
of	NULL
mutated	NULL
SIT	NULL
molecules	NULL
,	NULL
we	NULL
could	NULL
largely	NULL
rule	NULL
out	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
transfected	NULL
chimera	NULL
forms	NULL
disulfide-linked	NULL
heterodimers	NULL
with	NULL
endogenous	NULL
SIT	NULL
and	NULL
thus	NULL
generates	NULL
false	NULL
positive	NULL
results	NULL
during	NULL
our	NULL
experiments	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
use	NULL
of	NULL
the	NULL
extracellular	NULL
domain	NULL
of	NULL
CD8	NULL
allowed	NULL
us	NULL
to	NULL
perform	NULL
immunoprecipitation	NULL
experiments	NULL
us	NULL
ing	NULL
a	NULL
mouse	NULL
CD8	NULL
mAb	NULL
,	NULL
thus	NULL
preventing	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
immunoprecipitates	NULL
become	NULL
contaminated	NULL
with	NULL
endogenously	NULL
expressed	NULL
wild-type	NULL
SIT	NULL
molecules	NULL
.	NULL

Fig	NULL
.	NULL

7	NULL
C	NULL
demonstrates	NULL
that	NULL
,	NULL
as	NULL
expected	NULL
,	NULL
a	NULL
CD8	NULL
immunoprecipitate	NULL
prepared	NULL
from	NULL
either	NULL
nonstimulated	NULL
or	NULL
pervanadate-treated	NULL
wild-type	NULL
Jurkat	NULL
cells	NULL
(	NULL
lacking	NULL
CD8	NULL
expression	NULL
)	NULL
did	NULL
not	NULL
contain	NULL
detectable	NULL
levels	NULL
of	NULL
SHP2	NULL
.	NULL

However	NULL
,	NULL
when	NULL
The	NULL
interacting	NULL
Transmembrane	NULL
Adaptor	NULL
Protein	NULL
SIT	NULL
CD8	NULL
immunoprecipitates	NULL
were	NULL
prepared	NULL
from	NULL
cells	NULL
that	NULL
had	NULL
been	NULL
transiently	NULL
transfected	NULL
with	NULL
the	NULL
CCG	NULL
chimera	NULL
,	NULL
large	NULL
amounts	NULL
of	NULL
SHP2	NULL
were	NULL
detectable	NULL
in	NULL
the	NULL
precipitates	NULL
obtained	NULL
from	NULL
pervanadate-treated	NULL
cells	NULL
.	NULL

That	NULL
coprecipitation	NULL
of	NULL
SHP2	NULL
by	NULL
the	NULL
CCG	NULL
chimera	NULL
requires	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
cytoplasmic	NULL
part	NULL
of	NULL
SIT	NULL
was	NULL
evident	NULL
from	NULL
the	NULL
observation	NULL
that	NULL
SIT/	NULL
SHP2	NULL
interaction	NULL
was	NULL
completely	NULL
lost	NULL
when	NULL
the	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
CC-STOP	NULL
chimera	NULL
lacking	NULL
the	NULL
cytoplasmic	NULL
portion	NULL
of	NULL
SIT	NULL
.	NULL

Perhaps	NULL
more	NULL
importantly	NULL
,	NULL
coprecipitation	NULL
of	NULL
SHP2	NULL
was	NULL
also	NULL
almost	NULL
completely	NULL
lost	NULL
(	NULL
>	NULL
90	NULL
%	NULL
reduction	NULL
as	NULL
judged	NULL
from	NULL
densitometric	NULL
analysis	NULL
of	NULL
the	NULL
shown	NULL
blot	NULL
)	NULL
when	NULL
Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
CC-ITIM	NULL
chimera	NULL
.	NULL

The	NULL
latter	NULL
finding	NULL
formally	NULL
proves	NULL
that	NULL
the	NULL
interaction	NULL
between	NULL
SIT	NULL
and	NULL
SHP2	NULL
requires	NULL
a	NULL
functionally	NULL
intact	NULL
ITIM	NULL
.	NULL

We	NULL
next	NULL
investigated	NULL
whether	NULL
loss	NULL
of	NULL
interaction	NULL
between	NULL
SIT	NULL
and	NULL
SHP2	NULL
would	NULL
abolish	NULL
the	NULL
inhibition	NULL
of	NULL
TCR	NULL
and/or	NULL
PHA-mediated	NULL
induction	NULL
of	NULL
NF-AT	NULL
activity	NULL
exerted	NULL
by	NULL
wild-type	NULL
SIT	NULL
and	NULL
the	NULL
CCG	NULL
chimera	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7	NULL
D	NULL
,	NULL
overexpression	NULL
of	NULL
the	NULL
gp30/40-ITIM	NULL
mutant	NULL
(	NULL
top	NULL
)	NULL
or	NULL
of	NULL
the	NULL
CC-ITIM	NULL
chimera	NULL
(	NULL
bottom	NULL
)	NULL
downregulates	NULL
both	NULL
TCR-	NULL
and	NULL
PH	NULL
A-mediated	NULL
induction	NULL
of	NULL
NF-AT	NULL
activity	NULL
as	NULL
observed	NULL
for	NULL
the	NULL
wild-type	NULL
protein	NULL
.	NULL

Thus	NULL
,	NULL
although	NULL
expression	NULL
of	NULL
an	NULL
intact	NULL
ITIM	NULL
is	NULL
required	NULL
for	NULL
the	NULL
interaction	NULL
of	NULL
SIT	NULL
with	NULL
SHP2	NULL
,	NULL
it	NULL
does	NULL
not	NULL
mediate	NULL
the	NULL
negative	NULL
regulatory	NULL
effect	NULL
of	NULL
wild-type	NULL
SIT	NULL
or	NULL
of	NULL
the	NULL
CCG	NULL
chimera	NULL
on	NULL
TCR	NULL
-	NULL
and	NULL
PHA-mediated	NULL
induction	NULL
of	NULL
NF-	NULL
AT	NULL
activity	NULL
.	NULL

Discussion	NULL
In	NULL
this	NULL
report	NULL
we	NULL
describe	NULL
the	NULL
purification	NULL
,	NULL
nanoelectrospray	NULL
sequencing	NULL
,	NULL
molecular	NULL
cloning	NULL
,	NULL
and	NULL
functional	NULL
characterization	NULL
of	NULL
a	NULL
novel	NULL
transmembrane	NULL
adaptor	NULL
molecule	NULL
that	NULL
we	NULL
have	NULL
termed	NULL
SIT	NULL
(	NULL
SHP2-interacting	NULL
transmembrane	NULL
adaptor	NULL
protein	NULL
)	NULL
.	NULL

As	NULL
previously	NULL
reported	NULL
,	NULL
SIT	NULL
copurified	NULL
with	NULL
a	NULL
recently	NULL
cloned	NULL
disulfide-linked	NULL
dimer	NULL
called	NULL
TRIM	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Most	NULL
likely	NULL
the	NULL
expression	NULL
of	NULL
SIT	NULL
in	NULL
T	NULL
lymphocytes	NULL
was	NULL
not	NULL
appreciated	NULL
earlier	NULL
because	NULL
of	NULL
the	NULL
generally	NULL
low	NULL
levels	NULL
of	NULL
expression	NULL
of	NULL
SIT	NULL
in	NULL
lymphocytes	NULL
and	NULL
its	NULL
particular	NULL
biochemical	NULL
properties	NULL
(	NULL
high	NULL
levels	NULL
of	NULL
glycosylation	NULL
combined	NULL
with	NULL
variable	NULL
levels	NULL
of	NULL
phosphorylation	NULL
)	NULL
,	NULL
which	NULL
largely	NULL
impair	NULL
the	NULL
detectability	NULL
of	NULL
the	NULL
protein	NULL
by	NULL
biochemical	NULL
standard	NULL
methods	NULL
(	NULL
for	NULL
examples	NULL
,	NULL
see	NULL
Figs	NULL
.	NULL

2	NULL
A	NULL
and	NULL
4	NULL
B	NULL
)	NULL
.	NULL

SIT	NULL
represents	NULL
a	NULL
disulfide-linked	NULL
dimer	NULL
that	NULL
is	NULL
preferentially	NULL
expressed	NULL
in	NULL
T	NULL
and	NULL
B	NULL
lymphocytes	NULL
.	NULL

Thus	NULL
,	NULL
within	NULL
the	NULL
lymphatic	NULL
system	NULL
,	NULL
expression	NULL
of	NULL
SIT	NULL
seems	NULL
not	NULL
to	NULL
be	NULL
restricted	NULL
to	NULL
T	NULL
cells	NULL
as	NULL
was	NULL
recently	NULL
reported	NULL
for	NULL
LAT	NULL
(	NULL
21	NULL
,	NULL
22	NULL
)	NULL
and	NULL
TRIM	NULL
(	NULL
20	NULL
)	NULL
.	NULL

SIT	NULL
also	NULL
differs	NULL
from	NULL
LAT	NULL
and	NULL
TRIM	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
single	NULL
N-linked	NULL
glycosylation	NULL
site	NULL
that	NULL
is	NULL
located	NULL
directly	NULL
adjacent	NULL
to	NULL
the	NULL
cysteine	NULL
residue	NULL
that	NULL
is	NULL
responsible	NULL
for	NULL
dimerization	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
the	NULL
cysteine	NULL
residue	NULL
is	NULL
part	NULL
of	NULL
the	NULL
glycosylation	NULL
recognition	NULL
sequence	NULL
NxT	NULL
.	NULL

Deglycosylation	NULL
experiments	NULL
indicated	NULL
that	NULL
the	NULL
carbohydrate	NULL
moiety	NULL
of	NULL
SIT	NULL
accounts	NULL
for	NULL
~20	NULL
kD	NULL
of	NULL
mol	NULL
wt	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
C	NULL
)	NULL
.	NULL

Whether	NULL
the	NULL
carbohydrate	NULL
chain	NULL
represents	NULL
a	NULL
binding	NULL
domain	NULL
for	NULL
an	NULL
extracellular	NULL
ligand	NULL
is	NULL
unknown	NULL
at	NULL
present	NULL
but	NULL
represents	NULL
a	NULL
good	NULL
possibility	NULL
.	NULL

1191	NULL
Marie-Cardine	NULL
et	NULL
al	NULL
.	NULL

SIT	NULL
becomes	NULL
tyrosine	NULL
phosphorylated	NULL
after	NULL
TCR	NULL
-mediated	NULL
activation	NULL
of	NULL
HPB-	NULL
ALL	NULL
or	NULL
Jurkat	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

Coexpression	NULL
experiments	NULL
performed	NULL
in	NULL
COS	NULL
cells	NULL
revealed	NULL
that	NULL
SIT	NULL
represents	NULL
a	NULL
substrate	NULL
for	NULL
src	NULL
kinases	NULL
,	NULL
most	NULL
notably	NULL
Fyn	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
C	NULL
)	NULL
.	NULL

However	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
TRIM	NULL
,	NULL
which	NULL
is	NULL
exclusively	NULL
phosphorylated	NULL
by	NULL
src	NULL
kinases	NULL
(	NULL
20	NULL
)	NULL
,	NULL
and	NULL
LAT	NULL
,	NULL
which	NULL
is	NULL
probably	NULL
a	NULL
selective	NULL
substrate	NULL
for	NULL
ZAP7O	NULL
(	NULL
22	NULL
)	NULL
,	NULL
SIT	NULL
phosphorylation	NULL
seems	NULL
to	NULL
be	NULL
mediated	NULL
by	NULL
both	NULL
src	NULL
and	NULL
syk	NULL
PTKs	NULL
.	NULL

Thus	NULL
,	NULL
when	NULL
ZAP70	NULL
and	NULL
Fyn	NULL
are	NULL
coexpressed	NULL
in	NULL
COS	NULL
cells	NULL
SIT	NULL
reproducibly	NULL
migrates	NULL
at	NULL
a	NULL
slightly	NULL
higher	NULL
apparent	NULL
mol	NULL
wt	NULL
than	NULL
when	NULL
expressed	NULL
with	NULL
Fyn	NULL
alone	NULL
.	NULL

These	NULL
findings	NULL
could	NULL
indicate	NULL
that	NULL
SIT	NULL
phos	NULL
phorylation	NULL
occurs	NULL
in	NULL
two	NULL
subsequent	NULL
steps	NULL
that	NULL
are	NULL
mediated	NULL
by	NULL
src	NULL
and	NULL
syk	NULL
PTKs	NULL
,	NULL
respectively	NULL
.	NULL

One	NULL
attractive	NULL
model	NULL
would	NULL
be	NULL
that	NULL
,	NULL
immediately	NULL
after	NULL
triggering	NULL
of	NULL
the	NULL
TCR	NULL
,	NULL
SIT	NULL
becomes	NULL
phosphorylated	NULL
by	NULL
an	NULL
src	NULL
PTK	NULL
.	NULL

This	NULL
phosphorylation	NULL
event	NULL
could	NULL
induce	NULL
a	NULL
con-formational	NULL
change	NULL
of	NULL
SIT	NULL
,	NULL
resulting	NULL
in	NULL
accessibility	NULL
of	NULL
another	NULL
tyrosine	NULL
residue	NULL
representing	NULL
a	NULL
phosphorylation	NULL
site	NULL
for	NULL
ZAP70	NULL
.	NULL

To	NULL
investigate	NULL
this	NULL
possibility	NULL
it	NULL
will	NULL
be	NULL
neces	NULL
sary	NULL
to	NULL
generate	NULL
variants	NULL
of	NULL
the	NULL
gp30/40-N-Q	NULL
mutant	NULL
in	NULL
which	NULL
individual	NULL
tyrosine	NULL
residues	NULL
are	NULL
mutated	NULL
and	NULL
to	NULL
investigate	NULL
whether	NULL
coexpression	NULL
of	NULL
Fyn	NULL
and	NULL
ZAP7O	NULL
still	NULL
produces	NULL
a	NULL
higher	NULL
mol	NULL
wt	NULL
form	NULL
of	NULL
the	NULL
molecule	NULL
.	NULL

However	NULL
,	NULL
consistent	NULL
with	NULL
a	NULL
two-step	NULL
model	NULL
for	NULL
SIT	NULL
tyrosine	NULL
phosphorylation	NULL
is	NULL
our	NULL
observation	NULL
that	NULL
the	NULL
apparent	NULL
mol	NULL
wt	NULL
of	NULL
tyrosine	NULL
phosphorylated	NULL
wild-type	NULL
SIT	NULL
(	NULL
although	NULL
difficult	NULL
to	NULL
assess	NULL
because	NULL
of	NULL
its	NULL
heavy	NULL
glycosylation	NULL
)	NULL
also	NULL
increases	NULL
after	NULL
prolonged	NULL
stimulation	NULL
of	NULL
Jurkat	NULL
and	NULL
HPB-ALL	NULL
cells	NULL
(	NULL
our	NULL
unpublished	NULL
data	NULL
)	NULL
.	NULL

Overexpression	NULL
studies	NULL
performed	NULL
in	NULL
Jurkat	NULL
cells	NULL
with	NULL
the	NULL
intention	NULL
to	NULL
elucidate	NULL
the	NULL
function	NULL
of	NULL
SIT	NULL
indicated	NULL
that	NULL
wild-type	NULL
SIT	NULL
and	NULL
the	NULL
CCG	NULL
chimera	NULL
strongly	NULL
downregu-lated	NULL
both	NULL
TCR	NULL
-	NULL
and	NULL
PH	NULL
A-mediated	NULL
activation	NULL
of	NULL
NF-	NULL
AT	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
A-C	NULL
)	NULL
.	NULL

Inhibition	NULL
of	NULL
NF-AT	NULL
activity	NULL
required	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
cytoplasmic	NULL
portion	NULL
of	NULL
SIT	NULL
as	NULL
judged	NULL
from	NULL
analysis	NULL
of	NULL
Jurkat	NULL
cells	NULL
transfected	NULL
with	NULL
plasmids	NULL
coding	NULL
for	NULL
versions	NULL
of	NULL
SIT	NULL
lacking	NULL
the	NULL
cytoplasmic	NULL
domain	NULL
(	NULL
gp30/	NULL
40-STOP	NULL
and	NULL
CCS	NULL
chimera	NULL
,	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
B	NULL
and	NULL
C	NULL
)	NULL
.	NULL

Perhaps	NULL
more	NULL
importantly	NULL
,	NULL
the	NULL
observation	NULL
that	NULL
the	NULL
inhibitory	NULL
effect	NULL
of	NULL
SIT	NULL
could	NULL
be	NULL
bypassed	NULL
with	NULL
a	NULL
combination	NULL
of	NULL
PMA	NULL
and	NULL
ionomycin	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
B	NULL
)	NULL
strongly	NULL
suggested	NULL
that	NULL
SIT	NULL
controls	NULL
an	NULL
early	NULL
step	NULL
of	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

This	NULL
assumption	NULL
was	NULL
confirmed	NULL
in	NULL
a	NULL
Jurkat	NULL
variant	NULL
that	NULL
coexpresses	NULL
the	NULL
human	NULL
muscarinic	NULL
receptor	NULL
type	NULL
1	NULL
and	NULL
the	NULL
TCR-CD3	NULL
complex	NULL
.	NULL

Both	NULL
types	NULL
of	NULL
receptors	NULL
activate	NULL
PLC	NULL
via	NULL
distinct	NULL
mechanisms	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
TCR	NULL
couples	NULL
to	NULL
PLC	NULL
via	NULL
the	NULL
tyrosine	NULL
kinase	NULL
pathway	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
muscarinic	NULL
receptor	NULL
activates	NULL
PLC	NULL
via	NULL
a	NULL
pathway	NULL
involving	NULL
a	NULL
heterotrimeric	NULL
G	NULL
protein	NULL
.	NULL

Our	NULL
finding	NULL
that	NULL
overexpression	NULL
of	NULL
SIT	NULL
alters	NULL
signaling	NULL
via	NULL
the	NULL
TCR	NULL
but	NULL
not	NULL
via	NULL
the	NULL
muscarinic	NULL
receptor	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
D	NULL
)	NULL
thus	NULL
indicates	NULL
that	NULL
SIT	NULL
exerts	NULL
its	NULL
functional	NULL
effect	NULL
upstream	NULL
of	NULL
PLC	NULL
activation	NULL
and	NULL
that	NULL
it	NULL
selectively	NULL
regulates	NULL
signaling	NULL
via	NULL
the	NULL
PTK	NULL
pathway	NULL
.	NULL

However	NULL
,	NULL
further	NULL
investigations	NULL
are	NULL
required	NULL
to	NULL
elucidate	NULL
which	NULL
of	NULL
the	NULL
most	NULL
proximal	NULL
steps	NULL
of	NULL
TCR	NULL
-mediated	NULL
T	NULL
cell	NULL
activation	NULL
are	NULL
controlled	NULL
by	NULL
SIT	NULL
.	NULL

One	NULL
major	NULL
candidate	NULL
for	NULL
mediating	NULL
the	NULL
inhibitory	NULL
function	NULL
of	NULL
SIT	NULL
was	NULL
tyrosine	NULL
148	NULL
which	NULL
is	NULL
a	NULL
component	NULL
of	NULL
a	NULL
putative	NULL
ITIM	NULL
.	NULL

ITIMs	NULL
are	NULL
known	NULL
to	NULL
mediate	NULL
noncovalent	NULL
interactions	NULL
with	NULL
SH	NULL
2-domain	NULL
containing	NULL
phosphatases	NULL
such	NULL
as	NULL
SHP1	NULL
,	NULL
SHP2	NULL
or	NULL
SHIP	NULL
(	NULL
35	NULL
,	NULL
36	NULL
,	NULL
39-45	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
coprecipitation	NULL
experiments	NULL
demonstrated	NULL
that	NULL
SIT	NULL
specifically	NULL
interacts	NULL
with	NULL
SHP2	NULL
after	NULL
TCR-	NULL
and	NULL
PH	NULL
A-mediated	NULL
activation	NULL
of	NULL
Jurkat	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
A	NULL
)	NULL
.	NULL

The	NULL
association	NULL
between	NULL
SHP2	NULL
and	NULL
SIT	NULL
was	NULL
dependent	NULL
on	NULL
phosphorylation	NULL
of	NULL
Y'**	NULL
as	NULL
judged	NULL
from	NULL
a	NULL
transient	NULL
expression	NULL
experiment	NULL
which	NULL
revealed	NULL
that	NULL
a	NULL
SIT	NULL
mutant	NULL
in	NULL
which	NULL
Y	NULL
'	NULL
was	NULL
mutated	NULL
to	NULL
phenylalanine	NULL
(	NULL
CC-ITIM	NULL
mutant	NULL
)	NULL
had	NULL
largely	NULL
lost	NULL
its	NULL
ability	NULL
to	NULL
recruit	NULL
SHP2	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
B	NULL
)	NULL
.	NULL

The	NULL
residual	NULL
binding	NULL
of	NULL
SHP2	NULL
to	NULL
the	NULL
CC-ITIM	NULL
chimera	NULL
(	NULL
less	NULL
than	NULL
10	NULL
%	NULL
)	NULL
might	NULL
indicate	NULL
that	NULL
besides	NULL
Y	NULL
``	NULL
a	NULL
second	NULL
tyrosine	NULL
residue	NULL
of	NULL
SIT	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
interaction	NULL
between	NULL
the	NULL
two	NULL
molecules	NULL
and	NULL
that	NULL
SHP2	NULL
uses	NULL
both	NULL
SH2-domains	NULL
to	NULL
bind	NULL
to	NULL
SIT	NULL
.	NULL

Such	NULL
a	NULL
mode	NULL
of	NULL
interaction	NULL
would	NULL
be	NULL
in	NULL
line	NULL
with	NULL
recently	NULL
reported	NULL
data	NULL
describing	NULL
the	NULL
crystal	NULL
structure	NULL
of	NULL
SHP2	NULL
(	NULL
46	NULL
)	NULL
.	NULL

Experiments	NULL
are	NULL
under-way	NULL
to	NULL
prove	NULL
this	NULL
possibility	NULL
.	NULL

The	NULL
finding	NULL
that	NULL
SIT	NULL
selectively	NULL
associates	NULL
with	NULL
SHP2	NULL
in	NULL
Jurkat	NULL
cells	NULL
might	NULL
be	NULL
surprising	NULL
in	NULL
light	NULL
of	NULL
previous	NULL
data	NULL
indicating	NULL
that	NULL
the	NULL
binding	NULL
motifs	NULL
for	NULL
the	NULL
SH2-domains	NULL
of	NULL
SHP1	NULL
,	NULL
SHP2	NULL
and	NULL
SHIP	NULL
are	NULL
quite	NULL
similar	NULL
.	NULL

Indeed	NULL
,	NULL
coprecipitation	NULL
experiments	NULL
performed	NULL
on	NULL
pervanadate	NULL
treated	NULL
Jurkat	NULL
cells	NULL
revealed	NULL
that	NULL
tyrosine	NULL
phosphorylated	NULL
SIT	NULL
strongly	NULL
binds	NULL
to	NULL
the	NULL
isolated	NULL
SH2-domains	NULL
of	NULL
all	NULL
three	NULL
phosphatases	NULL
in	NULL
vitro	NULL
(	NULL
our	NULL
unpublished	NULL
observations	NULL
)	NULL
.	NULL

The	NULL
selective	NULL
in	NULL
vivo	NULL
association	NULL
of	NULL
SHP2	NULL
and	NULL
SIT	NULL
could	NULL
thus	NULL
result	NULL
from	NULL
a	NULL
selective	NULL
colocalization	NULL
of	NULL
both	NULL
molecules	NULL
within	NULL
the	NULL
cell	NULL
.	NULL

Another	NULL
possibility	NULL
would	NULL
be	NULL
that	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
positively	NULL
charged	NULL
lysine	NULL
residue	NULL
in	NULL
the	NULL
-1	NULL
position	NULL
relative	NULL
to	NULL
Y	NULL
``	NULL
``	NULL
selects	NULL
for	NULL
a	NULL
preferential	NULL
association	NULL
between	NULL
SIT	NULL
and	NULL
SHP2	NULL
.	NULL

Importantly	NULL
,	NULL
despite	NULL
that	NULL
fact	NULL
that	NULL
the	NULL
ITIM	NULL
of	NULL
SIT	NULL
recruits	NULL
SHP2	NULL
and	NULL
that	NULL
mutation	NULL
of	NULL
Y	NULL
'	NULL
in	NULL
the	NULL
ITIM	NULL
almost	NULL
completely	NULL
ablated	NULL
SHP2	NULL
binding	NULL
,	NULL
overexpression	NULL
of	NULL
a	NULL
SIT-ITIM	NULL
or	NULL
a	NULL
CC-ITIM	NULL
mutant	NULL
still	NULL
resulted	NULL
in	NULL
inhibition	NULL
of	NULL
TCR	NULL
-	NULL
and	NULL
PH	NULL
A-mediated	NULL
induction	NULL
of	NULL
NF-AT	NULL
activity	NULL
that	NULL
was	NULL
indistinguishable	NULL
from	NULL
the	NULL
functional	NULL
effect	NULL
exerted	NULL
by	NULL
the	NULL
wild-type	NULL
protein	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
D	NULL
)	NULL
.	NULL

These	NULL
data	NULL
collectively	NULL
suggest	NULL
that	NULL
,	NULL
although	NULL
expression	NULL
and	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
the	NULL
ITIM	NULL
of	NULL
SIT	NULL
is	NULL
required	NULL
to	NULL
mediate	NULL
its	NULL
association	NULL
with	NULL
SHP2	NULL
,	NULL
the	NULL
binding	NULL
of	NULL
SHP2	NULL
to	NULL
SIT	NULL
per	NULL
se	NULL
is	NULL
not	NULL
responsible	NULL
for	NULL
the	NULL
inhibitory	NULL
capacity	NULL
of	NULL
the	NULL
protein	NULL
under	NULL
the	NULL
experimental	NULL
conditions	NULL
used	NULL
in	NULL
this	NULL
study	NULL
.	NULL

The	NULL
finding	NULL
that	NULL
inhibition	NULL
of	NULL
binding	NULL
of	NULL
SHP2	NULL
to	NULL
SIT	NULL
does	NULL
not	NULL
rescue	NULL
NF-AT	NULL
activation	NULL
could	NULL
suggest	NULL
that	NULL
SIT	NULL
serves	NULL
several	NULL
functions	NULL
during	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

One	NULL
function	NULL
could	NULL
be	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
NF-	NULL
AT	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
SIT	NULL
could	NULL
serve	NULL
as	NULL
a	NULL
gate-keeping	NULL
molecule	NULL
that	NULL
helps	NULL
to	NULL
arrest	NULL
nonprimed	NULL
T	NULL
lymphocytes	NULL
in	NULL
a	NULL
quiescent	NULL
state	NULL
.	NULL

Which	NULL
part	NULL
of	NULL
the	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
SIT	NULL
is	NULL
involved	NULL
in	NULL
this	NULL
potential	NULL
function	NULL
requires	NULL
further	NULL
investigation	NULL
.	NULL

Preliminary	NULL
data	NULL
indicate	NULL
that	NULL
a	NULL
mutant	NULL
of	NULL
the	NULL
CCG	NULL
chimera	NULL
lacking	NULL
the	NULL
50	NULL
COOH-terminal	NULL
aa	NULL
of	NULL
the	NULL
cytoplasmic	NULL
domain	NULL
no	NULL
longer	NULL
interferes	NULL
with	NULL
TCR	NULL
-mediated	NULL
induction	NULL
of	NULL
NF-AT	NULL
activity	NULL
(	NULL
our	NULL
unpublished	NULL
obser-vation	NULL
)	NULL
.	NULL

This	NULL
strongly	NULL
suggests	NULL
that	NULL
the	NULL
50	NULL
COOH-terminal	NULL
aa	NULL
of	NULL
SIT	NULL
are	NULL
mainly	NULL
responsible	NULL
for	NULL
its	NULL
functional	NULL
effect	NULL
(	NULL
at	NULL
least	NULL
with	NULL
regard	NULL
to	NULL
the	NULL
induction	NULL
of	NULL
NF-AT	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
elucidation	NULL
of	NULL
the	NULL
question	NULL
,	NULL
which	NULL
of	NULL
the	NULL
50	NULL
COOH-terminal	NULL
aa	NULL
are	NULL
responsible	NULL
for	NULL
inhibition	NULL
of	NULL
NF-AT	NULL
activity	NULL
,	NULL
requires	NULL
establishing	NULL
additional	NULL
truncation	NULL
mutants	NULL
of	NULL
SIT	NULL
or	NULL
SIT	NULL
mutants	NULL
in	NULL
which	NULL
the	NULL
two	NULL
COOH-terminal	NULL
tyrosine-based	NULL
signaling	NULL
motifs	NULL
(	NULL
the	NULL
Y'Â®Â°ASV	NULL
motif	NULL
and	NULL
the	NULL
Y'*Â°ANS	NULL
motif	NULL
,	NULL
see	NULL
below	NULL
)	NULL
would	NULL
be	NULL
individually	NULL
or	NULL
concomitantly	NULL
mutated	NULL
.	NULL

Experiments	NULL
addressing	NULL
these	NULL
ques	NULL
tions	NULL
are	NULL
being	NULL
performed	NULL
.	NULL

Additional	NULL
roles	NULL
for	NULL
SIT	NULL
(	NULL
distinct	NULL
from	NULL
control	NULL
of	NULL
NF-	NULL
AT	NULL
activity	NULL
)	NULL
could	NULL
emerge	NULL
from	NULL
its	NULL
interaction	NULL
with	NULL
SHP2	NULL
.	NULL

Since	NULL
it	NULL
has	NULL
been	NULL
proposed	NULL
that	NULL
SHP2	NULL
is	NULL
involved	NULL
in	NULL
both	NULL
negative	NULL
and	NULL
positive	NULL
regulatory	NULL
pathways	NULL
of	NULL
T	NULL
cell	NULL
activation	NULL
,	NULL
further	NULL
investigations	NULL
are	NULL
required	NULL
to	NULL
elucidate	NULL
the	NULL
consequences	NULL
of	NULL
SHP2-binding	NULL
to	NULL
SIT	NULL
on	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

It	NULL
is	NULL
important	NULL
to	NULL
note	NULL
that	NULL
further	NULL
functions	NULL
for	NULL
SIT	NULL
could	NULL
result	NULL
from	NULL
the	NULL
existence	NULL
of	NULL
the	NULL
four	NULL
tyrosine-based	NULL
signaling	NULL
motifs	NULL
in	NULL
its	NULL
cytoplasmic	NULL
domain	NULL
that	NULL
are	NULL
unrelated	NULL
to	NULL
ITIMs	NULL
and	NULL
also	NULL
do	NULL
not	NULL
represent	NULL
IT	NULL
AMs	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
A	NULL
)	NULL
.	NULL

Although	NULL
these	NULL
motifs	NULL
are	NULL
potential	NULL
binding	NULL
sites	NULL
for	NULL
the	NULL
SH2	NULL
domain	NULL
of	NULL
Grb2	NULL
(	NULL
YÂ°*Â°GNL	NULL
and	NULL
Y'*Â°ANS	NULL
$	NULL
)	NULL
and	NULL
for	NULL
sre	NULL
kinases	NULL
(	NULL
Y*	NULL
``	NULL
TSL	NULL
and	NULL
Y'Â°ASV	NULL
)	NULL
,	NULL
thus	NULL
far	NULL
we	NULL
have	NULL
not	NULL
been	NULL
able	NULL
to	NULL
establish	NULL
a	NULL
direct	NULL
interaction	NULL
between	NULL
SIT	NULL
and	NULL
these	NULL
signal-transducing	NULL
polypeptides	NULL
.	NULL

Nevertheless	NULL
,	NULL
it	NULL
is	NULL
tempting	NULL
to	NULL
speculate	NULL
that	NULL
the	NULL
four	NULL
tyrosine-based	NULL
binding	NULL
motifs	NULL
in	NULL
the	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
SIT	NULL
contribute	NULL
to	NULL
its	NULL
function	NULL
in	NULL
vivo	NULL
.	NULL

The	NULL
three	NULL
transmembrane	NULL
adaptor	NULL
proteins	NULL
(	NULL
LAT	NULL
,	NULL
TRIM	NULL
and	NULL
SIT	NULL
)	NULL
identified	NULL
thus	NULL
far	NULL
altogether	NULL
possess	NULL
22	NULL
potential	NULL
tyrosine-	NULL
based	NULL
signaling	NULL
motifs	NULL
that	NULL
probably	NULL
mediate	NULL
tyrosine	NULL
phosphorylation-dependent	NULL
interactions	NULL
with	NULL
SH2	NULL
domain-containing	NULL
intracellular	NULL
signaling	NULL
molecules	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
these	NULL
multiple	NULL
tyrosine-based	NULL
signaling	NULL
motifs	NULL
close	NULL
to	NULL
the	NULL
membrane	NULL
not	NULL
only	NULL
offers	NULL
an	NULL
explanation	NULL
how	NULL
intracellular	NULL
signal	NULL
transducers	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
PLCy1	NULL
,	NULL
Grb2	NULL
,	NULL
PI3-K	NULL
,	NULL
SHP2	NULL
,	NULL
etc	NULL
.	NULL
)	NULL

are	NULL
recruited	NULL
to	NULL
the	NULL
plasma	NULL
membrane	NULL
but	NULL
also	NULL
provides	NULL
the	NULL
T	NULL
cell	NULL
with	NULL
potent	NULL
tools	NULL
for	NULL
fine	NULL
tuning	NULL
T	NULL
cell	NULL
activation	NULL
depending	NULL
on	NULL
the	NULL
quality	NULL
,	NULL
quantity	NULL
,	NULL
and	NULL
length	NULL
of	NULL
TCR	NULL
occupancy	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
transmembrane	NULL
adaptor	NULL
molecules	NULL
could	NULL
also	NULL
serve	NULL
to	NULL
integrate	NULL
signaling	NULL
events	NULL
mediated	NULL
via	NULL
secondary	NULL
signaling	NULL
receptors	NULL
.	NULL

We	NULL
would	NULL
like	NULL
to	NULL
thank	NULL
Drs	NULL
.	NULL

R.	NULL
Abraham	NULL
,	NULL
D.	NULL
Cantrell	NULL
,	NULL
G.	NULL
Koretzky	NULL
(	NULL
University	NULL
of	NULL
Iowa	NULL
,	NULL
Iowa	NULL
City	NULL
,	NULL
IA	NULL
)	NULL
,	NULL
B.	NULL
Neel	NULL
,	NULL
K.	NULL
Pfeffer	NULL
,	NULL
E.	NULL
Reinherz	NULL
(	NULL
Dana	NULL
Farber	NULL
Cancer	NULL
Center	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
)	NULL
,	NULL
A.	NULL
da	NULL
Silva	NULL
,	NULL
B.	NULL
Sefton	NULL
,	NULL
A.	NULL
Veillette	NULL
,	NULL
E.	NULL
Vivier	NULL
(	NULL
Centre	NULL
d'Immunologie	NULL
,	NULL
Marseille	NULL
,	NULL
France	NULL
)	NULL
,	NULL
A.	NULL
Weiss	NULL
,	NULL
and	NULL
J.	NULL
Wienands	NULL
(	NULL
Max-Planck	NULL
Institute	NULL
for	NULL
Immunobiology	NULL
,	NULL
Freiburg	NULL
,	NULL
Germany	NULL
)	NULL
,	NULL
and	NULL
Genentech	NULL
Inc.	NULL
,	NULL
for	NULL
kindly	NULL
providing	NULL
our	NULL
laboratory	NULL
with	NULL
reagents	NULL
.	NULL

Anne	NULL
Marie-Cardine	NULL
is	NULL
a	NULL
recipient	NULL
of	NULL
a	NULL
fellowship	NULL
from	NULL
the	NULL
Training	NULL
and	NULL
Mobility	NULL
of	NULL
Researchers	NULL
program	NULL
1192	NULL
The	NULL
interacting	NULL
Transmembrane	NULL
Adaptor	NULL
Protein	NULL
SIT	NULL
of	NULL
the	NULL
European	NULL
Community	NULL
(	NULL
ERBFMBICT950472	NULL
)	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
Deutsche	NULL
Forschungsgemeinschaft	NULL
grants	NULL
SCHR/533/	NULL
1-1	NULL
and	NULL
SCHR/533/4-1	NULL
and	NULL
by	NULL
Sonderforschungsbereich	NULL
(	NULL
SFB	NULL
)	NULL
405	NULL
,	NULL
projects	NULL
A5	NULL
(	NULL
to	NULL
B.	NULL
Schraven	NULL
)	NULL
and	NULL
B9	NULL
(	NULL
to	NULL
F.	NULL
Autschbach	NULL
)	NULL
.	NULL

The	NULL
work	NULL
in	NULL
M.	NULL
Mann	NULL
's	NULL
laboratory	NULL
was	NULL
partially	NULL
supported	NULL
by	NULL
a	NULL
grant	NULL
from	NULL
the	NULL
German	NULL
Technology	NULL
Ministry	NULL
(	NULL
BMBF	NULL
)	NULL
.	NULL

Address	NULL
correspondence	NULL
to	NULL
Burkhart	NULL
Schraven	NULL
,	NULL
Institute	NULL
for	NULL
Immunology	NULL
,	NULL
Immunomodulation	NULL
Laboratory	NULL
,	NULL
University	NULL
of	NULL
Heidelberg	NULL
,	NULL
Im	NULL
Neuenheimer	NULL
Feld	NULL
305	NULL
,	NULL
69120	NULL
Heidelberg	NULL
,	NULL
Germany	NULL
.	NULL

Phone	NULL
:	NULL
6221-56-4059	NULL
;	NULL
Fax	NULL
:	NULL
6221-56-5541	NULL
;	NULL
E-mail	NULL
:	NULL
m53	NULL
@	NULL
popix.urz.uni-	NULL
heidelberg.de	NULL
M.	NULL
Mann	NULL
's	NULL
present	NULL
address	NULL
is	NULL
Center	NULL
of	NULL
Experimental	NULL
Bioinformatics	NULL
,	NULL
Odense	NULL
University	NULL
,	NULL
Campusveij	NULL
55	NULL
,	NULL
DK-5230	NULL
Odense	NULL
M	NULL
,	NULL
Denmark	NULL
.	NULL

Received	NULL
for	NULL
publication	NULL
8	NULL
December	NULL
1998	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
8	NULL
Febuary	NULL
1999	NULL
.	NULL

References	NULL
1	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

Meuer	NULL
,	NULL
S.C.	NULL
,	NULL
J.C.	NULL
Hodgdon	NULL
,	NULL
R	NULL
.E	NULL
.	NULL

Hussey	NULL
,	NULL
J.P.	NULL
Protentis	NULL
,	NULL
SIF	NULL
.	NULL

Schlossman	NULL
,	NULL
and	NULL
EL	NULL
.	NULL

Reinherz	NULL
.	NULL

1983	NULL
.	NULL

Antigen-like	NULL
effects	NULL
of	NULL
monoclonal	NULL
antibodies	NULL
directed	NULL
at	NULL
receptors	NULL
on	NULL
human	NULL
T	NULL
cell	NULL
clones	NULL
.	NULL

J	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

158:988-993.	NULL
.	NULL

Meuer	NULL
,	NULL
S.C.	NULL
,	NULL
O.	NULL
Acuto	NULL
,	NULL
T.	NULL
Hercent	NULL
,	NULL
S.F	NULL
.	NULL

Schlossman	NULL
,	NULL
and	NULL
EL	NULL
.	NULL

Reinberz	NULL
.	NULL

1984	NULL
.	NULL

The	NULL
human	NULL
T-cell	NULL
receptor	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

2:23-50.	NULL
.	NULL

Chan	NULL
,	NULL
A.C.	NULL
,	NULL
D.M	NULL
.	NULL

Desai	NULL
,	NULL
and	NULL
A.	NULL
Weiss	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
role	NULL
of	NULL
protein	NULL
tyrosine	NULL
kinases	NULL
and	NULL
protein	NULL
tyrosine	NULL
phosphatases	NULL
in	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
signal	NULL
transduction	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

12:555-592.	NULL
.	NULL

Howe	NULL
,	NULL
LR	NULL
.	NULL

,	NULL
and	NULL
A.	NULL
Weiss	NULL
.	NULL

1995	NULL
.	NULL

Multiple	NULL
kinases	NULL
mediate	NULL
T-cell	NULL
receptor	NULL
signaling	NULL
.	NULL

Trends	NULL
Biochem	NULL
.	NULL

Sa	NULL
.	NULL

20:59-64.	NULL
.	NULL

Cohen	NULL
,	NULL
G.B	NULL
.	NULL

,	NULL
R.	NULL
Ren	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1995	NULL
.	NULL

Modular	NULL
binding	NULL
domains	NULL
in	NULL
signal	NULL
transduction	NULL
proteins	NULL
CÃ©	NULL
80	NULL
:	NULL
237-248.	NULL
.	NULL

Pawson	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
J.D	NULL
.	NULL

Scott	NULL
.	NULL

1997	NULL
.	NULL

Signaling	NULL
through	NULL
scaffold	NULL
,	NULL
anchoring	NULL
,	NULL
and	NULL
adaptor	NULL
proteins	NULL
.	NULL

Sdene	NULL
.	NULL

278:2075-2080.	NULL
.	NULL

Peterson	NULL
,	NULL
E.	NULL
,	NULL
JL	NULL
.	NULL

Clements	NULL
,	NULL
N.	NULL
Fang	NULL
,	NULL
and	NULL
G.	NULL
Koretzky	NULL
.	NULL

1998	NULL
.	NULL

Adaptor	NULL
proteins	NULL
in	NULL
lymphocyte	NULL
antigen	NULL
receptor	NULL
signaling	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

10:337-345.	NULL
.	NULL

Songyang	NULL
,	NULL
Z.	NULL
,	NULL
S.E	NULL
.	NULL

Shoelson	NULL
,	NULL
M.	NULL
Chaudhuri	NULL
,	NULL
G.	NULL
Gish	NULL
,	NULL
T.	NULL
Pawson	NULL
,	NULL
W.G	NULL
.	NULL

Haser	NULL
,	NULL
F.	NULL
King	NULL
,	NULL
T.	NULL
Roberts	NULL
,	NULL
S.	NULL
Ratnofsky	NULL
,	NULL
R.J.	NULL
Lechleider	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
.	NULL

SH2	NULL
domains	NULL
recognize	NULL
specific	NULL
phosphopeptide	NULL
sequences	NULL
.	NULL

Cell	NULL
.	NULL

72:767-778.	NULL
.	NULL

Harlan	NULL
,	NULL
J.E	NULL
.	NULL

,	NULL
P.J	NULL
.	NULL

Hajduk	NULL
,	NULL
H.S	NULL
.	NULL

Yoon	NULL
,	NULL
and	NULL
S.W	NULL
.	NULL

Fesik	NULL
.	NULL

1994	NULL
.	NULL

Pleckstrin	NULL
homology	NULL
domains	NULL
bind	NULL
to	NULL
phosphatidylinositol-4,5-	NULL
bisphosphate	NULL
.	NULL

Nature	NULL
.	NULL

371:168-170	NULL
.	NULL

Kavanaugh	NULL
,	NULL
W.M	NULL
.	NULL

,	NULL
and	NULL
LT.	NULL
Williams	NULL
.	NULL

1994	NULL
.	NULL

An	NULL
alternative	NULL
to	NULL
SH2	NULL
domains	NULL
for	NULL
binding	NULL
tyrosine	NULL
phosphorylated	NULL
proteins	NULL
.	NULL

Scene	NULL
.	NULL

266:1862-1865	NULL
.	NULL

Sudol	NULL
,	NULL
M.	NULL
,	NULL
H.I	NULL
.	NULL

Chen	NULL
,	NULL
C.	NULL
Bourgeret	NULL
,	NULL
A.	NULL
Einbond	NULL
,	NULL
and	NULL
P.	NULL
Bork	NULL
.	NULL

1995	NULL
.	NULL

Characterization	NULL
of	NULL
a	NULL
novel	NULL
protein-binding	NULL
module-the	NULL
WW	NULL
domain	NULL
.	NULL

FEBS	NULL
Let	NULL
.	NULL

369:67-71	NULL
.	NULL

Fanning	NULL
,	NULL
A.S.	NULL
,	NULL
and	NULL
J.M	NULL
.	NULL

Anderson	NULL
.	NULL

1996	NULL
.	NULL

Protein-protein	NULL
in-teractions	NULL
:	NULL
PDZ	NULL
domain-networks	NULL
.	NULL

Curr	NULL
:	NULL
Biol	NULL
6:1385-1388	NULL
.	NULL

Lowenstein	NULL
,	NULL
E.J	NULL
.	NULL

,	NULL
R	NULL
.J	NULL
.	NULL

Daly	NULL
,	NULL
A.G.	NULL
Batzer	NULL
,	NULL
W.	NULL
Li	NULL
,	NULL
B.	NULL
Margolis	NULL
,	NULL
R.	NULL
Lammers	NULL
,	NULL
A.	NULL
Ullrich	NULL
,	NULL
EY	NULL
.	NULL

Skolnik	NULL
,	NULL
D.	NULL
Bar-Sagi	NULL
,	NULL
and	NULL
J.	NULL
Schlessinger	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
SH2	NULL
and	NULL
SH3	NULL
domain-containing	NULL
protein	NULL
GR	NULL
B2	NULL
links	NULL
receptor	NULL
tyrosine	NULL
kinases	NULL
to	NULL
ras	NULL
signaling	NULL
.	NULL

Cell	NULL
.	NULL

70:431-442	NULL
.	NULL

Pelicci	NULL
,	NULL
G.	NULL
,	NULL
L.	NULL
Lanfrancone	NULL
,	NULL
F.	NULL
Grignani	NULL
,	NULL
J.	NULL
McGlade	NULL
,	NULL
F.	NULL
Ca-vallo	NULL
,	NULL
G.	NULL
Forni	NULL
,	NULL
I.	NULL
Nicoletti	NULL
,	NULL
F.	NULL
Grignani	NULL
,	NULL
T.	NULL
Pawson	NULL
,	NULL
and	NULL
P.G	NULL
.	NULL

Pelicci	NULL
.	NULL

1992	NULL
.	NULL

A	NULL
novel	NULL
transforming	NULL
protein	NULL
(	NULL
SHC	NULL
)	NULL
with	NULL
an	NULL
SH2	NULL
domain	NULL
is	NULL
implicated	NULL
in	NULL
mitogenic	NULL
signal	NULL
transduction	NULL
.	NULL

CÃ©al	NULL
.	NULL

70:93-104	NULL
.	NULL

1193	NULL
Marie-Cardine	NULL
et	NULL
al	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

Jackman	NULL
,	NULL
J.	NULL
,	NULL
D.	NULL
Motto	NULL
,	NULL
Q	NULL
.	NULL

Sun	NULL
,	NULL
M.	NULL
Tanemoto	NULL
,	NULL
C.	NULL
Turck	NULL
,	NULL
G.	NULL
Peltz	NULL
,	NULL
G.	NULL
Koretzky	NULL
,	NULL
and	NULL
P.	NULL
Findell	NULL
.	NULL

1995	NULL
.	NULL

Molecular	NULL
cloning	NULL
of	NULL
SLP-76	NULL
,	NULL
a	NULL
76	NULL
kDa	NULL
tyrosine	NULL
phosphoprotein	NULL
associated	NULL
with	NULL
Grb2	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

X	NULL
Biol	NULL
.	NULL

Chen	NULL
.	NULL

270:7029-7032.	NULL
da	NULL
Silva	NULL
,	NULL
A.J	NULL
.	NULL

,	NULL
Z.	NULL
Li	NULL
,	NULL
C.	NULL
de	NULL
Vera	NULL
,	NULL
E.	NULL
Canto	NULL
,	NULL
P.	NULL
Findell	NULL
,	NULL
and	NULL
C.E	NULL
.	NULL

Rudd	NULL
.	NULL

1997	NULL
.	NULL

Cloning	NULL
of	NULL
a	NULL
novel	NULL
T-cell	NULL
protein	NULL
FYB	NULL
that	NULL
binds	NULL
FYN	NULL
and	NULL
SH2-domain	NULL
containing	NULL
leukocyte	NULL
protein	NULL
76	NULL
and	NULL
modulates	NULL
interleukin	NULL
2	NULL
production	NULL
.	NULL

Proc	NULL
Nal	NULL
Aad	NULL
.	NULL

Sa	NULL
.	NULL

USA	NULL
.	NULL

94:7493-17498	NULL
.	NULL

Marie-Cardine	NULL
,	NULL
A.	NULL
,	NULL
E.	NULL
Bruyns	NULL
,	NULL
A.M.	NULL
Verhagen	NULL
,	NULL
C.	NULL
Eckerskorn	NULL
,	NULL
H.	NULL
Kirchgessner	NULL
,	NULL
S.C.	NULL
Meuer	NULL
,	NULL
and	NULL
B.	NULL
Schraven	NULL
.	NULL

1997	NULL
.	NULL

Molecular	NULL
cloning	NULL
of	NULL
SKAP55	NULL
,	NULL
a	NULL
novel	NULL
protein	NULL
that	NULL
associates	NULL
with	NULL
the	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
p59	NULL
%	NULL
Â®	NULL
in	NULL
human	NULL
T-lympho-cytes	NULL
.	NULL

J	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272:16077-16080	NULL
.	NULL

Musci	NULL
,	NULL
M.A	NULL
.	NULL

,	NULL
LR	NULL
.	NULL

Hendricks-Taylor	NULL
,	NULL
D.G	NULL
.	NULL

Motto	NULL
,	NULL
M.	NULL
Pas	NULL
kind	NULL
,	NULL
J.	NULL
Kamens	NULL
,	NULL
C.W	NULL
.	NULL

Turck	NULL
,	NULL
and	NULL
G.A	NULL
.	NULL

Koretzky	NULL
.	NULL

1997	NULL
.	NULL

Molecular	NULL
cloning	NULL
of	NULL
SLAP-130	NULL
,	NULL
a	NULL
SLP-76	NULL
associated	NULL
substrate	NULL
of	NULL
the	NULL
TCR	NULL
stimulated	NULL
protein	NULL
tyrosine	NULL
kinases	NULL
.	NULL

J.	NULL
Biol	NULL
Chem	NULL
.	NULL

272:11674-11677	NULL
.	NULL

Marie-Cardine	NULL
,	NULL
A.	NULL
,	NULL
A.	NULL
Verhagen	NULL
,	NULL
C.	NULL
Eckerskorn	NULL
,	NULL
and	NULL
B.	NULL
Schraven	NULL
.	NULL

1998	NULL
.	NULL

Cloning	NULL
of	NULL
SKAP-HOM	NULL
,	NULL
a	NULL
novel	NULL
protein	NULL
homologous	NULL
to	NULL
the	NULL
fyn-associated	NULL
protein	NULL
SKAP55	NULL
.	NULL

FEBS	NULL
Let	NULL
.	NULL

435:55-60	NULL
.	NULL

Bruyns	NULL
,	NULL
E.	NULL
,	NULL
A.	NULL
Marie-Cardine	NULL
,	NULL
H.	NULL
Kirchgessner	NULL
,	NULL
K.	NULL
Sagolla	NULL
,	NULL
A.	NULL
Shevchenko	NULL
,	NULL
M.	NULL
Mann	NULL
,	NULL
F.	NULL
Autschbach	NULL
,	NULL
A.	NULL
Bensussan	NULL
,	NULL
S.	NULL
Meuer	NULL
,	NULL
and	NULL
B.	NULL
Schraven	NULL
.	NULL

1998	NULL
.	NULL

T	NULL
cell	NULL
receptor	NULL
(	NULL
TCR	NULL
)	NULL
interacting	NULL
molecule	NULL
(	NULL
TRIM	NULL
)	NULL
,	NULL
a	NULL
novel	NULL
disulfide-linked	NULL
dimer	NULL
as	NULL
sociated	NULL
with	NULL
the	NULL
TCR-CD3-Â£	NULL
complex	NULL
,	NULL
recruits	NULL
intracellular	NULL
signalling	NULL
molecules	NULL
to	NULL
the	NULL
plasma	NULL
membrane	NULL
.	NULL

J	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

188:561-575	NULL
.	NULL

Weber	NULL
,	NULL
JR.	NULL
,	NULL
S.	NULL
Orstavik	NULL
,	NULL
K.M	NULL
.	NULL

Torgersen	NULL
,	NULL
N.C.	NULL
Danbolt	NULL
,	NULL
SF	NULL
.	NULL

Berg	NULL
,	NULL
JC	NULL
.	NULL

Ryan	NULL
,	NULL
K.	NULL
Tasken	NULL
,	NULL
J.B.	NULL
Imboden	NULL
,	NULL
and	NULL
JT	NULL
.	NULL

Vaage	NULL
.	NULL

1998	NULL
.	NULL

Molecular	NULL
cloning	NULL
of	NULL
the	NULL
cDNA	NULL
encoding	NULL
pp36	NULL
,	NULL
a	NULL
tyrosine-phosphorylated	NULL
adaptor	NULL
protein	NULL
selectively	NULL
expressed	NULL
by	NULL
T	NULL
cells	NULL
and	NULL
natural	NULL
killer	NULL
cells	NULL
.	NULL

J	NULL
Exp	NULL
.	NULL

Med	NULL
187	NULL
:	NULL
1157-1161	NULL
.	NULL

Zhang	NULL
,	NULL
W.	NULL
,	NULL
J.	NULL
Sloan-Lancaster	NULL
,	NULL
J	NULL
.	NULL

Kitchen	NULL
,	NULL
R.P	NULL
.	NULL

Trible	NULL
,	NULL
and	NULL
LE	NULL
.	NULL

Samelson	NULL
.	NULL

1998	NULL
.	NULL

LAT	NULL
:	NULL
the	NULL
ZAP-70	NULL
tyrosine	NULL
kinase	NULL
substrate	NULL
that	NULL
links	NULL
T	NULL
cell	NULL
receptor	NULL
to	NULL
cellular	NULL
activation	NULL
.	NULL

Cell	NULL
.	NULL

92	NULL
;	NULL
83-92	NULL
.	NULL

Mann	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
M.S	NULL
.	NULL

Wilm	NULL
.	NULL

1994	NULL
.	NULL

Error	NULL
tolerant	NULL
identification	NULL
of	NULL
peptides	NULL
in	NULL
sequence	NULL
databases	NULL
by	NULL
peptide	NULL
sequence	NULL
tags	NULL
.	NULL

Anal	NULL
.	NULL

Chem	NULL
.	NULL

66:4390-4399.	NULL
.	NULL

Wilm	NULL
,	NULL
M.	NULL
,	NULL
A.	NULL
Shevchenko	NULL
,	NULL
T.	NULL
Houthaeve	NULL
,	NULL
S.	NULL
Breit	NULL
,	NULL
L.	NULL
Schweigerer	NULL
,	NULL
T.	NULL
Fotsis	NULL
,	NULL
and	NULL
M.	NULL
Mann	NULL
.	NULL

1996	NULL
.	NULL

Femtomole	NULL
sequencing	NULL
of	NULL
proteins	NULL
form	NULL
polyacrylamide	NULL
gels	NULL
by	NULL
nano	NULL
elec-	NULL
25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36.	NULL
trospray	NULL
mass	NULL
spectrometry	NULL
.	NULL

Nature	NULL
.	NULL

379:466-469	NULL
.	NULL

Wilm	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
M.	NULL
Mann	NULL
.	NULL

1996	NULL
.	NULL

Analytical	NULL
properties	NULL
of	NULL
the	NULL
nano	NULL
electrospray	NULL
ion	NULL
source	NULL
.	NULL

Anal	NULL
.	NULL

Chem	NULL
.	NULL

66:1-8	NULL
.	NULL

Shevchenko	NULL
,	NULL
A.	NULL
,	NULL
M.	NULL
Wilm	NULL
,	NULL
O.	NULL
Vorm	NULL
,	NULL
and	NULL
M.	NULL
Mann	NULL
.	NULL

1996	NULL
.	NULL

Mass	NULL
spectrometry	NULL
sequencing	NULL
of	NULL
proteins	NULL
from	NULL
silver	NULL
stained	NULL
polyacrylamide	NULL
gels	NULL
.	NULL

Anal	NULL
.	NULL

Chen	NULL
.	NULL

68:850-858	NULL
.	NULL

Goldsmith	NULL
,	NULL
M.A	NULL
.	NULL

,	NULL
D.M	NULL
.	NULL

Desai	NULL
,	NULL
T.	NULL
Schultz	NULL
,	NULL
and	NULL
A.	NULL
Weiss	NULL
.	NULL

1989	NULL
.	NULL

Function	NULL
of	NULL
a	NULL
heterologous	NULL
muscarinic	NULL
receptor	NULL
in	NULL
T-cell	NULL
antigen	NULL
receptor	NULL
signal	NULL
transduction	NULL
mutants	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
.	NULL

264:17190-17197	NULL
.	NULL

Koretzky	NULL
,	NULL
G.A	NULL
.	NULL

,	NULL
J.	NULL
Picus	NULL
,	NULL
M.L	NULL
.	NULL

Thomas	NULL
,	NULL
and	NULL
A.	NULL
Weiss	NULL
.	NULL

1990	NULL
.	NULL

Tyrosine	NULL
phosphatase	NULL
CD45	NULL
is	NULL
essential	NULL
for	NULL
coupling	NULL
T-cell	NULL
antigen	NULL
receptor	NULL
to	NULL
the	NULL
phosphatidyl	NULL
inositol	NULL
pathway	NULL
.	NULL

Nature	NULL
346:66-68	NULL
.	NULL

Desai	NULL
,	NULL
D.V	NULL
.	NULL

,	NULL
M.E	NULL
.	NULL

Newton	NULL
,	NULL
T.	NULL
Kadlecek	NULL
,	NULL
and	NULL
A.	NULL
Weiss	NULL
.	NULL

1990	NULL
.	NULL

Stimulation	NULL
of	NULL
the	NULL
phosphatidyl-inositol	NULL
pathway	NULL
can	NULL
induce	NULL
T-cell	NULL
activation	NULL
.	NULL

Natwre	NULL
.	NULL

348:66-69	NULL
.	NULL

Qian	NULL
,	NULL
D.	NULL
,	NULL
M.N	NULL
.	NULL

Mollenhauer	NULL
,	NULL
and	NULL
A.	NULL
Weiss	NULL
1996	NULL
.	NULL

Domi-nant-negative	NULL
zeta-associated	NULL
protein	NULL
70	NULL
inhibits	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
signaling	NULL
.	NULL

J	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

183:611-620	NULL
.	NULL

Schraven	NULL
,	NULL
B.	NULL
,	NULL
D.	NULL
Schoenhaut	NULL
,	NULL
E.	NULL
Bruyns	NULL
,	NULL
G.	NULL
Koretzky	NULL
,	NULL
C.	NULL
Eckerskorn	NULL
,	NULL
R.	NULL
Wallich	NULL
,	NULL
H.	NULL
Kirchgessner	NULL
,	NULL
P.	NULL
Sakorafas	NULL
,	NULL
B.	NULL
Labkovsky	NULL
,	NULL
S.	NULL
Ratnofsky	NULL
,	NULL
and	NULL
S.	NULL
Meuer	NULL
.	NULL

1994	NULL
.	NULL

LPAP	NULL
,	NULL
a	NULL
novel	NULL
32-kDa	NULL
phosphoprotein	NULL
that	NULL
interacts	NULL
with	NULL
CD45	NULL
in	NULL
human	NULL
lymphocytes	NULL
.	NULL

J	NULL
Biol	NULL
.	NULL

Chen	NULL
.	NULL

269:29102-29111	NULL
.	NULL

Marie-Cardine	NULL
,	NULL
A.	NULL
,	NULL
H.	NULL
Kirchgessner	NULL
,	NULL
C.	NULL
Eckerskorn	NULL
,	NULL
S.C.	NULL
Meuer	NULL
,	NULL
and	NULL
B.	NULL
Schraven	NULL
.	NULL

1995	NULL
.	NULL

Human	NULL
T	NULL
lymphocyte	NULL
activation	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Â«	NULL
-tubulin	NULL
and	NULL
its	NULL
association	NULL
with	NULL
the	NULL
SH2	NULL
domain	NULL
of	NULL
the	NULL
p59	NULL
%	NULL
``	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
.	NULL

Eur	NULL
.	NULL

J	NULL
Immunol	NULL
.	NULL

25:3290-3297	NULL
.	NULL

Schraven	NULL
,	NULL
B.	NULL
,	NULL
S.	NULL
Ratnofsky	NULL
,	NULL
Y.	NULL
Gaumont	NULL
,	NULL
H.	NULL
Lindegger	NULL
,	NULL
H.	NULL
Kirchgessner	NULL
,	NULL
E.	NULL
Bruyns	NULL
U.	NULL
Moebius	NULL
,	NULL
and	NULL
S.C.	NULL
Meuer	NULL
.	NULL

1994	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
novel	NULL
dimeric	NULL
phosphoprotein	NULL
(	NULL
pp29/	NULL
30	NULL
)	NULL
associated	NULL
with	NULL
signaling	NULL
receptors	NULL
in	NULL
human	NULL
T	NULL
lymphocytes	NULL
and	NULL
natural	NULL
killer	NULL
cells	NULL
.	NULL

J	NULL
Exp	NULL
.	NULL

Med	NULL
180:897-906	NULL
.	NULL

Schraven	NULL
,	NULL
B.	NULL
,	NULL
A.	NULL
Schirren	NULL
,	NULL
H.	NULL
Kirchgessner	NULL
,	NULL
B.	NULL
Siebert	NULL
,	NULL
and	NULL
S.C.	NULL
Meuer	NULL
.	NULL

1992	NULL
.	NULL

Four	NULL
â¬CD45/	NULL
p56lck	NULL
associated	NULL
phospho-proteins	NULL
(	NULL
pp29-pp32	NULL
)	NULL
undergo	NULL
alterations	NULL
in	NULL
human	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

Eur	NULL
J	NULL
Immunol	NULL
.	NULL

22:1857-1863	NULL
.	NULL

Daeron	NULL
,	NULL
M.	NULL
,	NULL
S.	NULL
Latour	NULL
,	NULL
O.	NULL
Malbec	NULL
,	NULL
E.	NULL
Espinosa	NULL
,	NULL
P.	NULL
Pina	NULL
,	NULL
and	NULL
W.H	NULL
.	NULL

Fridman	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
same	NULL
tyrosine-based	NULL
inhibition	NULL
motif	NULL
,	NULL
in	NULL
the	NULL
intracytoplasmic	NULL
domain	NULL
of	NULL
FeyR	NULL
IIB	NULL
,	NULL
regulates	NULL
negatively	NULL
BCR	NULL
-	NULL
TCR	NULL
-	NULL
,	NULL
and	NULL
FcR	NULL
-dependent	NULL
cell	NULL
activation	NULL
.	NULL

Immunity	NULL
.	NULL

3:635-646	NULL
.	NULL

Vivier	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
M.	NULL
Daeron	NULL
.	NULL

1997	NULL
.	NULL

Immunoreceptor	NULL
tyrosine	NULL
1194	NULL
37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47.	NULL
based	NULL
inhibition	NULL
motifs	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
.	NULL

18:286-291	NULL
.	NULL

Lemmon	NULL
,	NULL
M.A	NULL
.	NULL

,	NULL
H.R	NULL
.	NULL

Treutlein	NULL
,	NULL
P.D	NULL
.	NULL

Adams	NULL
,	NULL
A.T	NULL
.	NULL

Briinger	NULL
,	NULL
and	NULL
D.M	NULL
.	NULL

Engelmann	NULL
.	NULL

1994	NULL
.	NULL

A	NULL
dimerization	NULL
motif	NULL
for	NULL
transmembrane	NULL
a-helices	NULL
.	NULL

Stud	NULL
.	NULL

Biol	NULL
.	NULL

1:157-163	NULL
.	NULL

Northrop	NULL
,	NULL
JP	NULL
.	NULL

,	NULL
K.S	NULL
.	NULL

Ullmann	NULL
,	NULL
and	NULL
G.R	NULL
.	NULL

Crabtree	NULL
.	NULL

1993	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
nuclear	NULL
and	NULL
cytoplasmic	NULL
components	NULL
of	NULL
the	NULL
lymphoid-specific	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
NF-AT	NULL
)	NULL
complex	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
.	NULL

268:2917-2923	NULL
.	NULL

D'Ambrosio	NULL
,	NULL
D.	NULL
,	NULL
KL	NULL
.	NULL

Hippen	NULL
,	NULL
S.A.	NULL
Minskoff	NULL
,	NULL
I.	NULL
Mellmann	NULL
,	NULL
G.	NULL
Pani	NULL
,	NULL
K.A	NULL
.	NULL

Siminovitch	NULL
,	NULL
and	NULL
J.C.	NULL
Cambier	NULL
.	NULL

1995	NULL
.	NULL

Recruitment	NULL
and	NULL
activation	NULL
of	NULL
PTP1C	NULL
in	NULL
negative	NULL
regulation	NULL
of	NULL
antigen	NULL
receptor	NULL
signaling	NULL
by	NULL
FeyRIIB1	NULL
.	NULL

Sagene	NULL
268:293-297	NULL
.	NULL

Marengere	NULL
,	NULL
LE.M	NULL
.	NULL

,	NULL
P.	NULL
Waterhouse	NULL
,	NULL
G.S	NULL
.	NULL

Duncan	NULL
,	NULL
H.-W.	NULL
Mittriicker	NULL
,	NULL
G.-S.	NULL
Feng	NULL
,	NULL
and	NULL
T.W	NULL
.	NULL

Mak	NULL
.	NULL

1966	NULL
.	NULL

Regulation	NULL
of	NULL
T	NULL
cell	NULL
receptor	NULL
signaling	NULL
by	NULL
tyrosine	NULL
phosphatase	NULL
SYP	NULL
association	NULL
with	NULL
CTLA-4	NULL
.	NULL

Sdene	NULL
.	NULL

272:1170-1173	NULL
.	NULL

Campbell	NULL
,	NULL
K.S	NULL
.	NULL

,	NULL
M.	NULL
Dessing	NULL
,	NULL
M.	NULL
Lopez-Botet	NULL
,	NULL
M.	NULL
Cella	NULL
,	NULL
and	NULL
M.	NULL
Colonna	NULL
.	NULL

1996	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
of	NULL
human	NULL
killer	NULL
inhibitory	NULL
receptor	NULL
recruits	NULL
protein	NULL
tyrosine	NULL
phos	NULL
phatase	NULL
1C	NULL
.	NULL

J	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

184:93-100	NULL
.	NULL

Lorenz	NULL
,	NULL
U.	NULL
,	NULL
K.S	NULL
.	NULL

Ravichandran	NULL
,	NULL
S.J	NULL
.	NULL

Burakoff	NULL
,	NULL
and	NULL
B.G	NULL
.	NULL

Neel	NULL
.	NULL

1996	NULL
.	NULL

Lack	NULL
of	NULL
SHPTP1	NULL
results	NULL
in	NULL
sec-	NULL
family	NULL
hyperacti-vation	NULL
and	NULL
thymocyte	NULL
hyperresponsiveness	NULL
.	NULL

Proc	NULL
Nal	NULL
.	NULL

Aar	NULL
.	NULL

Sa	NULL
.	NULL

USA	NULL
.	NULL

93:9624-9629	NULL
.	NULL

Ono	NULL
,	NULL
M.	NULL
,	NULL
S.	NULL
Bolland	NULL
,	NULL
P.	NULL
Tempst	NULL
,	NULL
and	NULL
J.V	NULL
.	NULL

Ravetch	NULL
.	NULL

1996	NULL
.	NULL

R	NULL
ole	NULL
of	NULL
the	NULL
inositol	NULL
phosphatase	NULL
SHIP	NULL
in	NULL
negative	NULL
regulation	NULL
of	NULL
the	NULL
immune	NULL
system	NULL
by	NULL
the	NULL
receptor	NULL
FoyR	NULL
IIB	NULL
.	NULL

Nature	NULL
383	NULL
:	NULL
263-266.	NULL
.	NULL

Plas	NULL
,	NULL
D.R	NULL
.	NULL

,	NULL
R.	NULL
Johnson	NULL
,	NULL
J.T	NULL
.	NULL

Pingel	NULL
,	NULL
R.J.	NULL
Matthews	NULL
,	NULL
M.	NULL
Dal-	NULL
ton	NULL
,	NULL
G.	NULL
Roy	NULL
,	NULL
A.	NULL
Chan	NULL
,	NULL
and	NULL
M.L	NULL
.	NULL

Thomas	NULL
.	NULL

1996	NULL
.	NULL

Direct	NULL
regulation	NULL
of	NULL
ZAP-70	NULL
by	NULL
SHP-1	NULL
in	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
signaling	NULL
.	NULL

Sdene	NULL
.	NULL

272:1173-1176	NULL
.	NULL

Maeda	NULL
,	NULL
A.	NULL
,	NULL
M.	NULL
Kurosaki	NULL
,	NULL
M.	NULL
Ono	NULL
,	NULL
T.	NULL
Takai	NULL
,	NULL
and	NULL
T.	NULL
Kuro-saki	NULL
.	NULL

1998	NULL
.	NULL

R	NULL
equirement	NULL
of	NULL
SH2-containing	NULL
protein	NULL
tyrosine	NULL
phosphatases	NULL
SHP-1	NULL
and	NULL
SHP-2	NULL
for	NULL
paired	NULL
immunoglobulin-like	NULL
receptor	NULL
B	NULL
(	NULL
PIR	NULL
-B	NULL
)	NULL
-mediated	NULL
inhibitory	NULL
signal	NULL
.	NULL

J	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

187:1355-1360	NULL
.	NULL

Hof	NULL
,	NULL
P.	NULL
,	NULL
S.	NULL
Pluskey	NULL
,	NULL
S.	NULL
Dhe-Paganon	NULL
,	NULL
M.J.	NULL
Eck	NULL
,	NULL
and	NULL
S.E	NULL
.	NULL

Shoelson	NULL
.	NULL

1998	NULL
.	NULL

Crystal	NULL
structure	NULL
of	NULL
the	NULL
tyrosine	NULL
phosphatase	NULL
SHP-2	NULL
.	NULL

Cell	NULL
.	NULL

92:441-450	NULL
.	NULL

Shevchenko	NULL
,	NULL
A.	NULL
,	NULL
I.	NULL
Chernushevich	NULL
,	NULL
K.G	NULL
.	NULL

Standing	NULL
,	NULL
B.	NULL
Thomp-son	NULL
,	NULL
M.	NULL
Wilm	NULL
,	NULL
and	NULL
M.	NULL
Mann	NULL
.	NULL

1997	NULL
.	NULL

R	NULL
apid	NULL
'de	NULL
novo	NULL
``	NULL
peptide	NULL
sequencing	NULL
by	NULL
a	NULL
combination	NULL
of	NULL
nanoelectrospray	NULL
,	NULL
isotopic	NULL
labelling	NULL
and	NULL
a	NULL
quadrupole/	NULL
time-of-flight	NULL
mass	NULL
spectrometer	NULL
.	NULL

Rapid	NULL
Commun	NULL
.	NULL

Mass	NULL
Spectrom	NULL
.	NULL

11:1015-1024	NULL
.	NULL

The	NULL
interacting	NULL
Transmembrane	NULL
Adaptor	NULL
Protein	NULL
SIT	NULL

